<SEC-DOCUMENT>0001213900-26-048135.txt : 20260428
<SEC-HEADER>0001213900-26-048135.hdr.sgml : 20260428
<ACCEPTANCE-DATETIME>20260427183116
ACCESSION NUMBER:		0001213900-26-048135
CONFORMED SUBMISSION TYPE:	10-K/A
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20251231
FILED AS OF DATE:		20260428
DATE AS OF CHANGE:		20260427

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Corvex, Inc.
		CENTRAL INDEX KEY:			0001734750
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMPUTER PROCESSING & DATA PREPARATION [7374]
		ORGANIZATION NAME:           	06 Technology
		EIN:				824233771
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40254
		FILM NUMBER:		26902602

	BUSINESS ADDRESS:	
		STREET 1:		3401 NORTH FAIRFAX DRIVE
		CITY:			ARLINGTON
		STATE:			VA
		ZIP:			22226
		BUSINESS PHONE:		866-438-4787

	MAIL ADDRESS:	
		STREET 1:		3401 NORTH FAIRFAX DRIVE
		CITY:			ARLINGTON
		STATE:			VA
		ZIP:			22226

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Movano Inc.
		DATE OF NAME CHANGE:	20190402

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Maestro Sensors Inc.
		DATE OF NAME CHANGE:	20180315
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K/A
<SEQUENCE>1
<FILENAME>ea0287600-10ka1_corvex.htm
<DESCRIPTION>AMENDMENT NO. 1 TO FORM 10-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- Generated by Broadridge Transform (tm) - http://www.broadridge.com -->
<!-- Created: Mon Apr 27 21:52:02 UTC 2026 -->
<html xmlns:compsci="http://compsciresources.com" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:ecd="http://xbrl.sec.gov/ecd/2025" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:move="http://www.movano.com/20251231" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:us-types="http://fasb.org/us-types/2025" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.w3.org/1999/xhtml">
<head>
     <title> </title>

<meta content="text/html" http-equiv="Content-Type"/>
</head>
<body><div style="font: 10pt Times New Roman, Times, Serif"><div>

</div><p style="margin: 0"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>WASHINGTON, D.C. 20549</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <ix:nonNumeric contextRef="c0" name="dei:DocumentType" id="ixv-4459">10-K/A</ix:nonNumeric></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Amendment No. 1</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Mark One)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><ix:nonNumeric contextRef="c0" format="ixt-sec:boolballotbox" name="dei:DocumentAnnualReport" id="ixv-4460">&#9746;</ix:nonNumeric> ANNUAL REPORT PURSUANT TO SECTION 13 OR
15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">For the Fiscal Year Ended <ix:nonNumeric contextRef="c0" format="ixt:date-monthname-day-year-en" name="dei:DocumentPeriodEndDate" id="ixv-4461"><ix:nonNumeric contextRef="c0" format="ixt:date-monthname-day-en" name="dei:CurrentFiscalYearEndDate" id="ixv-4462">December 31</ix:nonNumeric>, <ix:nonNumeric contextRef="c0" name="dei:DocumentFiscalYearFocus" id="ixv-4463">2025</ix:nonNumeric></ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><ix:nonNumeric contextRef="c0" format="ixt-sec:boolballotbox" name="dei:DocumentTransitionReport" id="ixv-4464">&#9744;</ix:nonNumeric> TRANSITION REPORT PURSUANT TO SECTION 13
OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">For the transition period from _________ to _________</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Commission file number: <ix:nonNumeric contextRef="c0" name="dei:EntityFileNumber" id="ixv-53"><span style="text-decoration:underline">001-40254</span></ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><ix:nonNumeric contextRef="c0" name="dei:EntityRegistrantName" id="ixv-59"><b>CORVEX, INC.</b></ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>(Exact name of registrant as specified in its
charter)</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td style="width: 49%; border-bottom: black 1.5pt solid; text-align: center"><ix:nonNumeric contextRef="c0" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="ixv-70"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Delaware</b></span></ix:nonNumeric></td> <td style="width: 2%; text-align: center">&#160;</td> <td style="width: 49%; border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><ix:nonNumeric contextRef="c0" name="dei:EntityTaxIdentificationNumber" id="ixv-4465">82-4233771</ix:nonNumeric> </b></span></td></tr> <tr style="vertical-align: top"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(State of incorporation)</i></span></td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(I.R.S. Employer Identification No.)</i></span></td></tr> </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><ix:nonNumeric contextRef="c0" name="dei:EntityAddressAddressLine1" id="ixv-4466">3401 North Fairfax Drive</ix:nonNumeric>,&#160;<ix:nonNumeric contextRef="c0" name="dei:EntityAddressAddressLine2" id="ixv-4467">Suite 3230</ix:nonNumeric>,&#160;<ix:nonNumeric contextRef="c0" name="dei:EntityAddressCityOrTown" id="ixv-4468">Arlington</ix:nonNumeric>,&#160;<ix:nonNumeric contextRef="c0" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="ixv-4469">Virginia</ix:nonNumeric>&#160;<ix:nonNumeric contextRef="c0" name="dei:EntityAddressPostalZipCode" id="ixv-4470">22226</ix:nonNumeric></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>(Address of principal executive office) (Zip
code)</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(866) GET-GPUS (<ix:nonNumeric contextRef="c0" name="dei:CityAreaCode" id="ixv-4471">(866)</ix:nonNumeric>&#160;<ix:nonNumeric contextRef="c0" name="dei:LocalPhoneNumber" id="ixv-4472">438-4787</ix:nonNumeric>)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>(Registrant&#8217;s telephone number, including
area code)</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Securities registered pursuant to Section 12(b)
of the Act:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr> <td style="vertical-align: bottom; width: 32%; border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title of each class</span></td> <td style="vertical-align: top; width: 2%; text-align: center">&#160;</td> <td style="vertical-align: bottom; width: 32%; border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trading Symbol(s)</span></td> <td style="vertical-align: top; width: 2%; text-align: center">&#160;</td> <td style="vertical-align: bottom; width: 32%; border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name of each exchange on which registered</span></td></tr> <tr style="vertical-align: top; background-color: #CCEEFF"> <td style="text-align: center"><ix:nonNumeric contextRef="c0" name="dei:Security12bTitle" id="ixv-120"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common Stock, par value $0.0001 per share</span></ix:nonNumeric></td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><ix:nonNumeric contextRef="c0" name="dei:TradingSymbol" id="ixv-124"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MOVE</span></ix:nonNumeric></td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The <ix:nonNumeric contextRef="c0" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="ixv-4473">Nasdaq</ix:nonNumeric> Stock Market LLC</span></td></tr> </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Indicate by check mark if
the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes&#160;&#9744;&#160;&#160;&#160;<ix:nonNumeric contextRef="c0" name="dei:EntityWellKnownSeasonedIssuer" id="ixv-4474">No</ix:nonNumeric>&#160;&#9746;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Indicate by check mark if
the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes&#160;&#9744;&#160;&#160;&#160;<ix:nonNumeric contextRef="c0" name="dei:EntityVoluntaryFilers" id="ixv-4475">No</ix:nonNumeric>&#160;&#9746;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Indicate by check mark whether
the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the
preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days.&#160;<ix:nonNumeric contextRef="c0" name="dei:EntityCurrentReportingStatus" id="ixv-4476">Yes</ix:nonNumeric>&#160;&#9746;&#160;&#160;&#160;No &#9744;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Indicate by check mark whether
the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T
(&#167; 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit
such files).&#160;<ix:nonNumeric contextRef="c0" name="dei:EntityInteractiveDataCurrent" id="ixv-4477">Yes</ix:nonNumeric>&#160;&#9746;&#160;&#160;&#160;No &#9744;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Indicate by check mark whether
the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging
growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting
company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0.5in">&#160;</td> <td style="white-space: nowrap; width: 2in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Large accelerated filer</span></td> <td style="white-space: nowrap; width: 1.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td> <td style="white-space: nowrap; width: 2in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accelerated filer</span></td> <td style="white-space: nowrap; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td></tr> <tr style="vertical-align: top"> <td>&#160;</td> <td style="white-space: nowrap; text-align: justify"><ix:nonNumeric contextRef="c0" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="ixv-166"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-accelerated filer</span></ix:nonNumeric></td> <td style="white-space: nowrap; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</span></td> <td style="white-space: nowrap; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Smaller reporting company</span></td> <td style="white-space: nowrap; text-align: justify"><ix:nonNumeric contextRef="c0" format="ixt-sec:boolballotbox" name="dei:EntitySmallBusiness" id="ixv-173"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</span></ix:nonNumeric></td></tr> <tr style="vertical-align: top"> <td>&#160;</td> <td style="white-space: nowrap; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging growth company</span></td> <td style="white-space: nowrap; text-align: justify"><ix:nonNumeric contextRef="c0" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="ixv-180"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</span></ix:nonNumeric></td> <td style="white-space: nowrap; text-align: justify">&#160;</td> <td style="white-space: nowrap; text-align: justify">&#160;</td></tr> </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If an&#160;emerging growth&#160;company,
indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;<ix:nonNumeric contextRef="c0" format="ixt-sec:boolballotbox" name="dei:EntityExTransitionPeriod" id="ixv-4478">&#9744;</ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Indicate by check mark whether
the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control
over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C.7262(b)) by the registered public accounting firm that
prepared or issued its audit report.&#160;<ix:nonNumeric contextRef="c0" format="ixt-sec:boolballotbox" name="dei:IcfrAuditorAttestationFlag" id="ixv-4479">&#9744;</ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If securities are registered
pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing
reflect the correction of an error to previously issued financial statements.&#160;<ix:nonNumeric contextRef="c0" format="ixt-sec:boolballotbox" name="dei:DocumentFinStmtErrorCorrectionFlag" id="ixv-4480">&#9744;</ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Indicate by check mark whether
any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the
registrant&#8217;s executive officers during the relevant recovery period pursuant to &#167;240.10D-1(b). &#9744;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Indicate by check mark whether
the registrant is a shell company (as defined in Rule 12b-2 of the Act):&#160;Yes&#160;&#9744;&#160;&#160;&#160;No&#160;<ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:EntityShellCompany" id="ixv-4481">&#9746;</ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">State the aggregate market
value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity
was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant&#8217;s most recently
completed second fiscal quarter. $<ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="dei:EntityPublicFloat" scale="0" unitRef="usd" id="ixv-4482">5,309,169</ix:nonFraction>.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of April 20, 2026, there
were (i)&#160;<ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" unitRef="shares" id="ixv-4483">1,981,462</ix:nonFraction>&#160;shares of the registrant&#8217;s common stock outstanding, (ii) 2,804 shares of the registrant&#8217;s Series
A Preferred Stock outstanding, (iii) 23,551.5195 shares of the registrant&#8217;s Series C Non-Voting Convertible Preferred Stock outstanding
and (iv) 30,227.0524 shares of the registrant&#8217;s Series D Non-Voting Convertible Preferred Stock outstanding.&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>DOCUMENTS INCORPORATED BY REFERENCE</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><ix:nonNumeric contextRef="c0" escape="true" name="dei:DocumentsIncorporatedByReferenceTextBlock" id="ixv-4484">None</ix:nonNumeric>.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin: 0pt"></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>EXPLANATORY NOTE</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_AmendmentDescription-c0_cont_1" name="dei:AmendmentDescription" id="ixv-248"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This Amendment No. 1 on Form 10-K/A (this &#8220;Amendment
No. 1&#8221;) amends Corvex, Inc.&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 2025 (the &#8220;2025 Annual
Report&#8221;), originally filed with the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) on March 31, 2026. As used in
this Amendment No. 1, unless otherwise stated or the context otherwise requires, the terms &#8220;Corvex,&#8221; &#8220;we,&#8221; &#8220;us,&#8221;
&#8220;our&#8221; and the &#8220;Company&#8221; refer to Corvex, Inc. and its wholly-owned subsidiaries.</p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><ix:continuation continuedAt="_AmendmentDescription-c0_cont_2" id="_AmendmentDescription-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are filing this Amendment No. 1 pursuant to
General Instruction G(3) of Form 10-K, as we do not intend to file a definitive proxy statement for the 2026 annual meeting of stockholders
(the &#8220;Annual Meeting&#8221;) within 120 days of the end of our fiscal year ended December 31, 2025. Accordingly, this Amendment
is being filed solely to:</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><ix:continuation continuedAt="_AmendmentDescription-c0_cont_3" id="_AmendmentDescription-c0_cont_2"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">amend and restate Part III, Items 10 (Directors, Executive Officers and Corporate Governance), 11 (Executive Compensation), 12 (Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters), 13 (Certain Relationships and Related Transactions, and Director Independence) and 14 (Principal Accountant Fees and Services) of the 2025 Annual Report, in their entirety as set forth herein;</span></td></tr>
  </table></ix:continuation><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><ix:continuation continuedAt="_AmendmentDescription-c0_cont_4" id="_AmendmentDescription-c0_cont_3"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">amend the reference on the cover page of our 2025 Annual Report to reflect that no documents will be incorporated by reference into our 2025 Annual Report; and</span></td></tr>
  </table></ix:continuation><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><ix:continuation continuedAt="_AmendmentDescription-c0_cont_5" id="_AmendmentDescription-c0_cont_4"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">file new certifications of our principal executive officer and principal financial officer pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934, as amended, a copy of the Company&#8217;s 2024 Equity Incentive Plan, and a new description of our common stock as exhibits to this Amendment No. 1 under Item 15 of Part IV hereof.</span></td></tr>
  </table></ix:continuation><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><ix:continuation continuedAt="_AmendmentDescription-c0_cont_6" id="_AmendmentDescription-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Because no financial statements have been included
in this Amendment No. 1, and because this Amendment No. 1 does not contain or amend any disclosure with respect to paragraphs 3, 4 and
5 of Items 307 and 308 of Regulation S-K, the corresponding certifications have been omitted. We are not including the certifications
under Section 906 of the Sarbanes-Oxley Act of 2002 as no financial statements are being filed with this Amendment No. 1.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><ix:continuation id="_AmendmentDescription-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Except as set forth above, no other Items of our
2025 Annual Report have been amended or revised in this Amendment No. 1, and all such other Items shall be as set forth in such 2025 Annual
Report. Accordingly, this Amendment No. 1 should be read in conjunction with the 2025 Annual Report and our other filings with the SEC.
Certain capitalized terms used and not otherwise defined in this Amendment No. 1 have the meanings given to them in the 2025 Annual Report.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin: 0pt">&#160;</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CORVEX, INC.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>TABLE OF CONTENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="background-color: #CCEEFF">
    <td colspan="2" style="vertical-align: top"><a href="#a_001"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PART III</span></a></td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
  <tr style="background-color: white">
    <td style="vertical-align: top; width: 10%; padding-left: 0.25in; text-align: justify"><a href="#a_002"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item&#160;10.
    </span></a></td>
    <td style="vertical-align: top; width: 80%; padding-left: 9pt; text-indent: -9pt; text-align: justify"><a href="#a_002"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Directors,
    Executive Officers and Corporate Governance.</span></a></td>
    <td style="vertical-align: bottom; width: 10%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; padding-left: 0.25in; text-align: justify"><a href="#a_003"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    11. </span></a></td>
    <td style="vertical-align: top; padding-left: 9pt; text-indent: -9pt; text-align: justify"><a href="#a_003"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive
    Compensation</span></a></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td></tr>
  <tr style="background-color: white">
    <td style="vertical-align: top; padding-left: 0.25in; text-align: justify"><a href="#a_004"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item&#160;12.
    </span></a></td>
    <td style="vertical-align: top; padding-left: 9pt; text-indent: -9pt; text-align: justify"><a href="#a_004"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Security
    Ownership of Certain Beneficial Owners and Management and Related Stockholders Matters.</span></a></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</span></td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; padding-left: 0.25in; text-align: justify"><a href="#a_005"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    13. </span></a></td>
    <td style="vertical-align: top; padding-left: 9pt; text-indent: -9pt; text-align: justify"><a href="#a_005"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
    Relationships and Related Transactions, and Director Independence</span></a></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</span></td></tr>
  <tr style="background-color: white">
    <td style="vertical-align: top; padding-left: 0.25in; text-align: justify"><a href="#a_006"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item&#160;14.
    </span></a></td>
    <td style="vertical-align: top; padding-left: 9pt; text-indent: -9pt; text-align: justify"><a href="#a_006"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal
    Accountant Fees and Services</span></a></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13</span></td></tr>
  <tr style="background-color: #CCEEFF">
    <td colspan="2" style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
  <tr style="background-color: white">
    <td colspan="2" style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_007">PART IV</a></span></td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; padding-left: 0.25in; text-align: justify"><a href="#a_008"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item&#160;15.
    </span></a></td>
    <td style="vertical-align: top; padding-left: 9pt; text-indent: -9pt; text-align: justify"><a href="#a_008"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibits,
    Financial Statements and Schedules</span></a></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 3; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><div><a id="a_001"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PART III</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><div><a id="a_002"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item&#160;10. Directors, Executive Officers
and Corporate Governance.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>INFORMATION CONCERNING DIRECTORS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: bottom; background-color: white">
    <td style="width: 39%; border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nominee&#8217;s or Director&#8217;s Name</b></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 18%; border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year First <br/>
Became Director</b></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 41%; border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Position with the Company</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">John Mastrototaro</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2020</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Operating Officer and Director</span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emily Wang Fairbairn</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2018</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director and Chair of the Board</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rub&#233;n Caballero</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2019</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brian Cullinan</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2020</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Seth Demsey</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2026</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Set forth below is background information for
each current director, as well as information regarding additional experience, qualifications, attributes or skills that led the Company&#8217;s
Board of Directors (the &#8220;Board) to conclude that such director should serve on the Board.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>John Mastrototaro, Ph.D., </b>age 65, has served
as Chief Operating Officer of the Company since March 30, 2026. Previously, Mr. Mastrototaro served as President and CEO from April 2021
to March 30, 2026. Mr. Mastrototaro has over 30 years of experience in the medical device industry, leading innovation and bringing new
products to the market. Mr. Mastrototaro served as the Chief Operating Officer of Orthosensor, Inc. from 2017 to March 2021. Previously,
Mr. Mastrototaro spent the majority of his career with Medtronic, PLC. and MiniMed, Inc., where he was instrumental in initiating and
leading a series of firsts in the world of diabetes, including the ambulatory continuous glucose monitoring system, the sensor augmented
insulin pump and the early generations of the artificial pancreas. Prior to joining Orthosensor, Mr. Mastrototaro was Medtronic&#8217;s
first VP of Informatics from 2013 to 2017, a role in which he helped develop a corporate strategy for the use of data and analytics to
improve healthcare delivery. During his tenure in Medtronic&#8217;s Diabetes division, Mr. Mastrototaro held a number of positions, including
CTO, VP of R&amp;D and Business Development and Global VP of Clinical Research and Health Affairs. Mr. Mastrototaro started his career
with Eli Lilly. He holds a B.A. in Mathematics and Physics from Holy Cross College and M.S. and Ph.D. in Biomedical Engineering from Duke
University. Mr. Mastrototaro has authored over 50 peer reviewed manuscripts and holds over 60 US patents. We believe Mr. Mastrototaro
is qualified to serve on the Board based on his background, experience, qualifications, attributes and skills, and that his significant
knowledge of, and breadth of experience in, the medical device industry in general and diabetes monitoring and care in particular, provides
valuable insight to our Board.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Emily Wang Fairbairn,</b> age 64, has served
as a director of the Company and as Chair of the Board since 2018. Ms. Fairbairn brings more than 40 years of experience in institutional
asset management, capital markets, and operations. She is the co-founder and served as Chief Executive Officer of Ascend Capital, a multi-billion-dollar
institutional hedge fund specializing in long/short equity strategies for global pension funds, endowments, and public entities, a position
she held for approximately two decades. Prior to founding Ascend Capital, Ms. Fairbairn managed equity portfolios for high-net-worth clients
at Merrill Lynch, and earlier in her career served as a process engineer and production supervisor at Frito-Lay, a subsidiary of PepsiCo,
where she gained experience in manufacturing operations, large-scale capital projects, and workforce management. Ms. Fairbairn has served
as an Independent Director of IN8bio, Inc., a clinical-stage biopharmaceutical company focused on &#947;&#948; T cell therapies for
the treatment of cancer, since 2021, and has served as a Funding Board Member of the MIT Sandbox Innovation Fund, which supports early-stage
technology ventures, since 2017. She also serves as a Board Advisor to Acelab Inc., an AI-driven materials platform serving the architecture
and design industry. Ms. Fairbairn holds a B.S. in Chemical Engineering from California State Polytechnic University, Pomona. We believe
Ms. Fairbairn is qualified to serve on the Board based on her background, experience, qualifications, attributes and skills, including
her background in investment and finance matters, and extensive executive leadership and management experience.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 4; Options: NewSection; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Rub&#233;n Caballero, </b>age 58, has served
as a director of the Company since November 2019. Since June 2024, Mr. Caballero has served as Chief Engineer and Strategy Officer at
Humane Inc. From April 2020 until June 2024, Mr. Caballero served as Microsoft&#8217;s Corporate Vice President of Devices &amp; Technology
Engineering for the Mixed Reality Division, where he oversaw Mixed Reality, AI and other special projects. Mr. Caballero served as a Vice
President of Engineering at Apple from 2005 until April 2019, where he was one of the founding leaders of the iPhone hardware design team
and later expanded his role to include iPad, Apple Watch, Macintosh, and other hardware products. Mr. Caballero&#8217;s senior role at
Apple provided him with the opportunity to build and scale global teams, including the Wireless Design and Technology team for all the
products/ecosystems at Apple, including the iPhone, iPad, Macs, AirPods, HomePod, and accessories. Before Apple, Mr. Caballero worked
at two start-ups, where he led efforts for designing innovative products and core technology for wireless networked audio components and
devices. Since August 2019, Mr. Caballero has served as a member of the board of directors of Resonant Inc. (Nasdaq: RESN), a company
that is working to transform the way radio frequency, or RF, front-ends are being designed and delivered for mobile handset and wireless
devices. Mr. Caballero received a Bachelor&#8217;s degree in Electrical Engineering from &#201;cole Polytechnique de Montr&#233;al,
a Master&#8217;s degree in Electrical Engineering from New Mexico State University and an Honorary Doctorate from &#201;cole Polytechnique
de Montr&#233;al. We believe that Mr. Caballero is qualified to serve on the Board because of his extensive experience in the technology
industry and commercializing products for one of the world&#8217;s largest technology companies.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Brian Cullinan, </b>age 66, has served as a
director of the Company since August 2020. Mr. Cullinan was a partner at PricewaterhouseCoopers LLP (&#8220;PwC&#8221;) from July 1997
through June 2020. While at PwC, Mr. Cullinan served as a Senior Relationship and Global Engagement Partner with responsibility for numerous
PwC Fortune 500 clients. In addition, he served on PwC&#8217;s U.S. Board of Partners &amp; Principals from 2010 to 2018, including two
terms as Lead Director from 2012 to 2016. Mr. Cullinan simultaneously served as a member of PwC&#8217;s Global Board from 2013 to 2017
and as Managing Partner &#8211; Southwest Region from 2011 to 2017. Mr. Cullinan has served in numerous other leadership roles during
his career at PwC, including West Region Assurance Leader from 2009 to 2012 and U.S. Entertainment, Media &amp; Communications Assurance
Leader from 2007 to 2009. He received a Bachelor of Arts from Cornell University and a Master of Science in Financial Accounting from
Northeastern University. We believe Mr. Cullinan is qualified to serve on our board of directors based on his extensive knowledge of,
and experience in, the application of accounting principles and the financial reporting process, as well as his extensive executive leadership
and management experience.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Seth Demsey, </b>age 49, has served as a member
of the Board since March 19, 2026. Mr. Demsey has served as the Co-Chief Executive Officer and Co-Founder of Corvex Legacy Holdings, Inc.,
a wholly owned subsidiary of the Company (&#8220;Corvex OpCo&#8221;) and on the Corvex OpCo board of directors since October 2024. Before
joining Corvex OpCo, Mr. Demsey served as the chief executive officer and co-founder of Configure8 from May 2021 through October 2024.
He has spent nearly three decades architecting and operating high-impact AI/ML and developer platforms across startups and industry leaders
including NASA, Microsoft, Google, and AOL/Yahoo!. He holds dozens of patents spanning high-performance computing, distributed systems,
security, and data management. Prior to co-founding Corvex, Mr. Demsey served in technical leadership roles driving innovation in large-scale
distributed computing and mission-critical infrastructure. His expertise encompasses the full stack of cloud infrastructure technologies
required to deliver reliable, high-performance AI computing at scale. Mr. Demsey received a Bachelor of Science degree in Computer Engineering
from Bucknell University and was previously a business fellow at The Wharton School of the University of Pennsylvania. We believe that
Mr. Demsey is qualified to serve on the Board because of his industry knowledge and broad previous experience as a co-founder and technology
leader.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 5; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>INFORMATION CONCERNING EXECUTIVE OFFICERS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Set forth below is background information relating
to our executive officers:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name</b></span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Age</b></span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Position</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 24%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jay Crystal</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">48</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 63%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer </span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">John Mastrototaro</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">65</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Operating Officer and Director</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jeremy (&#8220;J.&#8221;) Cogan</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">57</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Jay Crystal </b>has served as the Chief Executive
Officer of the Company since March 31, 2026. Mr. Crystal has served as the Co-Chief Executive Officer and Co-Founder of Corvex OpCo and
on the Corvex OpCo board of directors since October 2024. Prior to co-founding Corvex OpCo, Mr. Crystal previously co-founded and served
as a board director of clean.io (now HUMAN Security, Inc.) and configure8. Mr. Crystal also served in several management roles at AOL,
Inc. and its successors and subsidiaries, including as Director, Corporate Development and Vice President, Corporate Strategy and Partnerships,
from 2010 to 2017. Mr. Crystal began his career serving in growth equity, private equity, and investment banking roles at Staley Capital,
American Capital and Banc of America Securities between 2000 to 2010.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>John Mastrototaro </b>is discussed above under <i>Information Concerning
Directors.</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>J. Cogan</b> has served as the Company&#8217;s
Chief Financial Officer since May 2019. Mr. Cogan brings 30 years of financial experience to the Company. From July 2007 to December 2018,
Mr. Cogan managed the Leisure &amp; Media portfolio at Ascend Capital, a multi-billion-dollar, long/short equity hedge fund, based in
the San Francisco Bay Area. At Ascend, he was also a member of the firm&#8217;s Executive Committee. From January 1995 to May 2007, Mr.
Cogan was a member of the equity research team at Banc of America Securities LLC (and its predecessors). For the majority of his tenure
at Banc of America Securities, Mr. Cogan was a Principal and Senior Equity Research Analyst, responsible for the Gaming and Lodging sectors.
Mr. Cogan received a Bachelor of Arts degree in Communications from the University of Pennsylvania.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Family Relationships and Certain Legal Proceedings</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There are no family relationships between any
of our directors or executive officers. There are no legal proceedings related to any of the directors or executive officers that must
be disclosed pursuant to Item 401(f) of Regulation S-K.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Delinquent Section 16(a) Reports </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Section 16(a) of the Securities Exchange Act
of 1934, as amended, requires our directors, certain of our officers and any persons holding more than 10% of our common stock to
file reports of holdings and transactions in the Company&#8217;s equity securities with the SEC. Based solely upon a review of forms
filed with the SEC and the written representations of such persons, we believe that in 2025 our directors, officers and stockholders
who were subject to Section 16(a) met all applicable filing requirements, except, due to inadvertent administrative errors by the
Company, the following transactions were reported late:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">Each of Ms. Fairbairn, Mr. Caballero, Mr. Wirk, Mr. Cullinan, Mr. Mastrototaro, Mr. Leabman and Mr.
                                                                                       Cogan was late in filing a Form 4 to report the forfeiture of restricted stock units and the grant of stock options by the Company
                                                                                       in connection with the Board&#8217;s revision of the Director Equity Program (as defined below) on November 3, 2025, each such Form
                                                                                       4 reporting two transactions.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">Ms. Fairbairn was also late in filing a Form 4 to report
the grant of restricted stock units by the Company pursuant to the Director Equity Program on October 3, 2025.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 6; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Code of Business Conduct and Ethics</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have in place a Corporate Code of
Business Conduct and Ethics (the &#8220;Code of Conduct&#8221;) that applies to all of our directors, officers, employees, agents and
contractors. The Code of Conduct is designed to deter wrongdoing and to promote, among others:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">honest and ethical conduct, including the ethical handling
of actual or apparent conflicts of interest between personal and professional relationships;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">full, fair, accurate, timely and understandable disclosure
in reports and documents that we file with, or submit to, the SEC and in other public communications that we make;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">compliance with applicable governmental laws, rules and regulations;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">the prompt internal reporting of violations of the Code of
Conduct to an appropriate person identified in the Code of Conduct; and</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">accountability for adherence to the Code of Conduct.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A current copy of the Code of Conduct is available
in the Investor Relations section of our website at www.corvex.ai. A copy may also be obtained, free of charge, from us upon a request
directed to Corvex, Inc., 3401 North Fairfax Drive, Suite 3230, Arlington, VA 22226, attention: Investor Relations. We intend to disclose
any amendments to or waivers of a provision of the Code of Conduct required to be disclosed by applicable SEC rules by posting such information
on our website available at www.corvex.ai and/or in our public filings with the SEC.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b>&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b>Stockholder Nominees for Director</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">There have been no material
changes to the procedures by which stockholders may recommend nominees to the Board of Directors.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Audit Committee</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Board has a standing audit committee (the
&#8220;Audit Committee&#8221;), which retains the authority to engage its own advisors and consultants. The Audit Committee consists of
Mr. Caballero, Mr. Cullinan and Ms. Fairbairn. The Board has determined that each member of the Audit Committee is independent within
the meaning of the Nasdaq director independence standards and applicable rules of the SEC for audit committee members. The Board has elected
Mr. Cullinan as Chairperson of the Audit Committee and has determined that he qualifies as an &#8220;audit committee financial expert&#8221;
under the rules of the SEC.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Audit Committee is
responsible for assisting the Board in fulfilling its oversight responsibilities with respect to financial reports and other financial
information. The Audit Committee (1) reviews, monitors and reports to the Board on the adequacy of the Company&#8217;s financial reporting
process and system of internal controls over financial reporting, (2) has the ultimate authority to select, evaluate and replace the independent
auditor and is the ultimate authority to which the independent auditors are accountable, (3) in consultation with management, periodically
reviews the adequacy of the Company&#8217;s disclosure controls and procedures and approves any significant changes thereto, (4) provides
the audit committee report for inclusion in our proxy statement for our annual meeting of stockholders and (5) recommends, establishes
and monitors procedures for the receipt, retention and treatment of complaints relating to accounting, internal accounting controls or
auditing matters and the receipt of confidential, anonymous submissions by employees of concerns regarding questionable accounting or
auditing matters.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Insider Trading, Anti-Hedging
and Pledging Policies </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">We have <ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="ecd:InsiderTrdPoliciesProcAdoptedFlag" id="ixv-4485">adopted</ix:nonNumeric> an Insider
Trading Policy containing policies and procedures governing the purchase, sale and/or other dispositions of our securities by our directors,
officers, and employees, as well as by the Company itself. Such policies and procedures are reasonably designed to promote compliance
with insider trading laws, rules and regulations, and any listing standards applicable to us. Our Insider Trading Policy has been filed
as required by the rules and regulations of the SEC.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Pursuant to the Company&#8217;s
Insider Trading Policy, directors, officers, employees and consultants of the Company and its affiliates, as well as any immediate
family members sharing the household of any of the foregoing are prohibited from engaging in transactions in publicly traded options,
such as puts, calls and other derivative securities, relating to the Company.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 7; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><div>

</div><div><a id="a_003"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 11. Executive Compensation</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>COMPENSATION AND OTHER INFORMATION CONCERNING
</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>DIRECTORS AND OFFICERS </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our compensation philosophy is to offer our executive
officers compensation and benefits that are competitive and meet our goals of attracting, retaining and motivating highly skilled management,
which is necessary to achieve our financial and strategic objectives and create long-term value for our stockholders. We believe the levels
of compensation we provide should be competitive, reasonable and appropriate for our business needs and circumstances. The principal elements
of our executive compensation program have to date included base salary and long-term equity compensation in the form of stock options.
We believe successful long-term Company performance is more critical to enhancing stockholder value than short-term results. For this
reason and to conserve cash and better align the interests of management and our stockholders, we emphasize long-term performance-based
equity compensation over base annual salaries.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth information concerning
the compensation earned by the individual that served as our Principal Executive Officer during 2025 and our two most highly compensated
executive officers other than the individual who served as our Principal Executive Officer during the fiscal year ended December 31, 2025
(collectively, the &#8220;named executive officers&#8221;):</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>2025 Summary Compensation Table</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Name and Principal Position</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Salary <br/> ($)<sup>(1)</sup></b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Bonus <br/> ($)<sup>(2)</sup></b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Option <br/> Awards <br/> ($)<sup>(3)</sup></b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>All Other <br/> Compensation <br/> ($)<sup>(4)</sup></b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">TOTAL <br/> ($)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 28%; text-align: left">John Mastrototaro</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td><td style="width: 9%; text-align: center">2025</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">379,999</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">105,654</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">16,351</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">502,004</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 9.25pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Former Chief Executive Officer </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>(Current Chief Operating Officer)</i></p></td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">2024</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">361,042</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">268,876</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16,351</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">646,269</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Michael Leabman</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">2025</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">306,696</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">47,436</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">354,133</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: italic; text-align: left; padding-left: 9.25pt">Former Chief Technology Officer</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">2024</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">347,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">268,876</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">616,376</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">J. Cogan</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">2025</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">314,927</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">178,965</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">34,141</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">528,032</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: italic; text-align: left; padding-left: 9.25pt">Chief Financial Officer</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">2024</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">299,792</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">85,846</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">385,638</td><td style="text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.25in">(1)</td><td style="text-align: justify">The amounts in this column for fiscal 2025 include $229,999 for Mr.&#160;Mastrototaro, $134,763 for Mr.&#160;Leabman,
and $186,875 for Mr.&#160;Cogan, each representing the grant date fair value of RSUs, and the incremental accounting expense associated
with the issuance of discounted stock options, granted to each named executive officer in lieu of salary, as further described below under
&#8220;2025 Equity Compensation in Lieu of Cash Salary.&#8221;</td></tr></table><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.25in">(2)</td><td style="text-align: justify">The amounts in this column for fiscal 2025 include $105,654 for Mr.&#160;Mastrototaro, $47,436 for Mr.&#160;Leabman,
and $178,965 for Mr.&#160;Cogan, each representing the grant date fair value of discounted stock options, granted to each named executive
officer, as described further below under &#8220;Additional Discounted Options&#8221;.</td></tr></table><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.25in">(3)</td><td style="text-align: justify">The amounts shown in this column indicate the grant date fair value of option awards granted in the subject
year computed in accordance with FASB ASC Topic 718. For additional information regarding the assumptions made in calculating these amounts,
see note 12 to our audited financial statements included with our annual report on Form 10-K&#160;for the year ended December 31, 2024
filed with the SEC.</td></tr></table><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.25in">(4)</td><td style="text-align: justify">The amounts shown in this column represent reimbursement for certain health benefit plan premiums.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 8; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b>Outstanding Equity Awards at Year-End</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The following table provides
information regarding equity awards held by the named executive officers as of December&#160;31, 2025.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="17" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Option Awards</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Name</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of<br/> Securities<br/> Underlying<br/> Unexercised<br/> Options (#)<br/> Exercisable</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of<br/> Securities<br/> Underlying<br/> Unexercised<br/> Options<br/> Unexercisable<br/> (#)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Equity<br/> Incentive<br/> Plan&#160;Awards:<br/> Number of<br/> Securities<br/> Underlying<br/> Unexercised<br/> Unearned<br/> Options<br/> (#)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Option<br/> Exercise<br/> Price<br/> ($)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Option<br/> Expiration<br/> Date</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left">John Mastrototaro</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">1,932</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">&#8212;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">81.00</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: center">12/06/2030</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><p style="padding-left: 10pt; font-style: italic; text-align: left"><i>Former Chief Executive Officer<br/>
(Current
Chief Operating Officer)</i></p></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,665</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">489.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">2/09/2031</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">899</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">750.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">11/15/2031</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,249</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">193.50</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">3/20/2033</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,584</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">70.50</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">5/15/2034</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">77,834</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.25</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">06/30/2026</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Michael Leabman</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,600</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">57.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">11/18/2029</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; font-style: italic; text-align: left">Former Chief Technology Officer</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">900</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">193.50</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">3/20/2033</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,584</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">70.50</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">5/15/2034</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">42,250</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.25</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">06/30/2026</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">J.&#160;Cogan</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">533</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">300.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">12/06/2030</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; font-style: italic; text-align: left">Chief Financial Officer</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">432</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">750.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">11/15/2031</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,266</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">193.50</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">3/20/2033</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,421</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">70.50</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">5/15/2034</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">84,834</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.25</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">06/30/2026</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Employment Agreements and Change of Control Arrangements </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Employment Agreements </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following is a summary of the employment arrangements
with our named executive officers.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Michael
Leabman.&#160;&#160;</i></b>&#160;&#160;The Company entered into an &#8220;at-will&#8221; amended and restated offer letter with no
fixed term with Mr. Leabman, formerly the Company&#8217;s Chief Technology Officer and a Director, effective November 29, 2019,
which was amended pursuant to a first amendment dated February 10, 2021 (as amended, the &#8220;Leabman Offer Letter&#8221;). Under
the Leabman Offer Letter: (1) Mr. Leabman received an initial base salary of $250,000, which was adjusted to $315,000 in January
2022 and adjusted to $375,000 in June 2024, and was eligible to receive target performance bonuses equal to 80% of base salary (or
any other amount approved by the Board), and (2) Mr. Leabman was awarded stock options to acquire 3,600 shares of common stock, one
fourth of which options vested on the November 18, 2020, and the balance of which such options vested in 36 equal monthly
installments thereafter. The Leabman Offer Letter provided that, subject to execution of a release satisfactory to the Company, (1)
if Mr. Leabman was terminated by the Company other than for Cause he was entitled to receive cash severance in an amount equal to 12
months of base salary plus a pro-rated amount of his target bonus based on the number of days he is employed during the year of
termination and (2) if there occurred a Change in Control (as defined in the Omnibus Incentive Plan) and in the period prior to and
in connection with or in anticipation of such Change in Control and ending on the one-year anniversary of the consummation of such
Change in Control, Mr. Leabman was terminated by the Company other than for Cause, 100% of any such options that remain unvested
would immediately vest. &#8220;Cause&#8221; includes, among other items, Mr. Leabman&#8217;s conviction of a felony involving fraud,
misappropriation, embezzlement or dishonesty in conjunction with his duties to the Company or repeated willful failure to perform
his job duties as defined by the Board or uncured material breach of the Leabman Offer Letter or Mr. Leabman&#8217;s confidential
information and inventions assignment agreement with the Company. Mr. Leabman was also entitled to participate in the
Company&#8217;s regular health insurance and other employee benefit plans established by Corvex for its employees from time to time.
On March 18, 2026, Mr. Leabman&#8217;s employment with the Company terminated and he resigned from the Board on March 18, 2026. Pursuant to the Leabman Offer Letter, subject to his execution of a release of claims satisfactory to the Company, Mr. Leabman is entitled
to receive (1) cash severance of $375,000 and (2) full reimbursement of health care expenses pursuant to COBRA.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 9; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>J.
Cogan</i></b>.<b>&#160;&#160;&#160;</b>&#160;The Company entered into an offer letter with J. Cogan, the Company&#8217;s Chief
Financial Officer on similar terms to the agreement entered with Michael Leabman. Pursuant to his offer letter Mr. Cogan (1)
received an initial base salary of $250,000, which was adjusted to $270,000 in January 2022 and adjusted to $325,000 in June 2024,
(2) is entitled to a target performance bonus equal to 60% of base salary (or any other amount approved by the Board) and (3) was
awarded stock options to acquire 3,033 shares of common stock, one fourth of which options vested on the one year anniversary of the
grant date, and the balance of which such options vested in 36 equal monthly installments thereafter. Mr. Cogan&#8217;s Offer Letter
provides for severance in connection with an involuntary termination and the acceleration of his stock options in connection with a
Change of Control on identical terms as those described in the description of Mr. Leabman&#8217;s offer letter above. On March 16,
2026, the Company entered into an amendment to Mr. Cogan&#8217;s Offer Letter (the &#8220;Cogan Amendment&#8221;). Pursuant to the
Cogan Amendment, Mr. Cogan is entitled to (1) an annual base salary of $400,000, (2)  $325,000 in severance upon
termination by the Company other than for Cause and (3) full reimbursement of health care
expenses pursuant to COBRA upon termination by the Company other than for Cause. Following termination, Mr. Cogan will provide consulting services through December 31,
2026 if requested by the Company.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>John
Mastrototaro</i>.&#160;&#160;&#160;</b>&#160;The Company entered into an offer letter with John Mastrototaro, the Company&#8217;s
Chief Operating Officer and Director on similar terms to the agreement entered with Michael Leabman. Pursuant to his offer letter
Mr. Mastrototaro (1) received an initial base salary of $300,000, which was adjusted to $315,000 in January 2022 and adjusted to
$400,000 in June 2024, (2) is entitled to a target performance bonus equal to 80% of base salary (or any other amount approved by
the Board) and (3) was awarded stock options to acquire 6,667 shares of common stock, one fourth of which options vested on the one
year anniversary of the grant date, and the balance of which such options vested in 36 equal monthly installments thereafter. Mr.
Mastrototaro&#8217;s Offer Letter provides for severance in connection with an involuntary termination and the acceleration of his
stock options in connection with a Change of Control on identical terms as those described in the description of Mr. Leabman&#8217;s
offer letter above. On March 16, 2026, the Company entered into an amendment to Mr. Mastrototaro&#8217;s Offer Letter (the
&#8220;Mastrototaro Amendment&#8221;). Mr. Mastrototaro is entitled to (1) an annual base salary of $300,000, and (2) $400,000 in
severance in the event that Mr. Mastrototaro is terminated by the Company other than for Cause.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>2025 Equity Compensation&#160;in Lieu of
Cash Salary</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Corvex&#8217;s named executive officers that remain
employed with Corvex are eligible to receive equity awards under the Amended and Restated 2019 Omnibus Incentive Plan (the &#8220;2019
Plan&#8221;). Awards under the 2019 Plan are intended to align the interests of our named executive officers with those of Corvex&#8217;s
stockholders and to create a link between executive pay and the long-term&#160;performance of the Corvex common stock.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Due to the liquidity challenges facing Corvex
in 2025, the Board determined to offer certain employees, including all of the named executive officers, restricted stock unit awards
(&#8220;RSUs&#8221;) as consideration for such employees&#8217; voluntary agreement to forego payments of salary in cash for various periods
in fiscal year 2025 (the &#8220;NEO Equity Program&#8221;). The RSUs granted pursuant to the NEO Equity Program vested in daily installments
for each quarter in which they were granted, assuming that there was no separation from service for the employee during the vesting period.
Unvested RSUs would be forfeited upon a separation from service resulting from a death, disability, or for cause termination. If the employee
was terminated without cause, their RSUs would vest automatically as of the date of the termination.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 10; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On November&#160;3, 2025, the Board revised the
NEO Equity Program and replaced all previously granted RSUs with discounted option awards. The discounted option awards have an exercise
price of $1.25 a share and are exercisable until June 30, 2026 (extended from December&#160;31, 2025).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Additional Discounted Options</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On November&#160;3, 2025, the Board approved the
issuance of additional discounted option awards to the Company&#8217;s named executive officers. Messrs. Mastrototaro, Leabman, and Cogan
received 24,500, 11,000 and 41,500 discounted option awards, respectively. The discounted option awards have an exercise price of $1.25
a share and are exercisable until June 30, 2026 (extended from December&#160;31, 2025).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Potential Payments Upon a Termination or Change
in Control</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>2019 Plan</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the event of a merger or change in control
of Corvex, the treatment of each outstanding award granted under the 2019 Plan will be determined by the administrator of the 2019 Plan,
including whether each such award will be assumed, accelerated or an equivalent option or right substituted by the successor corporation.
The administrator will not be required to treat all awards similarly in the transaction.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Employee Agreements</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The employment agreements of Corvex&#8217;s executive
officers provide for post-employment&#160;compensation arrangements. These Corvex employment agreements establish the amount of severance
payments and benefits available in the event of a termination of employment by Corvex without &#8220;cause&#8221; (as such
term is defined in the respective agreements).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company entered into an
&#8220;at-will&#8221; amended and restated offer letter with no fixed term with Mr. Leabman, formerly the Company&#8217;s Chief
Technology Officer and a Director, effective November 29, 2019, which was amended pursuant to a first amendment dated February 10,
2021. The Leabman Offer Letter provided that, subject to execution of a release satisfactory to the Company, (1) if Mr. Leabman was
terminated by the Company other than for Cause he was entitled to receive cash severance in an amount equal to 12 months of base
salary plus a pro-rated amount of his target bonus based on the number of days he was employed during the year of termination and
(2) if there occurs a change in control and in the period prior to and in connection with or in anticipation of such change in
control and ending on the one-year anniversary of the consummation of such change in control, Mr. Leabman was terminated by the
Company other than for Cause, 100% of any such options that remain unvested would immediately vest. &#8220;Cause&#8221; includes,
among other items, Mr. Leabman&#8217;s conviction of a felony involving fraud, misappropriation, embezzlement or dishonesty in
conjunction with his duties to the Company or repeated willful failure to perform his job duties as defined by the Board or uncured
material breach of the Leabman Offer Letter or Mr. Leabman&#8217;s confidential information and inventions assignment agreement with
the Company. On March 18, 2026, Mr. Leabman&#8217;s employment with the Company terminated and he resigned from the Board on March
18, 2026.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has entered into an offer letter with
J. Cogan, the Company&#8217;s Chief Financial Officer on similar terms to the agreement entered with Michael Leabman. Mr. Cogan&#8217;s
Offer Letter provides the acceleration of his stock options in connection with a Change of Control on identical terms as those described
in the description of Mr. Leabman&#8217;s offer letter above. On March 16, 2026, the Company entered into the Cogan Amendment. Pursuant
to the Cogan Amendment, Mr. Cogan is (1) entitled to $400,000 annual base salary (2) in the event Mr. Cogan is terminated by Corvex other
than for Cause he is entitled to $325,000 in severance, (3) full reimbursement of health care expenses pursuant to COBRA and, (4) if requested
by Corvex, Mr. Cogan will provide consulting services through December 31, 2026.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company entered into an offer letter with
John Mastrototaro, the Company&#8217;s Chief Operating Officer and Director on similar terms to the agreement entered with Michael Leabman.
Mr. Mastrototaro&#8217;s Offer Letter provides for the acceleration of his stock options in connection with a Change of Control on identical
terms as those described in the description of Mr. Leabman&#8217;s offer letter above. On March 16, 2026, the Company entered into the
Mastrototaro Amendment. Pursuant to the Mastrototaro Amendment, Mr. Mastrototaro is (1) entitled to $300,000 annual base salary and (2)
in the event Mr. Mastrototaro is terminated by Corvex other than for Cause he is entitled to $400,000 in severance.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 11; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Director Compensation </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the Company&#8217;s non-employee&#160;director
compensation policy in place during fiscal year 2025, our non-employee&#160;directors receive a $50,000 annual cash retainer plus the
following additional annual cash fees: Chair of the Board, $25,000, Chair of the Audit Committee, $20,000 and Chair of the Compensation
Committee, $10,000. Our non-employee&#160;director compensation policy provided that each director were entitled to receive options to
purchase 1,000&#160;shares of our common stock at the beginning of each year.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Due to the liquidity challenges facing the Company
in 2025, the Board determined to offer all of its non-employee&#160;directors RSUs as consideration for such directors&#8217; voluntary
agreement to forego payments of cash fees for various periods in fiscal year 2025 (the &#8220;Director Equity Program&#8221;). The RSUs
granted pursuant to the Director Equity Program vested in full on the grant date, assuming that there was no separation from service for
the director during the vesting period. Unvested RSUs would be forfeited upon a separation from service resulting from a death, disability,
or for cause termination.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On November&#160;3, 2025, the Board revised the
Director Equity Program and replaced all previously granted RSUs with discounted option awards. The discounted option awards have an exercise
price of $1.25 a share and are exercisable until June 30, 2026 (extended from December&#160;31, 2025).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On November&#160;3, 2025, the Board approved the
issuance of additional discounted option awards to certain of Corvex&#8217;s non-employee&#160;directors. Mr.&#160;Caballero, Mr.&#160;Cullinan,
and Ms. Fairbairn received 9,000, 15,500, and 36,500 discounted option awards, respectively. The discounted option awards have an exercise
price of $1.25 a share and are exercisable until June 30, 2026 (extended from December&#160;31, 2025).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth information with
respect to compensation earned by or awarded to each of our independent directors who served on the Board during the year ended December
31, 2025.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Name</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fees Earned or<br/> Paid in Cash<br/> ($)<sup>(1)</sup></b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Option<br/> Awards<br/> ($)<sup>(2)</sup></b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total<br/> ($)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; text-indent: -10pt; padding-left: 10pt">Rub&#233;n Caballero</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">43,124</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">70,280</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">113,404</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">Brian Cullinan</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">68,998</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">98,310</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">167,308</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">Emily Wang Fairbairn</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">64,686</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">188,871</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">253,557</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">Shaheen Wirk</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">43,124</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">75,833</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">118,957</td><td style="text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.25in">(1)</td><td style="text-align: justify">The amounts in this column represent the grant date fair value of RSUs,
and the incremental accounting expense associated with the issuance of discounted stock options, granted to each director in lieu of
board fees on November 3, 2025, as further described above under &#8220;<i>Director Compensation</i>&#8221;.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: -27pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: -27pt"></p><div>

</div><!-- Field: Page; Sequence: 12; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: -27pt">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.25in">(2)</td><td style="text-align: justify">The amounts shown in this column indicate the grant date fair value of option awards granted in the subject
year computed in accordance with FASB ASC Topic 718. For additional information regarding the assumptions made in calculating these amounts,
see note 11 to our audited financial statements included with our annual report on Form 10-K&#160;for the year ended December 31, 2025
filed with the SEC. The following table shows the number of shares subject to outstanding option awards and unvested stock awards held
by each non-employee&#160;director as of December 31, 2025:</td></tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3pt 0pt 0"><b>Name</b></p></td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Shares Subject to Outstanding<br/>
    Stock Option<br/> Awards<br/> (#)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Unvested Shares<br/> of Restricted<br/> Stock</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; text-indent: -10pt; padding-left: 10pt">Rub&#233;n Caballero</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">26,499</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">&#8212;</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">Brian Cullinan</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">36,899</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">Emily Wang Fairbairn</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">56,715</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">Shaheen Wirk</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,330</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Following the completion of the Merger in March
of 2026, we adopted a new director compensation policy that will apply on a go-forward basis (the &#8220;Director Compensation Policy&#8221;).
Under the Director Compensation Policy, each non-employee director will receive the cash and equity compensation for board services described
below. The Company will also reimburse non-employee directors for reasonable, customary, and documented travel expenses to board or committee
meetings.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Cash Compensation</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under the Director Compensation Policy, each non-employee
director of Corvex will receive annual cash retainers, payable quarterly in arrears and prorated for partial years of service, and equity
awards as set forth below:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: justify">Annual Retainer for Board Membership</td><td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: justify">Annual service on the Corvex Board</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">65,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Additional retainer for annual service as non-executive chairperson or lead independent director</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">25,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: justify">Additional Annual Retainer for Committee Membership</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Annual service as audit committee chairperson</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">25,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Annual service as member of the audit committee (other than chairperson)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">12,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Annual service as compensation committee chairperson</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">20,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Annual service as member of the compensation committee (other than chairperson)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">10,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Annual service as nominating and governance committee chairperson</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">18,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Annual service as member of the nominating and governance committee (other than chairperson)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">7,500</td><td style="text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Each non-employee director who serves as the chair
of a committee will receive only the additional annual fee as the chair of the committee and not the annual fee as a member of the committee
while serving as such chair. A non-employee director who serves as the non-executive chair of Board, or if there is no non-executive chair
of the Board, the lead independent director,&#160;will receive the annual fee as a non-employee director and the additional annual fee
as the non-executive chair. All cash payments to outside directors are paid quarterly in arrears on a pro-rated basis.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Equity Compensation</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Non-employee directors will be entitled to receive
all types of equity awards other than incentive stock options under the Corvex, Inc. 2026 Equity Incentive Plan (the &#8220;2026 Plan&#8221;), subject to and effective upon stockholder approval of the 2026
Plan at the Company&#8217;s 2026 Annual Meeting of Stockholders, including discretionary awards not covered under the
Director Compensation Policy. Following the effective date of the Director Compensation Policy, on the first trading day following December
31 of each year, each non-employee director will be granted an award to purchase an aggregate value of $135,000 shares of Corvex&#8217;s
common stock under the 2026 Plan, on a pro-rated basis, with such number subject to equitable adjustment by the Board in the event of
certain capitalization adjustments (the &#8220;Annual Award&#8221;). The exercise price per share of such awards shall be the closing
price of Corvex&#8217;s common stock on the grant date. The Annual Award will be scheduled to vest in full on the first anniversary of
the date on which the Annual Award is granted, subject to the non-employee director continuing to be a non-employee director through the
applicable vesting date.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 13; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If a change in control occurs (as defined in the
2026 Plan), each non-employee director will fully vest in his or her outstanding equity awards immediately prior to the change in control,
subject to the non-employee director continuing to be a non-employee director through the date of the change in control.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Non-employee directors may also be eligible to
receive other compensation and benefits, as may be determined by the Board or any committee of the Board designated by the Board with
appropriate authority, as applicable, from time to time.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Board or any committee of the Board designated
by the Board with appropriate authority, as applicable and in its discretion, may change and revise the terms of the Annual Awards granted
under the Director Compensation Policy, including, without limitation, the number of shares subject to each award and type of award.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Policies and Practices Related to the Grant
of Certain Equity Awards</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We make awards of equity to certain employees,
including our named executive officers, contractors, and our non-employee directors. The timing of the grant of stock options and other
equity awards occurs independent of the release of any material, non-public information, and we do not time the disclosure of material
non-public information for the purpose of affecting the value or exercise price of stock options.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><div><a id="a_004"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item&#160;12. Security Ownership of Certain
Beneficial Owners and Management and Related Stockholders Matters.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Equity Compensation Plan Information</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">The following table presents information on the
Company&#8217;s equity compensation plans as of December 31, 2025. All outstanding awards relate to our common stock.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt">&#160;</p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Plan Category</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of<br/>
 Securities<br/>
to Be <br/>
Issued upon<br/>
Exercise of<br/>
Outstanding<br/>
 Options(a)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted-Average<br/>
 Exercise <br/>
Price of<br/>
 Outstanding<br/>
 Options(b)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of Securities<br/>
 Remaining Available for<br/>
 Future Issuance under<br/>
 Equity Compensation<br/>
 Plans (Excluding<br/>
 Securities in Column (a))</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Equity compensation plans approved by security holders</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">437,141</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;29.68</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">132,869</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; text-align: left">Equity compensation plans not approved by security holders</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,316</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">387.48</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">11,018</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt">Total</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">439,457</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">31.57</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">143,887</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 14; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES OWNERSHIP OF CERTAIN BENEFICIAL
OWNERS AND MANAGEMENT </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">The following table sets forth
certain information regarding beneficial ownership of our voting stock as of April 20, 2026 by:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">each
person or group of affiliated persons known by us to be the beneficial owner of more than 5% of any class of our voting stock;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">each
of our named executive officers (as defined in Item&#160;402(m)(2) of Regulation&#160;S-K);</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">each
of our directors; and</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
executive officers and directors as a group.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">Unless otherwise noted below,
the address of each person listed on the table is c/o Corvex, Inc. at 3401 North Fairfax Drive, Suite 3230, Arlington, Virginia 22226.
To our knowledge, each person listed below has sole voting and investment power over the shares shown as beneficially owned except to
the extent jointly owned with spouses or otherwise noted below.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">Beneficial ownership is determined
in accordance with the rules of the SEC. The information does not necessarily indicate ownership for any other purpose. Under these rules,
shares of stock which a person has the right to acquire (<i>i.e.</i>, by the exercise of an option or warrant) within 60 days after April
20, 2026 are deemed to be beneficially owned and outstanding for purposes of calculating the number of shares and the percentage beneficially
owned by that person. However, these shares are not deemed to be beneficially owned and outstanding for purposes of computing the percentage
beneficially owned by any other person. The applicable percentage of common stock as of April 20, 2026 is based upon 1,981,462 shares
outstanding on that date.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Name and Address of Beneficial Owner</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares of Common Stock</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares Underlying Options and Warrants</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of Shares Beneficially Owned</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Percentage of Class</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; font-style: italic; text-align: left">Named Executive Officers and Directors:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%"><span style="font-family: Times New Roman, Times, Serif">John Mastrototaro<sup>(1)</sup></span></td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">73,504</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">1,631</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">75,136</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">3.8</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Michael Leabman</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">32,323</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">81</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">32,404</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.6</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">J. Cogan<sup>(2)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">80,060</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">489</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">80,548</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4.1</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Rub&#233;n Caballero</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,820</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">29,397</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">38,217</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.9</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Jay Crystal<sup>(3)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18,132</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18,132</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">*</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Brian Cullinan</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13,067</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">48,631</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">61,697</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3.0</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Seth Demsey<sup>(4)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">24,671</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">24,671</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.2</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Emily Wang Fairbairn<sup>(5)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">142,689</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">142,689</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7.2</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Directors and Executive Officers as a group (7 persons)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">360,943</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">80,148</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">441,09</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">21.4</td><td style="font-weight: bold; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; font-style: italic">5% Stockholders:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#8194;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Peter Appel<sup>(6)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">88,106</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">106,734</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">194,840</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9.3</td><td style="text-align: left">%</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left">*</td><td style="text-align: justify">Less than one percent.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.25in">(1)</td><td style="text-align: justify">Includes 13,488 shares of common stock underlying vested restricted stock unit awards that will settle
within 60 days of April 20, 2026.</td></tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><p style="margin-top: 0; margin-bottom: 0"></p><div>

</div><!-- Field: Page; Sequence: 15; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.25in">(2)</td><td style="text-align: justify">26,434 shares of common stock and 489 warrants to purchase one share of common stock are held by the Cogan/Goldberg
Living Trust, the Jesse Gabriel Goldberg Cogan Irrevocable Trust and Maya Brooke Cogan Irrevocable Trust. J. Cogan is a trustee of each
of these trusts as a result of which he has voting and dispositive power over such securities. Includes 10,523 shares of common stock
underlying vested restricted stock unit awards that will settle within 60 days of April 20, 2026.</td></tr></table><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.25in">(3)</td><td style="text-align: justify">3,167 shares of common stock are held by the John Adler Crystal III Roth IRA. Mr. Crystal is a beneficial
owner of the John Adler Crystal III Roth IRA and therefore may be deemed to exercise voting and investment discretion over securities
held by John Adler Crystal III Roth IRA. The amounts reported in this table exclude approximately 3,345,523 shares of common stock issuable
upon conversion of shares of Series C Preferred Stock held by Mr. Crystal and 708,154 shares of common stock issuable upon conversion
of shares of Series C Preferred Stock held by the John Adler Crystal III Roth IRA, which will only convert upon the receipt of stockholder
approval at the Company&#8217;s 2026 Annual Meeting.</td></tr></table><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.25in">(4)</td><td style="text-align: justify">139 shares of common stock are held by Ainsworth Holdings LLC. Seth Demsey is a beneficial owner of Ainsworth
Holdings LLC and therefore may be deemed to exercise voting and investment discretion over securities held by Ainsworth Holdings LLC.
The amounts reported in this table exclude approximately 5,484,388 shares of common stock issuable upon conversion of shares of Series
C Preferred Stock held by Mr. Demsey and 312,700 shares of common stock issuable upon conversion of shares of Series C Preferred Stock
held by Ainsworth Holdings, which will only convert upon the receipt of stockholder approval at the Company&#8217;s 2026 Annual Meeting.</td></tr></table><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.25in">(5)</td><td style="text-align: justify">Consists of 4,783 shares of common stock held by Valley High Partners, LP, 9,231 shares of common stock
held by Moira Partners LLC, and 45,129 shares of common stock held by the Malcolm&#160;P.&#160;Fairbairn and Emily T. Fairbairn Charitable
Remainder Unitrust (the &#8220;Charitable Trust&#8221;). In addition, the Charitable Trust holds warrants to purchase 43,238 shares of
common which are exercisable within 60 days of April 20, 2026. Ms. Fairbairn and Malcolm Fairbairn are trustees of the Charitable Trust
and share voting and dispositive power over the shares held by the Charitable Trust. Also includes 14,162 shares of common stock underlying
vested restricted stock unit awards that will settle within 60 days of April 20, 2026. The amounts reported in this table exclude approximately
2,063,822 shares of common stock issuable upon conversion of shares of Series C Preferred Stock held by Moira Partners, which will only
convert upon the receipt of stockholder approval at the Company&#8217;s 2026 Annual Meeting.</td></tr></table><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.25in">(6)</td><td style="text-align: justify">Information based on a Schedule 13G filed April 4, 2024, which reports 88,106 shares of common stock held
directly and warrants to purchase 106,734 shares of common stock which are exercisable within 60 days of April 20, 2026. The address of
Mr.&#160;Appel is 3505 Main Lodge Drive, Coconut Grove, FL 33133.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 16; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="a_005"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 13. Certain Relationships and Related Transactions, and Director
Independence</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CERTAIN RELATIONSHIPS AND RELATED PERSON TRANSACTIONS
</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Certain Relationships and Related Person Transactions </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Board is responsible for reviewing and approving
all material transactions with any related person on a continuing basis. Related persons can include any of our directors, nominees for
director, officers, holders of 5% or more of our capital stock and their immediate family members. We may not enter into a related person
transaction unless our Board has reviewed and approved such transaction. We believe the transactions set forth below were executed on
terms no less favorable to us than we could have obtained from unaffiliated third parties.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">See &#8220;Compensation and Other Information Concerning Directors and Officers&#8221; above for a
discussion of director compensation, executive compensation and our named executive officers&#8217; employment agreements.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Except as described below, since January&#160;1, 2024, there has not been,
and there is not currently proposed, any transaction or series of similar transactions to which we were or will be a party in which the
amount involved exceeded or will exceed the lesser of (A) $120,000 or (B) 1% of the average of the Company&#8217;s total assets as of
the end of last two completed fiscal years, in which any director, executive officer, holder of 5% or more of any class of our capital
stock or any member of their immediate families had or will have a direct or indirect material interest.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>April 2024 Private Placement</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On April&#160;2, 2024, the Company entered into
a Securities Purchase Agreement with the purchasers named therein for a private placement (the &#8220;2024 Private Placement&#8221;) of
an aggregate of 30,152&#160;units (the &#8220;Units&#8221;) with each unit consisting of (1)&#160;one Share, or at the election of the
Purchaser a pre-funded&#160;warrant in lieu thereof (a &#8220;Pre-Funded&#160;Warrant&#8221;), and (2)&#160;one warrant to purchase one
share of common stock (each, a &#8220;2024 Private Placement Warrant&#8221;). Certain directors and officers participated in the 2024
Private Placement and purchased 1,917&#160;of the Units&#160;at an offering price of $84.80 per share and accompanying 2024 Private Placement
Warrant, which was the consolidated closing bid price of the Company&#8217;s common stock on The Nasdaq Capital Market on April&#160;1,
2024 of $66.00 per share plus $18.80 per 2024 Private Placement Warrant. The 2024 Private Placement closed on April&#160;4, 2024. Certain
of our directors and executive officers participated in the 2024 Private Placement as follows:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Name</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares of<br/> Common Stock<br/> Purchased</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares<br/> Underlying<br/> Warrants<br/> Purchased</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Purchase<br/> Price<br/> Paid</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">J.&#160;Cogan</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">300</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">300</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">25,425</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Ruben Caballero</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">146</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">146</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">12,500</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Brian Cullinan</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">293</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">293</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">24,860</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">John Mastrototaro</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,176</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,176</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">99,723</td><td style="text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Corvex OpCo Series&#160;Seed Preferred Stock and Warrant Financing</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On November&#160;18, 2024, Corvex OpCo issued
and sold an aggregate of 8,976,000&#160;shares of its Series&#160;Seed Preferred Stock, par value $0.00001 per share (the &#8220;Series&#160;Seed
Preferred Stock&#8221;), at a purchase price of $2.45098 per share for an aggregate purchase price of approximately $22&#160;million.
In addition, Corvex OpCo issued warrants to purchase 4,488,000&#160;shares of its Series&#160;Seed Preferred Stock with an exercise price
of $4.90196 per share (the &#8220;Series&#160;Seed Warrants&#8221;).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"></p><div>

</div><!-- Field: Page; Sequence: 17; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Purchasers of Corvex OpCo&#8217;s Series&#160;Seed
Preferred Stock and Series&#160;Seed Warrants included certain of its directors and holders of more than 5% of its capital stock at the
time of the financing (or subsequent closings of such financing). The following table presents the number of shares and the total purchase
price paid by these entities. In connection with the Merger, the Corvex OpCo Series Seed Preferred Stock and Series Seed Warrants presented
in the table below were exchanged for Series B Preferred Stock and Series D Preferred Stock based on the exchange ratio as set forth in
the Merger Agreement.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Investor</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares of<br/> Series&#160;Seed<br/> Preferred Stock</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Number of<br/>
 Series Seed<br/>
 Warrants</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total<br/> Purchase<br/> Price</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PV Klustr LLC<sup>(1)</sup></span></td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">3,264,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">1,632,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">8,000,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Cluster Capital LLC</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,836,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">918,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">4,500,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">VOC Capital LP</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,142,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,071,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">5,250,000</td><td style="text-align: left">&#160;</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.25in">(1)</td><td style="text-align: justify">Affiliated with Mateo Levy, a non-employee&#160;director of Corvex OpCo, who resigned from the Corvex OpCo board of directors on March
19, 2026 in connection with the closing of the Merger.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Corvex OpCo Investors&#8217; Rights Agreement</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Corvex OpCo was party to an investors&#8217; rights
agreement, dated November&#160;18, 2024, with certain holders of its capital stock (the &#8220;Investors&#8217; Rights Agreement&#8221;).
Under the Investors&#8217; Rights Agreement, certain holders of Corvex OpCo&#8217;s capital stock have the right to demand that Corvex
OpCo file a registration statement or request that their shares of Corvex OpCo capital stock be covered by a registration statement that
Corvex OpCo is otherwise filing. Corvex OpCo&#8217;s Investors&#8217; Rights Agreement was terminated by investors holding a majority
of the shares of the Series&#160;Seed Preferred Stock in connection with the closing of the Merger.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Corvex OpCo Right of First Refusal and Co-Sale
Agreement</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Corvex OpCo was party to a right of refusal and
co-sale&#160;agreement, dated November&#160;18, 2024, with certain holders of its capital stock (the &#8220;Right of First Refusal and
Co-Sale&#160;Agreement&#8221;). Under the Right of First Refusal and Co-Sale&#160;Agreement, Corvex OpCo has a first refusal right and
the investors have secondary refusal and co-sale&#160;rights with respect to proposed transfers of capital stock by key holders, subject
to customary exceptions, lock-up&#160;provisions and termination upon an IPO or a deemed liquidation event. Corvex OpCo&#8217;s Right
of First Refusal and Co-Sale&#160;Agreement was terminated by investors holding a majority of the shares of the Series&#160;Seed Preferred
Stock in connection with the closing of the Merger.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Corvex OpCo Voting Agreement</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Corvex OpCo was party to a voting agreement, dated
November&#160;18, 2024, with certain holders of its capital stock (the &#8220;Voting Agreement&#8221;). Pursuant to the Voting Agreement,
the parties agreed to vote their shares to elect designated directors, increase authorized common stock as needed for conversion of preferred
stock, and support drag-along sales of Corvex OpCo subject to customary conditions. Corvex OpCo&#8217;s Voting Agreement was terminated
by investors holding a majority of the shares of the Series&#160;Seed Preferred Stock in connection with the closing of the Merger.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 18; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Corvex OpCo SAFE Financing</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Corvex OpCo entered into a series of simple agreements
for future equity (&#8220;SAFE&#8221;) with multiple investors. The SAFEs were issued between October&#160;2025 and December&#160;2025,
and Corvex OpCo received an aggregate of $37.2 million in cash proceeds. Purchasers of Corvex OpCo&#8217;s SAFE included certain of its
directors and holders of more than 5% of Corvex Opco&#8217;s capital stock at the time of the financing and a director of the Company.
The following table presents the number of shares of Corvex OpCo common stock to be issued upon conversion of the SAFEs and the total
purchase price paid by these entities. Pursuant to the Merger Agreement, the Corvex OpCo SAFEs presented in the table below were exchanged
for Series B Preferred Stock and Series C Preferred Stock based on the exchange ratio as set forth in the Merger Agreement.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Investor</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares of<br/> Corvex&#160;OpCo<br/>
 Common Stock</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total<br/> Purchase<br/> Price</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ainsworth Holdings LLC<sup>(1)</sup></span></td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">14,114</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">150,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Cluster Capital LLC</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">188,183</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,000,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Moira Partners LLC<sup>(2)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">931,505</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">9,900,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PV Klustr LLC<sup>(3)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">553,399</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">5,881,500</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">VOC Capital LP</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">188,183</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,000,000</td><td style="text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.25in">(1)</td><td style="text-align: justify">Affiliated with Mr. Demsey, Co-CEO and director of Corvex OpCo prior to the Merger and member of the Board
of the Company following the Merger.</td></tr></table><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.25in">(2)</td><td style="text-align: justify">Affiliated with Ms. Fairbairn, a non-employee&#160;director of the Company.</td></tr></table><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.25in">(3)</td><td style="text-align: justify">Affiliated with Mateo Levy, a non-employee&#160;director of Corvex OpCo, who resigned from the Corvex
OpCo board of directors on March 19, 2026 in connection with the closing of the Merger.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>November 2025 Series A Preferred Stock Offering</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On November&#160;6, 2025, the Company entered
into a Preferred Stock Subscription Agreement (the &#8220;Series A Subscription Agreement&#8221;) with the purchasers named therein for
a private placement of an aggregate of 3,000 shares of Series A Preferred Stock, or a purchase price per share equal to $1,000 and an
aggregate purchase price of $3,000,000. 1,500 shares of such Series A Preferred Stock were purchased by PV Klustr LLC, an affiliate of
Mateo Levy, a non-employee director of Corvex OpCo, who resigned from the Corvex OpCo board of directors in connection with the closing
of the Merger. Each Series A Preferred Stock, including any accrued and unpaid dividends, shall be converted to common stock at the option
of the holder at a conversion price of $5.50 per share.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Indemnification Agreements and Directors&#8217; and Officers&#8217;
Liability Insurance</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have entered into indemnification agreements
with each of our directors and executive officers. These agreements, among other things, require us to indemnify each director and executive
officer to the fullest extent permitted by Delaware law, including indemnification of expenses such as attorneys&#8217; fees, judgments,
penalties, fines and settlement amounts incurred by the director or executive officer in any action or proceeding, including any action
or proceeding by or in right of us, arising out of the person&#8217;s services as a director or executive officer.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Policies and Procedures for Related Person Transactions</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Board has adopted a written related person
transaction policy setting forth the policies and procedures for the review and approval or ratification of related person transactions.
This policy covers, with certain exceptions set forth in Item&#160;404 of Regulation&#160;S-K under the Securities Act, any transaction,
arrangement or relationship, or any series of similar transactions, arrangements or relationships in which we were or are to be a participant,
where the amount involved exceeds $120,000 and a related person had or will have a direct or indirect material interest. In reviewing
and approving any such transactions, our Audit Committee, but only those independent directors who are disinterested, will be tasked to
consider all relevant facts and circumstances, including, but not limited to, whether the transaction is on terms comparable to those
that could be obtained in an arm&#8217;s length transaction with an unrelated third party and the extent of the related person&#8217;s
interest in the transaction.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 19; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><div><a id="a_006"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item&#160;14. Principal Accountant Fees and
Services</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Independent Registered Public Accounting Firm Fees</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth the aggregate fees
billed or expected to be billed by RBSM LLP for audit and non-audit services related to 2025 and 2024, respectively, including &#8220;out-of-pocket&#8221;
expenses incurred in rendering these services. The nature of the services provided for each category is described following the tables.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Fee Category</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">2025<br/>
 ($)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">2024<br/>
($)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Audit Fees<sup>(1)</sup></span></td><td>&#160;</td>
    <td colspan="2" style="text-align: right">188,041</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#8212;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 76%"><span style="font-family: Times New Roman, Times, Serif">Audit-Related Fees<sup>(2)</sup></span></td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">78,550</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">&#8212;</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Tax Fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; text-align: left">All Other Fees</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt">Total</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">266,591</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">&#8212;</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 27px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit fees include fees for professional services rendered for the audit of our annual statements, quarterly reviews, consents and assistance with and review of documents filed with the SEC. </span></td></tr>
  </table><div>
</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 27px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit-Related Fees include fees for due diligence services and review meetings related to the Company&#8217;s registration statements in fiscal year 2025. </span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Pre-Approval Policies and Procedures </i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Audit Committee has adopted a policy that
requires that all services to be provided by the Company&#8217;s independent public accounting firm, including audit services and permitted
non-audit services, to be pre-approved by the Audit Committee. The Audit Committee has delegated pre-approval authority to its chair when
necessary due to timing considerations. Any services pre-approved by such chair must be reported to the full Audit Committee at its next
scheduled meeting. The Audit Committee pre-approved all services provided by RBSM during the fiscal year ended December 31, 2025.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 20; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><div><a id="a_007"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PART IV</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><div><a id="a_008"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item&#160;15. Exhibits, Financial Statements
and Schedules</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">List of documents filed as part of this report:</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial Statements (see &#8220;Financial Statements and Supplementary Data&#8221; at Item&#160;8 and incorporated herein by reference).</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial Statement Schedules (Schedules to the Financial Statements have been omitted because the information required to be set forth therein is not applicable or is shown in the accompanying Financial Statements or notes thereto)</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit Index (The exhibits required to be filed as a part of this Report are listed in the Exhibit Index).</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px"><tr style="vertical-align: top"><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="7" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Incorporated
    by Reference</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SEC File/</b></span></td></tr>
  <tr>
    <td style="border-bottom: black 1.5pt solid; vertical-align: bottom; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit
    Number</b></span></td>
    <td style="vertical-align: bottom; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; vertical-align: bottom; width: 51%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit
    Description</b></span></td>
    <td style="vertical-align: bottom; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; vertical-align: bottom; width: 5%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Filed
    Herewith</b></span></td>
    <td style="vertical-align: bottom; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; vertical-align: bottom; width: 5%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Form</b></span></td>
    <td style="vertical-align: bottom; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; vertical-align: bottom; width: 5%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit</b></span></td>
    <td style="vertical-align: bottom; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; vertical-align: bottom; width: 13%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Filing
    Date</b></span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; vertical-align: top; width: 10%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Registration
    Number</b></span></td></tr>

  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1#</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1734750/000121390025107857/ea026448601ex2-1_movano.htm">Agreement and Plan of Merger, dated as of November&#160;6, 2025, by and among the Registrant, Corvex Legacy Holdings, Inc., and Thor Merger Sub Inc.</a></td>
    <td>&#160;</td>
<td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">8-K</td>
    <td>&#160;</td>
    <td style="text-align: center">2.1</td>
    <td>&#160;</td>
    <td style="text-align: center">November&#160;10, 2025</td>
    <td>&#160;</td>
    <td style="text-align: center">001-40254</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify">2.2#</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1734750/000121390026036609/ea027832001ex2-2.htm">Amended and Restated Agreement and Plan of Merger, dated as of March 19, 2026, by and among the Registrant, Thor Merger Sub Inc., and Corvex Legacy Holdings, In.</a></td>
    <td>&#160;</td>
<td>&#160;</td><td>&#160;</td>
    <td style="text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">10-K</p></td>
    <td>&#160;</td>
    <td style="text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2.2</p></td>
    <td>&#160;</td>
    <td style="text-align: center">March 31, 2026</td>
    <td>&#160;</td>
    <td style="text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">001-40254</p></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1734750/000121390021017771/ea138381ex3-1_movano.htm">Third
    Amended and Restated Certificate of Incorporation of the Registrant</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 25, 2021</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">001-40254</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1734750/000121390023050498/ea180615ex3-1_movano.htm">Certificate
    of Amendment to the Third Amended and Restated Certificate of Incorporation of the Registrant</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 21, 2023</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">001-40254</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1734750/000121390024060520/ea020913101ex3-1_movano.htm">Certificate
    of Amendment to the Third Amended and Restated Certificate of Incorporation of the Registrant</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">July 10, 2024</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">001-40254</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1734750/000121390024090544/ea021815101ex3-1_movano.htm">Certificate
    of Amendment to the Third Amended and Restated Certificate of Incorporation of the Registrant</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">October 25, 2024</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">001-40254</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.5</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1734750/000121390025097422/ea026068401ex3-1_movano.htm">Certificate
    of Amendment to the Third Amended and Restated Certificate of Incorporation of the Registrant.</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K/A</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">October 8, 2025</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">001-40254</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.6</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1734750/000121390026031846/ea028203201ex3-4.htm">Certificate of Amendment to the Third Amended and Restated Certificate of Incorporation of Corvex, Inc.</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-K</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><p style="margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.6</span></p></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><p style="margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 31, 2026</span></p></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; text-align: center"><p style="margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">001-40254</span></p></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.7</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1734750/000121390025107857/ea026448601ex3-1_movano.htm">Certificate
    of Designations for Series&#160;A Preferred Stock</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">November 10, 2025</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">001-40254</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.8</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1734750/000121390026031846/ea028203201ex3-1.htm">Certificate
    of Designations for Series&#160;B Preferred Stock</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 19, 2026</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">001-40254</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.9</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1734750/000121390026031846/ea028203201ex3-2.htm">Certificate
    of Designations for Series&#160;C Preferred Stock</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 19, 2026</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">001-40254</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.10</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1734750/000121390026031846/ea028203201ex3-3.htm">Certificate
    of Designations for Series&#160;D Preferred Stock</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 19, 2026</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">001-40254</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.11</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1734750/000121390026031846/ea028203201ex3-5.htm">Second Amended and Restated Bylaws of the Registrant</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-K</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.11</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 31, 2026</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">001-40254</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1734750/000121390021014638/ea136285ex4-1_movano.htm">Specimen
    Certificate representing shares of common stock of the Registrant</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1/A</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 10, 2021</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">333-252671</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1734750/000121390021014638/ea136285ex4-2_movano.htm">Form
    of Underwriter Warrant</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1/A</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 10, 2021</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">333-252671</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1734750/000121390021006218/ea134117ex4-3_movano.htm">Form
    of Amended and Restated Warrant to Purchase Common Stock issued to the placement agent in the Registrant&#8217;s 2018 private placement
    offering</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">February 2, 2021</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">333-252671</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1734750/000121390021006218/ea134117ex4-4_movano.htm">Form
    of Amended and Restated Warrant to Purchase Common Stock issued to the placement agent in the Registrant&#8217;s 2019 private placement
    offering</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">February 2, 2021</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">333-252671</span></td></tr>
  </table><div>

</div><p style="margin: 0">&#160;</p><div>

</div><p style="margin: 0"></p><div>

</div><!-- Field: Page; Sequence: 21; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="margin: 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px">
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify; width: 5%">4.5</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: justify; width: 51%"><a href="https://www.sec.gov/Archives/edgar/data/1734750/000121390021006218/ea134117ex4-6_movano.htm">Form
        of Warrant to Purchase Common Stock issued in 2020</a></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 5%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: center; width: 5%">S-1</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: center; width: 5%">4.6</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: center; width: 13%">February 2, 2021</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: center; width: 10%">333-252671</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify">4.6</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="ea028760001ex4-6.htm">Description of Common Stock of the Registrant Registered Pursuant to Section 12 of the Securities Exchange Act of 1934</a></td>
    <td>&#160;</td>
    <td style="text-align: center">x</td>
    <td>&#160;</td>
    <td style="text-align: center"/>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"/>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"/>
    <td>&#160;</td>
    <td style="text-align: center"/></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify">4.7</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1734750/000121390023006456/ea172434ex4-1_movanoinc.htm">Form
        of Warrant to Purchase Common Stock</a></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">8-K</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">4.1</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">January 31, 2023</td>
    <td>&#160;</td>
    <td style="text-align: center">001-40254</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify">4.8</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1734750/000121390023006456/ea172434ex4-2_movanoinc.htm">Warrant
        Agent Agreement, dated January 31, 2023, by and between the Registrant and Pacific Stock Transfer Company</a></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">8-K</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">4.2</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">January 31, 2023</td>
    <td>&#160;</td>
    <td style="text-align: center">001-40254</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify">4.9</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1734750/000121390024029886/ea020310901ex4-1_movano.htm">Form
        of Pre-Funded Warrant issued in April 2024</a></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">8-K</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">4.1</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">April 3, 2024</td>
    <td>&#160;</td>
    <td style="text-align: center">001-40254</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify">4.10</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1734750/000121390024029886/ea020310901ex4-2_movano.htm">Form
        of Warrant issued in April 2024</a></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">8-K</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">4.2</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">April 3, 2024</td>
    <td>&#160;</td>
    <td style="text-align: center">001-40254</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify">4.11</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1734750/000121390024098474/ea021243101ex4-11_movano.htm">Form
        of Warrant issued in August 2024</a></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">10-Q</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">4.11</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">November&#160;14,&#160;2024</td>
    <td>&#160;</td>
    <td style="text-align: center">001-40254</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify">10.1</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1734750/000121390021014638/ea136285ex10-1_movano.htm">Movano
        Inc. Amended and Restated 2019 Omnibus Incentive Plan &#8224;</a></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">S-1/A</td>
    <td>&#160;</td>
    <td style="text-align: center">10.1</td>
    <td>&#160;</td>
    <td style="text-align: center">March 10, 2021</td>
    <td>&#160;</td>
    <td style="text-align: center">333-252671</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify">10.2</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1734750/000121390021006218/ea134117ex10-2_movano.htm">Form
        of Stock Option Award Agreement under 2019 Omnibus Incentive Plan&#160;&#8224;</a></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">S-1</td>
    <td>&#160;</td>
    <td style="text-align: center">10.2</td>
    <td>&#160;</td>
    <td style="text-align: center">February 2, 2021</td>
    <td>&#160;</td>
    <td style="text-align: center">333-252671</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify">10.3</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1734750/000121390022016132/f10k2021ex10-3_movanoinc.htm">Non-Employee
        Director Compensation Policy &#8224;(effective in fiscal year 2025)</a></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">10-K</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">10.3</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">March 30, 2022</td>
    <td>&#160;</td>
    <td style="text-align: center">001-40254</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify">10.4</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1734750/000121390021006218/ea134117ex10-4_movano.htm">Form
        of Indemnification Agreement by and between the Registrant and each of its directors and executive officers &#8224;&#160;</a></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">S-1</td>
    <td>&#160;</td>
    <td style="text-align: center">10.4</td>
    <td>&#160;</td>
    <td style="text-align: center">February 2, 2021</td>
    <td>&#160;</td>
    <td style="text-align: center">333-252671</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify">10.5</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1734750/000121390021006218/ea134117ex10-5_movano.htm">Offer
        Letter, dated November 29, 2019, by and between the Registrant and Michael Leabman &#8224;</a></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">S-1</td>
    <td>&#160;</td>
    <td style="text-align: center">10.5</td>
    <td>&#160;</td>
    <td style="text-align: center">February 2, 2021 </td>
    <td>&#160;</td>
    <td style="text-align: center">333-252671</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify">10.6</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1734750/000121390021006218/ea134117ex10-7_movano.htm">Offer
        Letter, dated November 29, 2019, by and between the Registrant and J. Cogan &#8224;</a></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">S-1</td>
    <td>&#160;</td>
    <td style="text-align: center">10.7</td>
    <td>&#160;</td>
    <td style="text-align: center">February 2, 2021</td>
    <td>&#160;</td>
    <td style="text-align: center">333-252671</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify">10.7</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1734750/000121390021006218/ea134117ex10-16_movano.htm">Form
        of 2020 Note Purchase Agreement</a></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">S-1 </td>
    <td>&#160;</td>
    <td style="text-align: center">10.16</td>
    <td>&#160;</td>
    <td style="text-align: center">February 2, 2021</td>
    <td>&#160;</td>
    <td style="text-align: center">333-252671</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify">10.8</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1734750/000121390021006218/ea134117ex10-17_movano.htm">Amended
        and Restated Lead Investor Agreement, dated August 27, 2020, between the Registrant and Maestro Venture Partners, LLC</a></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">S-1</td>
    <td>&#160;</td>
    <td style="text-align: center">10.17</td>
    <td>&#160;</td>
    <td style="text-align: center">February 2, 2021</td>
    <td>&#160;</td>
    <td style="text-align: center">333-252671</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify">10.9</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1734750/000121390021014638/ea136285ex10-17_movano.htm">Offer
        Letter, dated February 8, 2021, by and between the Registrant and John Mastrototaro &#8224;</a></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">S-1/A</td>
    <td>&#160;</td>
    <td style="text-align: center">10.17</td>
    <td>&#160;</td>
    <td style="text-align: center">March 10, 2021</td>
    <td>&#160;</td>
    <td style="text-align: center">333-252671</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify">10.10</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1734750/000121390021014638/ea136285ex10-18_movano.htm">First
        Amendment to Employment Letter Agreement, dated February 10, 2021, by and between the Registrant and Michael Leabman &#8224;</a></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">S-1/A</td>
    <td>&#160;</td>
    <td style="text-align: center">10.18</td>
    <td>&#160;</td>
    <td style="text-align: center">March 10, 2021</td>
    <td>&#160;</td>
    <td style="text-align: center">333-252671</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify">10.11</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1734750/000121390021014638/ea136285ex10-20_movano.htm">First
        Amendment to Employment Letter Agreement, dated February 10, 2021, by and between the Registrant and J. Cogan&#160;&#8224;</a></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">S-1/A</td>
    <td>&#160;</td>
    <td style="text-align: center">10.20</td>
    <td>&#160;</td>
    <td style="text-align: center">March 10, 2021</td>
    <td>&#160;</td>
    <td style="text-align: center">333-252671</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify">10.12</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1734750/000121390022034332/ea161876ex10-1_movano.htm">Amendment
        No. 1 to Movano Inc. Amended and Restated Omnibus Incentive Plan &#8224;</a></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">8-K</td>
    <td>&#160;</td>
    <td style="text-align: center">10.1</td>
    <td>&#160;</td>
    <td style="text-align: center">June 22, 2022</td>
    <td>&#160;</td>
    <td style="text-align: center">001-40254</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify">10.13</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1734750/000121390024060520/ea020913101ex10-1_movano.htm">Amendment
        No. 2 to Movano Inc. Amended and Restated Omnibus Incentive Plan &#8224;</a></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">8-K</td>
    <td>&#160;</td>
    <td style="text-align: center">10.1</td>
    <td>&#160;</td>
    <td style="text-align: center">July 10, 2024</td>
    <td>&#160;</td>
    <td style="text-align: center">001-40254</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify">10.14</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1734750/000121390025122540/ea026986201ex10-1_movano.htm">Amendment
        No. 3 to Movano Inc. Amended and Restated Omnibus Incentive Plan &#8224;</a></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">8-K</td>
    <td>&#160;</td>
    <td style="text-align: center">10.1</td>
    <td>&#160;</td>
    <td style="text-align: center">December 17, 2025</td>
    <td>&#160;</td>
    <td style="text-align: center">001-40254</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify">10.15</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="ea028760001ex10-15.htm">Corvex, Inc. 2024 Equity Incentive Plan</a></td>
    <td>&#160;</td>
    <td style="text-align: center">x</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify">10.16</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1734750/000121390025030345/ea022715301ex10-18_movano.htm">Office
        Lease, dated March 29, 2021, by and between Bernal Corporate Park II-E, LLC and the Company</a></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">10-K</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">10.18</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">April 9, 2025</td>
    <td>&#160;</td>
    <td style="text-align: center">001-40254</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify">10.17</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1734750/000121390025030345/ea022715301ex10-19_movano.htm">First
        Amendment to Office Lease, dated April 22, 2022, by and between Bernal Corporate Park II-E, LLC and the Company</a></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">10-K</td>
    <td style="text-align: center"/>
    <td style="text-align: center">10.19&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">April 9, 2025</td>
    <td>&#160;</td>
    <td style="text-align: center">001-40254</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify">10.18</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1734750/000121390025030345/ea022715301ex10-20_movano.htm">Second
        Amendment to Office Lease, dated January 9, 2024, by and between Bernal Corporate Park II-E, LLC and the Company</a></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">10-K</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">10.20</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">April 9, 2025</td>
    <td>&#160;</td>
    <td style="text-align: center">001-40254</td></tr>
  </table><div>

</div><p style="margin: 0">&#160;</p><div>

</div><p style="margin: 0"></p><div>

</div><!-- Field: Page; Sequence: 22; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="margin: 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px">
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify">10.19</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1734750/000121390025030345/ea022715301ex10-21_movano.htm">Third
        Amendment to Office Lease, dated June 19, 2024, by and between Bernal Corporate Park II-E, LLC and the Company</a></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">10-K</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">10.21</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">April 9, 2025</td>
    <td>&#160;</td>
    <td style="text-align: center">001-40254</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="width: 5%; text-align: justify">10.20</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 51%; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1734750/000121390025110877/ea026138901ex10-1_movano.htm">Loan
        Agreement and Promissory Note, dated August 6, 2025, by and between the Registrant and Evie Holdings LLC</a></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 5%; text-align: center">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 5%; text-align: center">10-Q</td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 5%; text-align: center">10.1</td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 13%; text-align: center">November 14, 2025</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 10%; text-align: center">001-40254</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify">10.21</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1734750/000121390025110877/ea026138901ex10-2_movano.htm">First
        Amendment to Loan Agreement, dated November 3, 2025, by and between the Registrant and Evie Holdings LLC</a></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">10-Q</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">10.2</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">November 14, 2025</td>
    <td>&#160;</td>
    <td style="text-align: center">001-40254</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify">10.22</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1734750/000121390025110877/ea026138901ex10-3_movano.htm">Second
        Amendment to Loan Agreement, dated November 6, 2025, by and between the Registrant and Evie Holdings LLC</a></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">10-Q</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">10.3</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">November 14, 2025</td>
    <td>&#160;</td>
    <td style="text-align: center">001-40254</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify">10.23</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1734750/000121390026031846/ea028203201ex10-3.htm">Third Amendment to Loan Agreement,
        dated March 19, 2026, by and between the Registrant and Evie Holdings, LLC</a></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">8-K</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">10.3</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">March 19, 2026</td>
    <td>&#160;</td>
    <td style="text-align: center">001-40254</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify">10.24</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1734750/000121390025110877/ea026138901ex10-4_movano.htm">Security
        Agreement, dated August 6, 2025, by and between the Registrant and Evie Holdings LLC</a></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">10-Q</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">10.4</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">November 14, 2025</td>
    <td>&#160;</td>
    <td style="text-align: center">001-40254</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify">10.25</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1734750/000121390025110877/ea026138901ex10-5_movano.htm">Intellectual
        Property Security Agreement, dated August 6, 2025, by and between the Registrant and Evie Holdings LLC</a></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">10-Q</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">10.5</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">November 14, 2025</td>
    <td>&#160;</td>
    <td style="text-align: center">001-40254</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify">10.26</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1734750/000121390025107857/ea026448601ex10-1_movano.htm">Form
        of Support Agreement</a></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">8-K</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">10.1</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">November 10, 2025</td>
    <td>&#160;</td>
    <td style="text-align: center">001-40254</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify">10.27</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1734750/000121390025107857/ea026448601ex10-2_movano.htm">Form
        of Lock-Up Agreement</a></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">8-K</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">10.2</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">November 10, 2025</td>
    <td>&#160;</td>
    <td style="text-align: center">001-40254</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify">10.28</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1734750/000121390025107857/ea026448601ex10-3_movano.htm">Form
        of Series A Subscription Agreement</a></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">8-K</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">10.3</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">November 10, 2025</td>
    <td>&#160;</td>
    <td style="text-align: center">001-40254</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify">10.29</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1734750/000121390025107857/ea026448601ex10-4_movano.htm">ChEF
        Purchase Agreement, by and between the Registrant and Chardan Capital Markets LLC</a></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">8-K</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">10.4</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">November 10, 2025</td>
    <td>&#160;</td>
    <td style="text-align: center">001-40254</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify">10.30</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1734750/000121390025107857/ea026448601ex10-5_movano.htm">ChEF
        Registration Rights Agreement, by and between the Registrant and Chardan Capital Markets LLC</a></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">8-K</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">10.5</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">November 10, 2025</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;001-40254</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify">10.31</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1734750/000121390026031846/ea028203201ex10-4.htm">Corvex,
        Inc. Director Compensation Policy&#8224; (effective fiscal year 2026)</a> </td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">8-K</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">10.4</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">March 19, 2026</td>
    <td>&#160;</td>
    <td style="text-align: center">001-40254</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify">10.32</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1734750/000121390026031846/ea028203201ex10-5.htm">Employment
        Agreement, dated as March 19, 2026, by and between the Company and Seth Demsey&#8224;</a></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">8-K</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">10.5</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">March 19, 2026</td>
    <td>&#160;</td>
    <td style="text-align: center">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">001-40254</p></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify">10.33</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1734750/000121390026031846/ea028203201ex10-6.htm">Employment
        Agreement, dated as March 19, 2026, by and between the Company and Jay Crystal&#8224;</a></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">8-K</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">10.6</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">March 19, 2026</td>
    <td>&#160;</td>
    <td style="text-align: center">001-40254</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify">10.34</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1734750/000121390026031846/ea028203201ex10-7.htm">Form
        of Indemnification Agreement&#8224;</a></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">8-K</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">10.7</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">March 19, 2026</td>
    <td>&#160;</td>
    <td style="text-align: center">001-40254</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify">19.1</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1734750/000121390026036609/ea027832001ex19-1.htm">Insider Trading Policy</a></td>
    <td>&#160;</td>
    <td style="text-align: center"/>
    <td>&#160;</td>
    <td style="text-align: center">10-K</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">19.1</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">March 31, 2026</td>
    <td>&#160;</td>
    <td style="text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">001-40254</p></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify">21.1</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1734750/000121390026036609/ea027832001ex21-1.htm">Subsidiaries of the Company</a></td>
    <td>&#160;</td>
    <td style="text-align: center"/>
    <td>&#160;</td>
    <td style="text-align: center">10-K</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">21.1</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">March 31, 2026</td>
    <td>&#160;</td>
    <td style="text-align: center">001-40254</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify">23.1</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1734750/000121390026036609/ea027832001ex23-1.htm">Consent of RBSM LLP, Independent Registered Public Accounting Firm of Movano Inc.</a></td>
    <td>&#160;</td>
    <td style="text-align: center"/>
    <td>&#160;</td>
    <td style="text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">10-K</p></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">23.1</p>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">March 31, 2026</p>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">001-40254</p>&#160;</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify">23.2</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1734750/000121390026036609/ea027832001ex23-2.htm">Consent of Baker Tilly US, LLP, former Independent Registered Public Accounting Firm of Movano Inc.</a></td>
    <td>&#160;</td>
    <td style="text-align: center"/>
    <td>&#160;</td>
    <td style="text-align: center">10-K</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">23.2</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">March 31, 2026</td>
    <td>&#160;</td>
    <td style="text-align: center">001-40254</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify">24.1 </td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1734750/000121390026036609/ea0278320-10k_corvex.htm#a_028">Power of Attorney (included on signature page)</a></td>
    <td>&#160;</td>
    <td style="text-align: center"/>
    <td>&#160;</td>
    <td style="text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">10-K</p></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">24.1</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">March 31, 2026</td>
    <td>&#160;</td>
    <td style="text-align: center">001-40254</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify">31.1</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1734750/000121390026036609/ea027832001ex31-1.htm">Rule 13(a)-14(a)/15(d)-14(a) Certification of Principal Executive Officer</a></td>
    <td>&#160;</td>
    <td style="text-align: center"/>
    <td>&#160;</td>
    <td style="text-align: center">10-K</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">32.1</p></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">March 31, 2026</p></td>
    <td>&#160;</td>
    <td style="text-align: center">001-40254</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify">31.2</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1734750/000121390026036609/ea027832001ex31-2.htm">Rule 13(a)-14(a)/15(d)-14(a) Certification of Principal Financial and Accounting Officer</a></td>
    <td>&#160;</td>
    <td style="text-align: center"/>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">10-K</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">32.1</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">March 31, 2026</td>
    <td>&#160;</td>
    <td style="text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">001-40254</p></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify">31.3</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="ea028760001ex31-3.htm">Rule 13(a)-14(a)/15(d)-14(a) Certification of Principal Executive Officer</a></td>
    <td>&#160;</td>
    <td style="text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">x</p></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify">31.4</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="ea028760001ex31-4.htm">Rule 13(a)-14(a)/15(d)-14(a) Certification of Principal Financial and Accounting Officer</a></td>
    <td>&#160;</td>
    <td style="text-align: center">x</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify">32.1</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1734750/000121390026036609/ea027832001ex32-1.htm">Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002*</a></td>
    <td>&#160;</td>
    <td style="text-align: center"/>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">10-K</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">32.1</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">March 31, 2026</td>
    <td>&#160;</td>
    <td style="text-align: center">001-40254</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify">97.1</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1734750/000121390026036609/ea027832001ex97-1.htm">Incentive-Based Compensation Recovery Policy&#8224;</a></td>
    <td>&#160;</td>
    <td style="text-align: center"/>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">10-K</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">97.1</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">March 31, 2026</p></td>
    <td>&#160;</td>
    <td style="text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">001-40254</p></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td>101.INS</td>
    <td>&#160;</td>
    <td colspan="11">Inline XBRL Instance Document </td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td>101.SCH</td>
    <td>&#160;</td>
    <td colspan="11">Inline XBRL Taxonomy Extension Schema Document.</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td>101.CAL</td>
    <td>&#160;</td>
    <td colspan="11">Inline XBRL Taxonomy Extension Calculation Linkbase
        Document.</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td>101.DEF</td>
    <td>&#160;</td>
    <td colspan="11">Inline XBRL Taxonomy Extension Definition Linkbase
        Document.</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td>101.LAB</td>
    <td>&#160;</td>
    <td colspan="11">Inline XBRL Taxonomy Extension Label Linkbase Document.</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td>101.PRE</td>
    <td>&#160;</td>
    <td colspan="11">Inline XBRL Taxonomy Extension Presentation Linkbase
        Document.</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td>104</td>
    <td>&#160;</td>
    <td colspan="11">Cover Page Interactive Data File (formatted as
        Inline XBRL and contained in Exhibit 101).</td></tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8224;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management contract or compensatory plan or arrangement</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furnished herewith</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">#</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The schedules and exhibits to the Merger Agreement have been omitted pursuant to Item&#160;601(b)(2)&#160;of Regulation&#160;S-K.&#160;A copy of any omitted schedule and/or exhibit will be furnished to the Securities and Exchange Commission upon request</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 23; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the requirements of Section 13 or
15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Corvex, Inc.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="width: 62%">&#160;</td>
    <td style="width: 3%">&#160;</td>
    <td style="width: 35%">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated: April 27, 2026</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ J Cogan</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">J Cogan<br/>
Chief Financial Officer<br/>
(Principal Financial and Accounting Officer)</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 24; Options: Last --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><div style="display: none"><ix:header>
<ix:hidden>
<ix:nonNumeric contextRef="c0" name="dei:EntityCentralIndexKey" id="ixv-4488">0001734750</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:AmendmentFlag" id="ixv-4489">true</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:DocumentFiscalPeriodFocus" id="ixv-4490">FY</ix:nonNumeric>
</ix:hidden>
<ix:references><link:schemaRef xlink:href="move-20251231.xsd" xlink:type="simple"/></ix:references>
<ix:resources xmlns="http://www.xbrl.org/2003/instance"><xbrli:context xmlns="" id="c0">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001734750</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c1">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001734750</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c2">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001734750</xbrli:identifier>
  </xbrli:entity>
<!-- [WMV7][UIvqGt2gtTWrTEu5uvDatQufRkfvsj8JGTHBWWsujCuOtITZVOTuQ/B48iACoFzx+q/P/UQHIuTwME/MKyWMkjkGfI/Swy1Us+3uVmSOFeoiKxr++R812LB7WCx7VCkSVZRunRR+Zi36tNJRmX5Quinlkr+70crzWnU/ed+xPiSNUelzhcdoGX6bPtDE0powowNMYsIFwQPH6IFKMSPDXkxWMFxS8HCmIvM7eobpKcJseiva/3cZNYWtgTIL1DlfK6KEOPdsw4v936Ggvte4J3F0luao7ezFGleCJRsSyVtTHl2/6RDWusrABBWlRmU1K/5Gu3HOH+7jEbc+OITemi7i+PnhuTr1qFcBi76e9Hhdw9NlT2TO/NT9ssJrzWIMUA==] CSR-->
  <xbrli:period>
    <xbrli:instant>2026-04-20</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:unit xmlns="" id="usd">
  <xbrli:measure>iso4217:USD</xbrli:measure>
</xbrli:unit><xbrli:unit xmlns="" id="shares">
  <xbrli:measure>xbrli:shares</xbrli:measure>
</xbrli:unit></ix:resources></ix:header>
</div></div></body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.6
<SEQUENCE>2
<FILENAME>ea028760001ex4-6.htm
<DESCRIPTION>DESCRIPTION OF COMMON STOCK OF THE REGISTRANT REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
4.6</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DESCRIPTION
OF COMMON STOCK OF CORVEX, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>REGISTERED
PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a brief description of our common stock. This summary does not purport to be complete in all respects. This description
is subject to and qualified entirely by the terms of our Third Amended and Restated Certificate of Incorporation (the &ldquo;Certificate
of Incorporation&rdquo;), and our Second Amended and Restated Bylaws (the &ldquo;Bylaws&rdquo;), each of which are incorporated by reference
as an exhibit to the Annual Report on Form 10-K of which this Exhibit 4.6 is a part.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Authorized
Common Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Certificate of Incorporation authorizes the issuance of 500,000,000 shares of Common Stock. Our authorized but unissued shares of Common
Stock are available for issuance without further action by our stockholders, unless such action is required by applicable law or the
rules of any stock exchange or automated quotation system on which our securities may be listed or traded.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Voting</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
outstanding share of our Common Stock is entitled to one vote on all matters submitted to a vote of shareholders. There is no cumulative
voting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Dividends</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
holders of outstanding shares of our Common Stock are entitled to receive dividends out of assets legally available for the payment of
dividends at the times and in the amounts as our board of directors may from time to time determine.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Rights
and Preferences</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
of Common Stock are neither redeemable nor convertible. Holders of Common Stock have no preemptive or subscription rights to purchase
any of our securities and no sinking fund provisions apply to our Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Liquidation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event of our liquidation, dissolution or winding up, holders of Common Stock are entitled to receive, pro rata, our assets which
are legally available for distribution, after payments of all debts and other liabilities and subject to the prior rights of any holders
of preferred stock then outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Preferred
Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors has the authority, without further action by our stockholders, to issue up to 5,000,000 shares of preferred stock
in one or more series and to fix the designations, powers, rights, preferences, qualifications, limitations and restrictions thereof.
These designations, powers, rights and preferences could include voting rights, dividend rights, dissolution rights, conversion rights,
exchange rights, redemption rights, liquidation preferences, and the number of shares constituting any series or the designation of such
series, any or all of which may be greater than the rights of Common Stock. The issuance of preferred stock could adversely affect the
voting power of holders of Common Stock and the likelihood that such holders will receive dividend payments and payments upon liquidation.
In addition, the issuance of preferred stock could have the effect of delaying, deferring or preventing a change in our control or other
corporate action.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Anti-Takeover
Provisions</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a summary of certain provisions of Delaware law, our Certificate of Incorporation and our Bylaws. This summary does not
purport to be complete and is qualified in its entirety by reference to the corporate law of Delaware and our Certificate of Incorporation
and bylaws. The provisions of Delaware law, the Certificate of Incorporation and the By-Laws could have the effect of delaying, deferring
or discouraging another person from acquiring control of us. These provisions, which are summarized below, may have the effect of discouraging
takeover bids. They are also designed, in part, to encourage persons seeking to acquire control of us to negotiate first with our board
of directors. We believe that the benefits of increased protection of our potential ability to negotiate with an unfriendly or unsolicited
acquirer outweigh the disadvantages of discouraging a proposal to acquire us because negotiation of these proposals could result in an
improvement of their terms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Delaware
Law</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
must comply with Section 203 of the Delaware General Corporation Law, an anti-takeover law. In general, Section 203 prohibits a publicly
held Delaware corporation from engaging in a &ldquo;business combination&rdquo; with an &ldquo;interested stockholder&rdquo; for a period
of three years following the date the person became an interested stockholder, unless the business combination or the transaction in
which the person became an interested stockholder is approved in a prescribed manner or certain other exceptions are met. Generally,
a &ldquo;business combination&rdquo; includes a merger, asset or stock sale, or other transaction resulting in a financial benefit to
an interested stockholder. An &ldquo;interested stockholder&rdquo; includes a person who, together with affiliates and associates, owns,
or did own within three years prior to the determination of interested stockholder status, 15% or more of the corporation&rsquo;s voting
stock. The existence of this provision generally will have an anti-takeover effect for transactions not approved in advance by the board
of directors, including discouraging attempts that might result in a premium over the market price for the shares of Common Stock held
by stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Certificate
of Incorporation and Bylaws Provisions</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Certificate of Incorporation and Bylaws include provisions that may have the effect of discouraging, delaying or preventing a change
in control or an unsolicited acquisition proposal that a stockholder might consider favorable, including a proposal that might result
in the payment of a premium over the market price for the shares held by our stockholders. Certain of these provisions are summarized
in the following paragraphs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Authorized
but Unissued Shares</U>. One of the effects of the existence of authorized but unissued common stock may be to enable our board of directors
to make more difficult or to discourage an attempt to obtain control of our Company by means of a merger, tender offer, proxy contest
or otherwise, and thereby to protect the continuity of management. If, in the due exercise of its fiduciary obligations, the board of
directors were to determine that a takeover proposal was not in our best interest, such shares could be issued by the board of directors
without stockholder approval in one or more transactions that might prevent or render more difficult or costly the completion of the
takeover transaction by diluting the voting or other rights of the proposed acquirer or insurgent stockholder group, by putting a substantial
voting block in institutional or other hands that might undertake to support the position of the incumbent board of directors, by effecting
an acquisition that might complicate or preclude the takeover, or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Undesignated
Preferred Stock</U>. Our board of directors has the ability to issue preferred stock with voting or other rights, preferences and privileges
that could have the effect of deterring hostile takeovers or delaying changes in control of our Company or management.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Cumulative
Voting</U>. Our Certificate of Incorporation does not provide for cumulative voting in the election of directors, which would allow holders
of less than a majority of the stock to elect some directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Classified
Board of Directors</U>. Our Certificate of Incorporation and Bylaws provide that our board of directors is divided into three classes,
with members of each class serving staggered three-year terms. Our classified Board of Directors could have the effect of delaying or
discouraging an acquisition of us or a change in management.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Vacancies</U>.
Our Certificate of Incorporation provides that all vacancies may be filled by the affirmative vote of a majority of directors then in
office, even if less than a quorum.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Actions
at Meetings of Stockholders; Special Meeting of Stockholders and Advance Notice Requirements for Stockholder Proposals</U>. Our Certificate
of Incorporation and Bylaws require that any action required or permitted to be taken by our stockholders must be effected at a duly
called annual or special meeting of the stockholders and may not be effected by a consent in writing. Our Certificate of Incorporation
and Bylaws also provide that special meetings of stockholders may be called from time to time only by a majority of our board of directors,
our president, chief executive officer or the chairman of the board for the purpose specified in the notice of meeting. In addition,
the Bylaws provide that candidates for director may be nominated and other business brought before an annual meeting only by the Board
of Directors or by a stockholder who gives written notice to us not less than 90 days, nor more than 120 days, prior to the first anniversary
of the preceding year&rsquo;s annual meeting, subject to certain exceptions. Such stockholder&rsquo;s notice must set forth certain information
required by the Bylaws. These provisions may have the effect of deterring unsolicited offers to acquire our company or delaying stockholder
actions, even if they are favored by the holders of a majority of our outstanding voting securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Supermajority
Voting for Amendments to Our Governing Documents</U>. Amendments to certain provisions our Certificate of Incorporation relating to our
board of directors, actions of stockholders, director liability, choice of forum and amendments to our Certificate of Incorporation will
require the affirmative vote of at least 66 2/3% of the voting power of all shares of our capital stock then outstanding. Our Certificate
of Incorporation provides that the board of directors is expressly authorized to adopt, amend or repeal our Bylaws and that our stockholders
may amend our Bylaws only with the approval of at least 66 2/3% of the voting power of all shares of our capital stock then outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Choice
of Forum</U>. Our Certificate of Incorporation provides that, subject to certain exceptions, the Court of Chancery of the State of Delaware
will be the exclusive forum for any claim, including any derivative claim, (i) that is based upon a violation of a duty by a current
or former director or officer or stockholder in such capacity or (ii) as to which the Delaware General Corporation Law, or any other
provision of Title 8 of the Delaware Code, confers jurisdiction upon the Court of Chancery. Additionally, our Certificate of Incorporation
provides that the federal district courts of the United States of America shall be the exclusive forum for the resolution of any complaint
asserting a cause of action arising under the Securities Act of 1933.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Listing
on the Nasdaq Capital Market</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
of Common Stock are listed on the Nasdaq Capital Market under the symbol &ldquo;MOVE.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">3</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.15
<SEQUENCE>3
<FILENAME>ea028760001ex10-15.htm
<DESCRIPTION>CORVEX, INC. 2024 EQUITY INCENTIVE PLAN
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 10.15</B></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>KLUSTR, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>2024 EQUITY INCENTIVE PLAN</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>ADOPTED BY THE BOARD OF DIRECTORS:
November 5, 2024<BR>
 APPROVED BY THE STOCKHOLDERS: November 5, 2024<BR>
 TERMINATION DATE: November 4, 2034</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 35.95pt"><B>1.</B></TD><TD STYLE="text-align: left"><B>General</B>.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Eligible Stock Award Recipients</B>. Employees, Directors and Consultants are eligible to receive Stock Awards.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Available Stock Awards</B>. The Plan provides for the grant of the following types of Stock Awards: (i) Incentive Stock Options,
(ii) Nonstatutory Stock Options, (iii) Stock Appreciation Rights, (iv) Restricted Stock Awards, (v) Restricted Stock Unit Awards and (vi)
Other Stock Awards.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Purpose</B>. The Plan, through the grant of Stock Awards, is intended to help the Company secure and retain the services of eligible
award recipients, provide incentives for such persons to exert maximum efforts for the success of the Company and any Affiliate and provide
a means by which the eligible recipients may benefit from increases in value of the Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 35.95pt">2.</TD><TD>Administration<FONT STYLE="font-weight: normal">.</FONT></TD></TR></TABLE>

<P STYLE="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Administration by the Board</B>. The Board will administer the Plan. The Board may delegate administration of the Plan to a Committee
or Committees, as provided in Section 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Powers of the Board</B>. The Board will have the power, subject to, and within the limitations of, the express provisions of the
Plan:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><B>(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT></B>To determine (A) who will be granted Stock Awards; (B) when and how each Stock Award will be granted; (C) what type of Stock
Award will be granted; (D) the provisions of each Stock Award (which need not be identical), including when a person will be permitted
to exercise or otherwise receive cash or Common Stock under the Stock Award; (E) the number of shares of Common Stock subject to, or the
cash value of, a Stock Award; and (F) the Fair Market Value applicable to a Stock Award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><B>(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT></B>To construe and interpret the Plan and Stock Awards granted under it, and to establish, amend and revoke rules and regulations
for administration of the Plan and Stock Awards. The Board, in the exercise of these powers, may correct any defect, omission or inconsistency
in the Plan or in any Stock Award Agreement, in a manner and to the extent it will deem necessary or expedient to make the Plan or Stock
Award fully effective.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"> <B>(iii)</B> To settle all controversies regarding the Plan and Stock Awards granted under it.</P>



<P STYLE="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><B>(iv)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT></B>To accelerate, in whole or in part, the time at which a Stock Award may be exercised or vest (or the time at which cash or
shares of Common Stock may be issued in settlement thereof).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->.</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><B>(v)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT></B>To suspend or terminate the Plan at any time. Except as otherwise provided in the Plan or a Stock Award Agreement, suspension
or termination of the Plan will not impair a Participant&rsquo;s rights under the Participant&rsquo;s then-outstanding Stock Award without
the Participant&rsquo;s written consent except as provided in subsection (viii) below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><B>(vi)</B> To
amend the Plan in any respect the Board deems necessary or advisable, including, without limitation, by adopting amendments relating
to Incentive Stock Options and certain nonqualified deferred compensation under Section 409A of the Code and/or bringing the Plan or
Stock Awards granted under the Plan into compliance with the requirements for Incentive Stock Options or ensuring that they are
exempt from, or compliant with, the requirements for nonqualified deferred compensation under Section 409A of the Code, subject to
the limitations, if any, of applicable law. If required by applicable law or listing requirements, and except as provided in Section
9(a) relating to Capitalization Adjustments, the Company will seek stockholder approval of any amendment of the Plan that (A)
materially increases the number of shares of Common Stock available for issuance under the Plan, (B) materially expands the class of
individuals eligible to receive Stock Awards under the Plan, (C) materially increases the benefits accruing to Participants under
the Plan, (D) materially reduces the price at which shares of Common Stock may be issued or purchased under the Plan, (E) materially
extends the term of the Plan, or (F) materially expands the types of Stock Awards available for issuance under the Plan. Except as
otherwise provided in the Plan or a Stock Award Agreement, no amendment of the Plan will materially impair a Participant&rsquo;s
rights under an outstanding Stock Award without the Participant&rsquo;s written consent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><B>(vii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT></B>To submit any amendment to the Plan for stockholder approval, including, but not limited to, amendments to the Plan intended
to satisfy the requirements of Section 422 of the Code regarding Incentive Stock Options.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><B>(viii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT></B>To approve forms of Stock Award Agreements for use under the Plan and to amend the terms of any one or more Stock Awards, including,
but not limited to, amendments to provide terms more favorable to the Participant than previously provided in the Stock Award Agreement,
subject to any specified limits in the Plan that are not subject to Board discretion; <I>provided however, </I>that a Participant&rsquo;s
rights under any Stock Award will not be impaired by any such amendment unless (A) the Company requests the consent of the affected Participant,
and (B) such Participant consents in writing. Notwithstanding the foregoing, (1) a Participant&rsquo;s rights will not be deemed to have
been impaired by any such amendment if the Board, in its sole discretion, determines that the amendment, taken as a whole, does not materially
impair the Participant&rsquo;s rights, and (2) subject to the limitations of applicable law, if any, the Board may amend the terms of
any one or more Stock Awards without the affected Participant&rsquo;s consent (A) to maintain the qualified status of the Stock Award
as an Incentive Stock Option under Section 422 of the Code; (B) to change the terms of an Incentive Stock Option, if such change results
in impairment of the Stock Award solely because it impairs the qualified status of the Stock Award as an Incentive Stock Option under
Section 422 of the Code; (C) to clarify the manner of exemption from, or to bring the Stock Award into compliance with, Section 409A of
the Code; or (D) to comply with other applicable laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><B>(ix)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT></B>Generally, to exercise such powers and to perform such acts as the Board deems necessary or expedient to promote the best interests
of the Company and that are not in conflict with the provisions of the Plan or Stock Awards.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><B>(x)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT></B>To adopt such procedures and sub-plans as are necessary or appropriate to permit participation in the Plan by Employees, Directors
or Consultants who are foreign nationals or employed outside the United
States (provided that Board approval will not be necessary for immaterial modifications to the Plan or any Stock Award Agreement that
are required for compliance with the laws of the relevant foreign jurisdiction).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->.</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><B>(xi)</B> To effect,
with the consent of any adversely affected Participant, (A) the reduction of the exercise, purchase or strike price of any outstanding
Stock Award; (B) the cancellation of any outstanding Stock Award and the grant in substitution therefor of a new (1) Option or SAR, (2)
Restricted Stock Award, (3) Restricted Stock Unit Award, (4) Other Stock Award, (5) cash and/or (6) other valuable consideration determined
by the Board, in its sole discretion, with any such substituted award (x) covering the same or a different number of shares of Common
Stock as the cancelled Stock Award and (y) granted under the Plan or another equity or compensatory plan of the Company; or (C) any other
action that is treated as a repricing under generally accepted accounting principles.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Delegation to Committee</B>. The Board may delegate some or all of the administration of the Plan to a Committee or Committees.
If administration of the Plan is delegated to a Committee, the Committee will have, in connection with the administration of the Plan,
the powers theretofore possessed by the Board that have been delegated to the Committee, including the power to delegate to a subcommittee
of the Committee any of the administrative powers the Committee is authorized to exercise (and references in this Plan to the Board will
thereafter be to the Committee or subcommittee, as applicable). Any delegation of administrative powers will be reflected in resolutions,
not inconsistent with the provisions of the Plan, adopted from time to time by the Board or Committee (as applicable). The Board may retain
the authority to concurrently administer the Plan with the Committee and may, at any time, revest in the Board some or all of the powers
previously delegated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Delegation to Other Person or Body</B>. The Board may delegate to one or more persons or bodies, in addition to the Board, the
authority to do one or both of the following: (i) designate recipients of Options and SARs (and, to the extent permitted by applicable
law, other Stock Awards) and, to the extent permitted by applicable law, the terms of such Stock Awards, and (ii) determine the number
of shares of Common Stock to be subject to such Stock Awards granted to such recipients; <I>provided, however</I>, that the Board resolutions
regarding such delegation will fix the terms of such delegation in accordance with applicable law, including without limitation Sections
152 and/or 157 of the Delaware General Corporation Law, and <I>provided </I>that no Board resolution may permit a person or body to grant
a Stock Award to such person or body. Any such Stock Awards will be granted on the form of Stock Award Agreement most recently approved
for use by the Committee or the Board, unless otherwise provided in the resolutions approving the delegation authority. The Board may
not delegate authority to determine the Fair Market Value pursuant to Section 13(t) below to any person or body, except that the Board
may delegate such authority to a Committee or Committees of the Board in accordance with Section 2(c) above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Effect of Board&rsquo;s Decision</B>. All determinations, interpretations and constructions made by the Board in good faith will
not be subject to review by any person and will be final, binding and conclusive on all persons.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->.</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 35.95pt">3.</TD><TD STYLE="text-align: justify">Shares Subject to the Plan<FONT STYLE="font-weight: normal">.</FONT></TD></TR></TABLE>

<P STYLE="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 35.9pt"><B>(a)</B></TD><TD STYLE="text-align: justify"><B>Share Reserve</B>.</TD></TR></TABLE>

<P STYLE="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><B>(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT></B>Subject to Section 9(a) relating to Capitalization Adjustments, the aggregate number of shares of Common Stock that may be
issued pursuant to Stock Awards from and after the Effective Date will not exceed 2,295,000 shares (the <B><I>&ldquo;Share Reserve&rdquo;</I></B>).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><B>(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT></B>For clarity, the Share Reserve in this Section 3(a) is a limitation on the number of shares of Common Stock that may be issued
pursuant to the Plan. Accordingly, this Section 3(a) does not limit the granting of Stock Awards except as provided in Section 7(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><B>(b) Reversion of Shares to the Share Reserve</B>.
If a Stock Award or any portion thereof (i) expires or otherwise terminates without all of the shares covered by such Stock Award having
been issued or (ii) is settled in cash (i.e., the Participant receives cash rather than stock), such expiration, termination or settlement
will not reduce (or otherwise offset) the number of shares of Common Stock that may be available for issuance under the Plan. If any
shares of Common Stock issued pursuant to a Stock Award are forfeited back to or repurchased by the Company because of the failure to
meet a contingency or condition required to vest such shares in the Participant, then the shares that are forfeited or repurchased will
be immediately retired and resume the status of authorized and unissued shares of the capital stock of the Company, and will revert to
and again become available for issuance under the Plan. Any shares reacquired by the Company in satisfaction of tax withholding obligations
on a Stock Award or as consideration for the exercise or purchase price of a Stock Award will again become available for issuance under
the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Incentive Stock Option Limit</B>. Subject to the Share Reserve and Section 9(a) relating to Capitalization Adjustments, the aggregate
maximum number of shares of Common Stock that may be issued pursuant to the exercise of Incentive Stock Options will be a number of shares
of Common Stock equal to three multiplied by the Share Reserve.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Source of Shares</B>. The stock issuable under the Plan will be shares of authorized but unissued or reacquired Common Stock, including
shares repurchased by the Company on the open market or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 35.95pt">4.</TD><TD STYLE="text-align: justify">Eligibility<FONT STYLE="font-weight: normal">.</FONT></TD></TR></TABLE>

<P STYLE="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Eligibility for Specific Stock Awards</B>. Incentive Stock Options may be granted only to employees of the Company or a &ldquo;parent
corporation&rdquo; or &ldquo;subsidiary corporation&rdquo; thereof (as such terms are defined in Sections 424(e) and 424(f) of the Code).
Stock Awards other than Incentive Stock Options may be granted to Employees, Directors and Consultants; <I>provided, however</I>, that
Stock Awards may not be granted to Employees, Directors and Consultants who are providing Continuous Service only to any &ldquo;parent&rdquo;
of the Company, as such term is defined in Rule 405, unless (i) the stock underlying such Stock Awards is treated as &ldquo;service recipient
stock&rdquo; under Section 409A of the Code (for example, because the Stock Awards are granted pursuant to a corporate transaction such
as a spin off transaction), (ii) the Company, in consultation with its legal counsel, has determined that such Stock Awards are otherwise
exempt from Section 409A of the Code, or (iii) the Company, in consultation with its legal counsel, has determined that such Stock Awards
comply with the distribution requirements of Section 409A of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->.</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Ten Percent Stockholders</B>. A Ten Percent Stockholder will not be granted an Incentive Stock Option unless the exercise price
of such Option is at least 110% of the Fair Market Value on the date of grant and the Option is not exercisable after the expiration of
five years from the date of grant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>(c) Consultants</B>.
A Consultant will not be eligible for the grant of a Stock Award if, at the time of grant, either the offer or sale of the Company&rsquo;s
securities to such Consultant is not exempt under Rule 701 because of the nature of the services that the Consultant is providing to
the Company, because the Consultant is not a natural person, or because of any other provision of Rule 701, unless the Company determines
that such grant need not comply with the requirements of Rule 701 and will satisfy another exemption under the Securities Act as well
as comply with the securities laws of all other relevant jurisdictions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 35.95pt">5.</TD><TD>Provisions Relating to Options and Stock Appreciation Rights<FONT STYLE="font-weight: normal">.</FONT></TD></TR></TABLE>

<P STYLE="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">Each Option or
SAR will be in such form and will contain such terms and conditions as the Board deems appropriate. All Options will be separately designated
Incentive Stock Options or Nonstatutory Stock Options at the time of grant, and, if certificates are issued, a separate certificate or
certificates will be issued for shares of Common Stock purchased on exercise of each type of Option. If an Option is not specifically
designated as an Incentive Stock Option, or if an Option is designated as an Incentive Stock Option but some portion or all of the Option
fails to qualify as an Incentive Stock Option under the applicable rules, then the Option (or portion thereof) will be a Nonstatutory
Stock Option. The provisions of separate Options or SARs need not be identical; <I>provided, however</I>, that each Stock Award Agreement
will conform to (through incorporation of provisions hereof by reference in the applicable Stock Award Agreement or otherwise) the substance
of each of the following provisions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Term</B>. Subject to the provisions of Section 4(b) regarding Ten Percent Stockholders, no Option or SAR will be exercisable after
the expiration of 10 years from the date of its grant or such shorter period specified in the Stock Award Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Exercise Price</B>. Subject to the provisions of Section 4(b) regarding Ten Percent Stockholders, the exercise or strike price
of each Option or SAR will be not less than 100% of the Fair Market Value of the Common Stock subject to the Option or SAR on the date
the Stock Award is granted. Notwithstanding the foregoing, an Option or SAR may be granted with an exercise or strike price lower than
100% of the Fair Market Value of the Common Stock subject to the Stock Award if such Stock Award is granted pursuant to an assumption
of or substitution for another option or stock appreciation right pursuant to a Corporate Transaction and in a manner consistent with
the provisions of Section 409A of the Code and, if applicable, Section 424(a) of the Code. Each SAR will be denominated in shares of Common
Stock equivalents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Purchase Price for Options</B>. The purchase price of Common Stock acquired pursuant to the exercise of an Option may be paid,
to the extent permitted by applicable law and as determined by the Board in its sole discretion, by any combination of the methods of
payment set forth below. The Board will have the authority to grant Options that do not permit all of the following methods of payment
(or otherwise restrict the ability to use certain methods) and to grant Options that require the consent of the Company to use a particular
method of payment. The permitted methods of payment are as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 1in; margin-top: 0pt; margin-bottom: 0pt"><B>(i)</B> by cash, check, bank draft, electronic
funds transfer or money order payable to the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0in">&nbsp;</P>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->.</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><B>(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT></B>subject to Company and/or Board consent at the time of exercise and provided that at the time of exercise the Common Stock
is publicly traded, pursuant to a program developed under Regulation T as promulgated by the Federal Reserve Board that, prior to the
issuance of Common Stock, results in either the receipt of cash (or check) by the Company or the receipt of irrevocable instructions to
pay the aggregate exercise price to the Company from the sales proceeds. This manner of payment is also known as a &ldquo;broker-assisted
exercise&rdquo;, &ldquo;same day sale&rdquo;, or &ldquo;sell to cover&rdquo;;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><B>(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT></B>subject to Company and/or Board consent at the time of exercise and provided that at the time of exercise the Common Stock
is publicly traded, by delivery to the Company (either by actual delivery or attestation) of already-owned shares of Common Stock that
are owned free and clear of any liens, claims, encumbrances or security interests, and that are valued at Fair Market Value on the date
of exercise. &ldquo;Delivery&rdquo; for these purposes, in the sole discretion of the Company and/or the Board, at the time Participant
exercises their Option, will include delivery to the Company of Participant&rsquo;s attestation of ownership of such shares of Common
Stock in a form approved by the Company. Participant may not exercise their option by delivery to the Company of Common Stock if doing
so would violate the provisions of any law, regulation or agreement restricting the redemption of the Company&rsquo;s stock;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><B>(iv)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT></B>subject to Company and/or Board consent at the time of exercise, and provided that the Option is a Nonstatutory Stock Option,
by a &ldquo;net exercise&rdquo; arrangement pursuant to which the Company will reduce the number of shares of Common Stock issued upon
exercise of the Option by the largest whole number of shares with a Fair Market Value that does not exceed the aggregate exercise price
plus, to the extent permitted by the Company and/or Board at the time of exercise, the aggregate withholding obligations in respect of
the Option exercise; provided, further that Participant must pay any remaining balance of the aggregate exercise price not satisfied by
the &ldquo;net exercise&rdquo; in cash or other permitted form of payment. Shares of Common Stock will no longer be subject to the Option
and will not be exercisable thereafter to the extent that (A) shares issuable upon exercise are used to pay the exercise price pursuant
to the &ldquo;net exercise,&rdquo; (B) shares are delivered to the Participant as a result of such exercise, and (C) shares are withheld
to satisfy tax withholding obligations;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><B>(v)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT></B>according to a deferred payment or similar arrangement with the Optionholder; <I>provided, however</I>, that interest will
compound at least annually and will be charged at the minimum rate of interest necessary to avoid (A) the imputation of interest income
to the Company and compensation income to the Optionholder under any applicable provisions of the Code, and (B) the classification of
the Option as a liability for financial accounting purposes; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"> <B>(vi)</B> in any other form of legal consideration that may be acceptable to the Board.</P>



<P STYLE="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Exercise and Payment of a SAR</B>. To exercise any outstanding SAR, the Participant must provide written notice of exercise to
the Company in compliance with the provisions of the Stock Appreciation Right Agreement evidencing such SAR. The appreciation distribution
payable on the exercise of a SAR will be not greater than an amount equal to the excess of (A) the aggregate Fair Market Value (on the
date of the exercise of the SAR) of a number of shares of Common Stock equal to the number of Common Stock equivalents in which the Participant
is vested under such SAR, and with respect to which the Participant is exercising the SAR on such date, over (B) the aggregate strike
price of the number of Common Stock equivalents with respect to which the Participant is exercising the SAR on such date. The appreciation
distribution may be paid in Common Stock, in cash, in any combination of the two or in any other form of consideration, as determined
by the Board and contained in the Stock Award Agreement evidencing such SAR.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->.</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Transferability of Options and SARs</B>. The Board may, in its sole discretion, impose such limitations on the transferability
of Options and SARs as the Board will determine. In the absence of such a determination by the Board to the contrary, the following restrictions
on the transferability of Options and SARs will apply:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><B>(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Restrictions on Transfer</B>. An Option or SAR will not be transferable except by will or by the laws of descent and distribution
(or pursuant to subsections (ii) and (iii) below), and will be exercisable during the lifetime of the Participant only by the Participant.
The Board may permit transfer of the Option or SAR in a manner that is not prohibited by applicable tax and securities laws. Except as
explicitly provided in the Plan, neither an Option nor a SAR may be transferred for consideration.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><B>(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Domestic Relations Orders</B>. Subject to the approval of the Board or a duly authorized Officer, an Option or SAR may be transferred
pursuant to the terms of a domestic relations order, official marital settlement agreement or other divorce or separation instrument as
permitted by Treasury Regulation 1.421-1(b)(2). If an Option is an Incentive Stock Option, such Option may be deemed to be a Nonstatutory
Stock Option as a result of such transfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><B>(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Beneficiary Designation</B>. Subject to the approval of the Board or a duly authorized Officer, a Participant may, by delivering
written notice to the Company, in a form approved by the Company (or the designated broker), designate a third party who, upon the death
of the Participant, will thereafter be entitled to exercise the Option or SAR and receive the Common Stock or other consideration resulting
from such exercise. In the absence of such a designation, upon the death of the Participant, the executor or administrator of the Participant&rsquo;s
estate will be entitled to exercise the Option or SAR and receive the Common Stock or other consideration resulting from such exercise.
However, the Company may prohibit designation of a beneficiary at any time, including due to any conclusion by the Company that such designation
would be inconsistent with the provisions of applicable laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Vesting Generally</B>. The total number of shares of Common Stock subject to an Option or SAR may vest and therefore become exercisable
in periodic installments that may or may not be equal. The Option or SAR may be subject to such other terms and conditions on the time
or times when it may or may not be exercised (which may be based on the satisfaction of performance goals or other criteria) as the Board
may deem appropriate. The vesting provisions of individual Options or SARs may vary. The provisions of this Section 5(f) are subject to
any Option or SAR provisions governing the minimum number of shares of Common Stock as to which an Option or SAR may be exercised.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Termination of Continuous Service</B>. Except as otherwise provided in the applicable Stock Award Agreement or other agreement
between the Participant and the Company, if a Participant&rsquo;s Continuous Service terminates (other than for Cause and other than upon
the Participant&rsquo;s death or Disability), the Participant may exercise his or her Option or SAR (to the extent that the Participant
was entitled to exercise such Stock Award as of the date of termination of Continuous Service) within the period of time ending on the
earlier of (i) the date three months following the termination of the Participant&rsquo;s Continuous Service (or such longer or shorter
period specified in the applicable Stock Award Agreement, which period will not be less than 30 days if necessary to comply with applicable
laws unless such termination is for Cause) and (ii) the expiration of the term of the Option or SAR as set forth in the Stock Award Agreement.
If, after termination of Continuous Service, the Participant does not exercise his or her Option or SAR (as applicable) within the applicable
time frame, the Option or SAR will terminate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->.</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>(h)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Extension of Termination Date</B>. If the exercise of an Option or SAR following the termination of the Participant&rsquo;s Continuous
Service (other than for Cause and other than upon the Participant&rsquo;s death or Disability) would be prohibited at any time solely
because the issuance of shares of Common Stock would violate the registration requirements under the Securities Act, then the Option or
SAR will terminate on the earlier of (i) the expiration of a total period of time (that need not be consecutive) equal to the applicable
post-termination exercise period after the termination of the Participant&rsquo;s Continuous Service during which the exercise of the
Option or SAR would not be in violation of such registration requirements, and (ii) the expiration of the term of the Option or SAR as
set forth in the applicable Stock Award Agreement. In addition, unless otherwise provided in a Participant&rsquo;s Stock Award Agreement,
if the sale of any Common Stock received upon exercise of an Option or SAR following the termination of the Participant&rsquo;s Continuous
Service (other than for Cause) would violate the Company&rsquo;s insider trading policy, then the Option or SAR will terminate on the
earlier of (i) the expiration of the period of time (that need not be consecutive) equal to the applicable post-termination exercise period
after the termination of the Participant&rsquo;s Continuous Service during which the sale of the Common Stock received upon exercise of
the Option or SAR would not be in violation of the Company&rsquo;s insider trading policy, and (ii) the expiration of the term of the
Option or SAR as set forth in the applicable Stock Award Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>(i) Disability
of Participant</B>. Except as otherwise provided in the applicable Stock Award Agreement or other agreement between the Participant and
the Company, if a Participant&rsquo;s Continuous Service terminates as a result of the Participant&rsquo;s Disability, the Participant
may exercise his or her Option or SAR (to the extent that the Participant was entitled to exercise such Option or SAR as of the date
of termination of Continuous Service), but only within such period of time ending on the earlier of (i) the date 12 months following
such termination of Continuous Service (or such longer or shorter period specified in the Stock Award Agreement, which period will not
be less than six months if necessary to comply with applicable laws unless such termination is for Cause), and (ii) the expiration of
the term of the Option or SAR as set forth in the Stock Award Agreement. If, after termination of Continuous Service, the Participant
does not exercise his or her Option or SAR within the applicable time frame, the Option or SAR (as applicable) will terminate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>(j)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Death of Participant</B>. Except as otherwise provided in the applicable Stock Award Agreement or other agreement between the Participant
and the Company, if (i) a Participant&rsquo;s Continuous Service terminates as a result of the Participant&rsquo;s death, or (ii) the
Participant dies within the period (if any) specified in the Stock Award Agreement for exercisability after the termination of the Participant&rsquo;s
Continuous Service (for a reason other than death), then the Option or SAR may be exercised (to the extent the Participant was entitled
to exercise such Option or SAR as of the date of death) by the Participant&rsquo;s estate, by a person who acquired the right to exercise
the Option or SAR by bequest or inheritance or by a person designated to exercise the Option or SAR upon the Participant&rsquo;s death,
but only within the period ending on the earlier of (i) the date 18 months following the date of death (or such longer or shorter period
specified in the Stock Award Agreement, which period will not be less than six months if necessary to comply with applicable laws unless
such termination is for Cause), and (ii) the expiration of the term of such Option or SAR as set forth in the Stock Award Agreement. If,
after the Participant&rsquo;s death, the Option or SAR is not exercised within the applicable time frame, the Option or SAR (as applicable)
will terminate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>(k)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Termination for Cause</B>. Except as explicitly provided otherwise in a Participant&rsquo;s Stock Award Agreement or other individual
written agreement between the Company or any Affiliate and the Participant, if a Participant&rsquo;s Continuous Service is terminated
for Cause, the Option or SAR will terminate immediately upon such Participant&rsquo;s termination of Continuous Service, and the Participant
will be prohibited from
exercising his or her Option or SAR (whether vested or unvested) from and after the date of such termination of Continuous Service.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->.</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>(l)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Non-Exempt Employees</B>. If an Option or SAR is granted to an Employee who is a non- exempt employee for purposes of the Fair
Labor Standards Act of 1938, as amended, the Option or SAR will not be first exercisable for any shares of Common Stock until at least
six months following the date of grant of the Option or SAR (although the Stock Award may vest prior to such date). Consistent with the
provisions of the Worker Economic Opportunity Act, (i) if such non-exempt Employee dies or suffers a Disability, (ii) upon a Corporate
Transaction in which such Option or SAR is not assumed, continued, or substituted, (iii) upon a Change in Control, or (iv) upon the Participant&rsquo;s
retirement (as such term may be defined in the Participant&rsquo;s Stock Award Agreement, in another agreement between the Participant
and the Company, or, if no such definition, in accordance with the Company&rsquo;s then current employment policies and guidelines), the
vested portion of any Options and SARs may be exercised earlier than six months following the date of grant. The foregoing provision is
intended to operate so that any income derived by a non-exempt employee in connection with the exercise or vesting of an Option or SAR
will be exempt from his or her regular rate of pay. To the extent permitted and/or required for compliance with the Worker Economic Opportunity
Act to ensure that any income derived by a non-exempt employee in connection with the exercise, vesting or issuance of any shares under
any other Stock Award will be exempt from the employee&rsquo;s regular rate of pay, the provisions of this Section 5(l) will apply to
all Stock Awards and are hereby incorporated by reference into such Stock Award Agreements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>(m)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Early Exercise of Options</B>. An Option may, but need not, include a provision whereby the Optionholder may elect at any time
before the Optionholder&rsquo;s Continuous Service terminates to exercise the Option as to any part or all of the shares of Common Stock
subject to the Option prior to the full vesting of the Option. Subject to the &ldquo;Repurchase Limitation&rdquo; in Section 8(l), any
unvested shares of Common Stock so purchased may be subject to a repurchase right in favor of the Company or to any other restriction
the Board determines to be appropriate. Provided that the &ldquo;Repurchase Limitation&rdquo; in Section 8(l) is not violated, the Company
will not be required to exercise its repurchase right until at least six months (or such longer or shorter period of time required to
avoid classification of the Option as a liability for financial accounting purposes) have elapsed following exercise of the Option unless
the Board otherwise specifically provides in the Option Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>(n)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Right of Repurchase</B>. Subject to the &ldquo;Repurchase Limitation&rdquo; in Section 8(l), the Option or SAR may include a provision
whereby the Company may elect to repurchase all or any part of the vested shares of Common Stock acquired by the Participant pursuant
to the exercise of the Option or SAR.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>(o)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Right of First Refusal</B>. The Option or SAR may include a provision whereby the Company may elect to exercise a right of first
refusal following receipt of notice from the Participant of the intent to transfer all or any part of the shares of Common Stock received
upon the exercise of the Option or SAR. Such right of first refusal will be subject to the &ldquo;Repurchase Limitation&rdquo; in Section
8(l). Except as expressly provided in this Section 5(o) or in the Stock Award Agreement, such right of first refusal will otherwise comply
with any applicable provisions of the bylaws of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->.</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 35.95pt">6.</TD><TD>Provisions of Stock Awards Other than Options and SARs<FONT STYLE="font-weight: normal">.</FONT></TD></TR></TABLE>

<P STYLE="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>(a)
Restricted Stock Awards</B>. Each Restricted Stock Award Agreement will be in such form and will contain such terms and conditions
as the Board will deem appropriate. To the extent consistent with the Company&rsquo;s bylaws, at the Board&rsquo;s election, shares
of Common Stock underlying a Restricted Stock Award may be (i) held in book entry form subject to the Company&rsquo;s instructions
until any restrictions relating to the Restricted Stock Award lapse; or (ii) evidenced by a certificate, which certificate will be
held in such form and manner as determined by the Board. The terms and conditions of Restricted Stock Award Agreements may change
from time to time, and the terms and conditions of separate Restricted Stock Award Agreements need not be identical. Each Restricted
Stock Award Agreement will conform to (through incorporation of the provisions hereof by reference in the agreement or otherwise)
the substance of each of the following provisions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; text-indent: 1in; margin-top: 0pt; margin-bottom: 0pt"><B>(i) Consideration</B>.
A Restricted Stock Award may be awarded in consideration for (A) cash, check, bank draft or money order payable to the Company, (B) past
services to the Company or an Affiliate, or (C) any other form of legal consideration (including future services) that may be acceptable
to the Board, in its sole discretion, and permissible under applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><B>(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Vesting</B>. Subject to the &ldquo;Repurchase Limitation&rdquo; in Section 8(l), shares of Common Stock awarded under the Restricted
Stock Award Agreement may be subject to forfeiture to the Company in accordance with a vesting schedule to be determined by the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><B>(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Termination of Participant&rsquo;s Continuous Service</B>. If a Participant&rsquo;s Continuous Service terminates, the Company
may receive through a forfeiture condition or a repurchase right, any or all of the shares of Common Stock held by the Participant that
have not vested as of the date of termination of Continuous Service under the terms of the Restricted Stock Award Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><B>(iv)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Transferability</B>. Rights to acquire shares of Common Stock under the Restricted Stock Award Agreement will be transferable by
the Participant only upon such terms and conditions as are set forth in the Restricted Stock Award Agreement, as the Board will determine
in its sole discretion, so long as Common Stock awarded under the Restricted Stock Award Agreement remains subject to the terms of the
Restricted Stock Award Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><B>(v)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Dividends</B>. A Restricted Stock Award Agreement may provide that any dividends paid on Restricted Stock will be subject to the
same vesting and forfeiture restrictions as apply to the shares subject to the Restricted Stock Award to which they relate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Restricted Stock Unit Awards</B>. Each Restricted Stock Unit Award Agreement will be in such form and will contain such terms and
conditions as the Board will deem appropriate. The terms and conditions of Restricted Stock Unit Award Agreements may change from time
to time, and the terms and conditions of separate Restricted Stock Unit Award Agreements need not be identical. Each Restricted Stock
Unit Award Agreement will conform to (through incorporation of the provisions hereof by reference in the Agreement or otherwise) the substance
of each of the following provisions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><B>(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Consideration</B>. At the time of grant of a Restricted Stock Unit Award, the Board will determine the consideration, if any, to
be paid by the Participant upon delivery of each share of Common Stock subject to the Restricted Stock Unit Award. The consideration to
be paid (if any) by the Participant for each share of Common Stock subject to a Restricted Stock Unit Award may be paid in any form of
legal consideration that may be acceptable to the Board, in its sole discretion, and permissible under applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><B>(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Vesting</B>. At the time of the grant of a Restricted Stock Unit Award, the Board may impose such restrictions on or conditions
to the vesting of the Restricted Stock Unit Award as it, in its sole discretion, deems appropriate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->.</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><B>(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Payment</B>. A Restricted Stock Unit Award may be settled by the delivery of shares of Common Stock, their cash equivalent, any
combination thereof or in any other form of consideration, as determined by the Board and contained in the Restricted Stock Unit Award
Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><B>(iv)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Additional Restrictions</B>. At the time of the grant of a Restricted Stock Unit Award, the Board, as it deems appropriate, may
impose such restrictions or conditions that delay the delivery of the shares of Common Stock (or their cash equivalent) subject to a Restricted
Stock Unit Award to a time after the vesting of such Restricted Stock Unit Award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><B>(v)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Dividend Equivalents</B>. Dividend equivalents may be credited in respect of shares of Common Stock covered by a Restricted Stock
Unit Award, as determined by the Board and contained in the Restricted Stock Unit Award Agreement. At the sole discretion of the Board,
such dividend equivalents may be converted into additional shares of Common Stock covered by the Restricted Stock Unit Award in such manner
as determined by the Board. Any additional shares covered by the Restricted Stock Unit Award credited by reason of such dividend equivalents
will be subject to all of the same terms and conditions of the underlying Restricted Stock Unit Award Agreement to which they relate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><B>(vi)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Termination of Participant&rsquo;s Continuous Service</B>. Except as otherwise provided in the applicable Restricted Stock Unit
Award Agreement, such portion of the Restricted Stock Unit Award that has not vested will be forfeited upon the Participant&rsquo;s termination
of Continuous Service.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><B>(vii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Compliance with Section 409A of the Code</B>. Notwithstanding anything to the contrary set forth herein, any Restricted Stock Unit
Award granted under the Plan that is not exempt from the requirements of Section 409A of the Code will contain such provisions so that
such Restricted Stock Unit Award will comply with the requirements of Section 409A of the Code. Such restrictions, if any, will be determined
by the Board and contained in the Restricted Stock Unit Award Agreement evidencing such Restricted Stock Unit Award. For example, such
restrictions may include, without limitation, a requirement that any Common Stock that is to be issued in a year following the year in
which the Restricted Stock Unit Award vests must be issued in accordance with a fixed pre-determined schedule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Other Stock Awards</B>. Other forms of Stock Awards valued in whole or in part by reference to, or otherwise based on, Common Stock,
including the appreciation in value thereof (e.g., options or stock rights with an exercise price or strike price less than 100% of the
Fair Market Value of the Common Stock at the time of grant) may be granted either alone or in addition to Stock Awards provided for under
Section 5 and the preceding provisions of this Section 6. Subject to the provisions of the Plan, the Board will have sole and complete
authority to determine the persons to whom and the time or times at which such Other Stock Awards will be granted, the number of shares
of Common Stock (or the cash equivalent thereof) to be granted pursuant to such Other Stock Awards and all other terms and conditions
of such Other Stock Awards.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 35.95pt">7.</TD><TD>Covenants of the Company<FONT STYLE="font-weight: normal">.</FONT></TD></TR></TABLE>

<P STYLE="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Availability of Shares</B>. The Company will keep available at all times the number of shares of Common Stock reasonably required
to satisfy then-outstanding Stock Awards.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->.</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>(b)
Securities Law Compliance</B>. The Company will seek to obtain from each regulatory commission or agency having jurisdiction over
the Plan such authority as may be required to grant Stock Awards and to issue and sell shares of Common Stock upon exercise of the
Stock Awards; <I>provided, however, </I>that this undertaking will not require the Company to register under the Securities Act the
Plan, any Stock Award or any Common Stock issued or issuable pursuant to any such Stock Award. If, after reasonable efforts and at a
reasonable cost, the Company is unable to obtain from any such regulatory commission or agency the authority that counsel for the
Company deems necessary for the lawful issuance and sale of Common Stock under the Plan, the Company will be relieved from any
liability for failure to issue and sell Common Stock upon exercise of such Stock Awards unless and until such authority is obtained.
A Participant will not be eligible for the grant of a Stock Award or the subsequent issuance of cash or Common Stock pursuant to the
Stock Award if such grant or issuance would be in violation of any applicable securities law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>No Obligation to Notify or Minimize Taxes</B>. The Company will have no duty or obligation to any Participant to advise such holder
as to the time or manner of exercising such Stock Award. Furthermore, the Company will have no duty or obligation to warn or otherwise
advise such holder of a pending termination or expiration of a Stock Award or a possible period in which the Stock Award may not be exercised.
The Company has no duty or obligation to minimize the tax consequences of a Stock Award to the holder of such Stock Award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 35.95pt">8.</TD><TD>Miscellaneous<FONT STYLE="font-weight: normal">.</FONT></TD></TR></TABLE>

<P STYLE="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Use of Proceeds from Sales of Common Stock</B>. Proceeds from the sale of shares of Common Stock pursuant to Stock Awards will
constitute general funds of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Corporate Action Constituting Grant of Stock Awards</B>. Corporate action constituting a grant by the Company of a Stock Award
to any Participant will be deemed completed as of the date of such corporate action, unless otherwise determined by the Board, regardless
of when the instrument, certificate, or letter evidencing the Stock Award is communicated to, or actually received or accepted by, the
Participant. In the event that the corporate records (e.g., Board consents, resolutions or minutes) documenting the corporate action constituting
the grant contain terms (e.g., exercise price, vesting schedule or number of shares) that are inconsistent with those in the Stock Award
Agreement or related grant documents as a result of a clerical error in the papering of the Stock Award Agreement or related grant documents,
the corporate records will control and the Participant will have no legally binding right to the incorrect term in the Stock Award Agreement
or related grant documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Stockholder Rights</B>. No Participant will be deemed to be the holder of, or to have any of the rights of a holder with respect
to, any shares of Common Stock subject to a Stock Award unless and until (i) such Participant has satisfied all requirements for exercise
of, or the issuance of shares of Common Stock under, the Stock Award pursuant to its terms, and (ii) the issuance of the Common Stock
subject to the Stock Award has been entered into the books and records of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>No Employment or Other Service Rights</B>. Nothing in the Plan, any Stock Award Agreement or any other instrument executed thereunder
or in connection with any Stock Award granted pursuant thereto will confer upon any Participant any right to continue to serve the Company
or an Affiliate in the capacity in effect at the time the Stock Award was granted or will affect the right of the Company or an Affiliate
to terminate (i) the employment of an Employee with or without notice and with or without cause, (ii) the service of a Consultant pursuant
to the terms of such Consultant&rsquo;s agreement with the Company or an Affiliate, or (iii) the service of a Director pursuant to the
bylaws of the Company or an Affiliate, and any applicable provisions of the corporate law of the state in which the Company or the Affiliate
is incorporated, as the case may be.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->.</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Change in Time Commitment</B>. In the event a Participant&rsquo;s regular level of time commitment in the performance of his or
her services for the Company and any Affiliates is reduced (for example, and without limitation, if the Participant is an Employee of
the Company and the Employee has a change in status from a full-time Employee to a part-time Employee or takes an extended leave of absence)
after the date of grant of any Stock Award to the Participant, the Board has the right in its sole discretion to (x) make a corresponding
reduction in the number of shares subject to any portion of such Stock Award that is scheduled to vest or become payable after the date
of such change in time commitment, and (y) in lieu of or in combination with such a reduction, extend the vesting or payment schedule
applicable to such Stock Award. In the event of any such reduction, the Participant will have no right with respect to any portion of
the Stock Award that is so reduced or extended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Incentive Stock Option Limitations</B>. To the extent that the aggregate Fair Market Value (determined at the time of grant) of
Common Stock with respect to which Incentive Stock Options are exercisable for the first time by any Optionholder during any calendar
year (under all plans of the Company and any Affiliates) exceeds $100,000 (or such other limit established in the Code) or otherwise does
not comply with the rules governing Incentive Stock Options, the Options or portions thereof that exceed such limit (according to the
order in which they were granted) or otherwise do not comply with such rules will be treated as Nonstatutory Stock Options, notwithstanding
any contrary provision of the applicable Option Agreement(s).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Investment Assurances</B>. The Company may require a Participant, as a condition of exercising or acquiring Common Stock under
any Stock Award, (i) to give written assurances satisfactory to the Company as to the Participant&rsquo;s knowledge and experience in
financial and business matters and/or to employ a purchaser representative reasonably satisfactory to the Company who is knowledgeable
and experienced in financial and business matters and that the Participant is capable of evaluating, alone or together with the purchaser
representative, the merits and risks of exercising the Stock Award; and (ii) to give written assurances satisfactory to the Company stating
that the Participant is acquiring Common Stock subject to the Stock Award for the Participant&rsquo;s own account and not with any present
intention of selling or otherwise distributing the Common Stock. The foregoing requirements, and any assurances given pursuant to such
requirements, will be inoperative if (A) the issuance of the shares upon the exercise or acquisition of Common Stock under the Stock Award
has been registered under a then currently effective registration statement under the Securities Act, or (B) as to any particular requirement,
a determination is made by counsel for the Company that such requirement need not be met in the circumstances under the then applicable
securities laws. The Company may, upon advice of counsel to the Company, place legends on stock certificates issued under the Plan as
such counsel deems necessary or appropriate in order to comply with applicable securities laws, including, but not limited to, legends
restricting the transfer of the Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>(h)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Withholding Obligations</B>. Unless prohibited by the terms of a Stock Award Agreement, the Company may, in its sole discretion,
satisfy any federal, state or local tax withholding obligation relating to a Stock Award by any of the following means or by a combination
of such means: (i) causing the Participant to tender a cash payment; (ii) withholding shares of Common Stock from the shares of Common
Stock issued or otherwise issuable to the Participant in connection with the Stock Award; <I>provided, however</I>, that no shares of
Common Stock are withheld with a value exceeding the maximum amount of tax required to be withheld by law (or such lesser amount as may
be necessary to avoid classification of the Stock Award as a liability for financial accounting purposes); (iii) withholding cash from
a Stock Award settled in cash; (iv) withholding payment from any amounts otherwise payable to the Participant; or (v) by such other method
as may be set forth in the Stock Award Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->.</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Electronic Delivery</B>. Any reference herein to a &ldquo;written&rdquo; agreement or document will include any agreement or document
delivered electronically or posted on the Company&rsquo;s intranet (or other shared electronic medium controlled by the Company to which
the Participant has access).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>(j)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Deferrals</B>. To the extent permitted by applicable law, the Board, in its sole discretion, may determine that the delivery of
Common Stock or the payment of cash, upon the exercise, vesting or settlement of all or a portion of any Stock Award may be deferred and
may establish programs and procedures for deferral elections to be made by Participants. Deferrals by Participants will be made in accordance
with Section 409A of the Code. Consistent with Section 409A of the Code, the Board may provide for distributions while a Participant is
still an employee or otherwise providing services to the Company. The Board is authorized to make deferrals of Stock Awards and determine
when, and in what annual percentages, Participants may receive payments, including lump sum payments, following the Participant&rsquo;s
termination of Continuous Service, and implement such other terms and conditions consistent with the provisions of the Plan and in accordance
with applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>(k)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Compliance with Section 409A of the Code</B>. To the extent that the Board determines that any Stock Award granted hereunder is
subject to Section 409A of the Code, the Stock Award Agreement evidencing such Stock Award will incorporate the terms and conditions necessary
to avoid the consequences specified in Section 409A(a)(1) of the Code. To the extent applicable, the Plan and Stock Award Agreements will
be interpreted in accordance with Section 409A of the Code. Notwithstanding anything to the contrary in the Plan (and unless the Stock
Award Agreement specifically provides otherwise), if the shares of Common Stock are publicly traded, and if a Participant holding a Stock
Award that constitutes &ldquo;deferred compensation&rdquo; under Section 409A of the Code is a &ldquo;specified employee&rdquo; for purposes
of Section 409A of the Code, no distribution or payment of any amount that is due because of a &ldquo;separation from service&rdquo; (as
defined in Section 409A of the Code without regard to alternative definitions thereunder) will be issued or paid before the date that
is six months following the date of such Participant&rsquo;s &ldquo;separation from service&rdquo; (as defined in Section 409A of the
Code without regard to alternative definitions thereunder) or, if earlier, the date of the Participant&rsquo;s death, unless such distribution
or payment can be made in a manner that complies with Section 409A of the Code, and any amounts so deferred will be paid in a lump sum
on the day after such six month period elapses, with the balance paid thereafter on the original schedule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>(l)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Repurchase Limitation</B>. The terms of any repurchase right will be specified in the Stock Award Agreement. The repurchase price
for vested shares of Common Stock will be the Fair Market Value of the shares of Common Stock on the date of repurchase. The repurchase
price for unvested shares of Common Stock will be the lower of (i) the Fair Market Value of the shares of Common Stock on the date of
repurchase or (ii) their original purchase price. However, the Company will not exercise its repurchase right until at least six months
(or such longer or shorter period of time necessary to avoid classification of the Stock Award as a liability for financial accounting
purposes) have elapsed following delivery of shares of Common Stock subject to the Stock Award, unless otherwise specifically provided
by the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>(m)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Further Information and Action</B>. Upon request from the Company at any time, any Participant (and any individuals affiliated
with a Participant that are beneficial owners of the Company, if applicable) will promptly provide the Company with such information and
take such other actions as the Company may request in connection with any obligations the Company may have under applicable law, rule,
or regulation, or to comply with requests by applicable regulatory authorities. All information provided by a Participant (or an individual
affiliated with a Participant) pursuant to this paragraph shall be accurate and complete. Any Participant (and any individuals affiliated
with a Participant that are beneficial owners
of the Company, if applicable) will submit to the Company (or other recipient as directed by the Company) any updates to such information
within 15 days after any change in, or correction to, any such information. For purposes of this paragraph, the term &ldquo;beneficial
owner&rdquo; shall have the meaning ascribed to it in the Bank Secrecy Act as amended by the Corporate Transparency Act and any regulations
promulgated thereunder (as amended from time to time).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->.</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 35.95pt">9.</TD><TD>Adjustments upon Changes in Common Stock; Other Corporate Events<FONT STYLE="font-weight: normal">.</FONT></TD></TR></TABLE>

<P STYLE="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Capitalization Adjustments</B>. In the event of a Capitalization Adjustment, then: (i) the class(es) and maximum number of securities
subject to the Plan pursuant to Section 3(a), (ii) the class(es) and maximum number of securities that may be issued pursuant to the exercise
of Incentive Stock Options pursuant to Section 3(c), and (iii) the class(es) and number of securities and price per share of stock subject
to outstanding Stock Awards will be proportionately adjusted and such adjustment shall occur automatically. To the extent such adjustments
cannot occur automatically, the Board shall have the power to make determinations as it deems necessary and its determinations and any
adjustments under this section will be final, binding and conclusive.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Dissolution or Liquidation</B>. Except as otherwise provided in the Stock Award Agreement, in the event of a dissolution or liquidation
of the Company, all outstanding Stock Awards (other than Stock Awards consisting of vested and outstanding shares of Common Stock not
subject to a forfeiture condition or the Company&rsquo;s right of repurchase) will terminate immediately prior to the completion of such
dissolution or liquidation, and the shares of Common Stock subject to the Company&rsquo;s repurchase rights or subject to a forfeiture
condition may be repurchased or reacquired by the Company notwithstanding the fact that the holder of such Stock Award is providing Continuous
Service, <I>provided, however, </I>that the Board may, in its sole discretion, cause some or all Stock Awards to become fully vested,
exercisable and/or no longer subject to repurchase or forfeiture (to the extent such Stock Awards have not previously expired or terminated)
before the dissolution or liquidation is completed but contingent on its completion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Corporate Transaction</B>. The following provisions will apply to Stock Awards in the event of a Corporate Transaction unless otherwise
provided in the instrument evidencing the Stock Award or any other written agreement between the Company or any Affiliate and the Participant
or unless otherwise expressly provided by the Board at the time of grant of a Stock Award. In the event of a Corporate Transaction, then,
notwithstanding any other provision of the Plan, the Board may take one or more of the following actions with respect to Stock Awards,
contingent upon the closing or completion of the Corporate Transaction:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><B>(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT></B>arrange for the surviving corporation or acquiring corporation (or the surviving or acquiring corporation&rsquo;s parent company)
to assume or continue the Stock Award or to substitute a similar stock award for the Stock Award (including, but not limited to, an award
to acquire the same consideration paid to the stockholders of the Company pursuant to the Corporate Transaction);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><B>(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT></B>arrange for the assignment of any reacquisition or repurchase rights held by the Company in respect of Common Stock issued
pursuant to the Stock Award to the surviving corporation or acquiring corporation (or the surviving or acquiring corporation&rsquo;s parent
company);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><B>(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT></B>accelerate the vesting, in whole or in part, of the Stock Award (and, if applicable, the time at which the Stock Award may
be exercised) to a date prior to the effective time of such Corporate Transaction as the Board determines (or, if the Board does not determine
such a date, to the date that is five
days prior to the effective date of the Corporate Transaction), with such Stock Award terminating if not exercised (if applicable) at
or prior to the effective time of the Corporate Transaction; <I>provided, however</I>, that the Board may require Participants to complete
and deliver to the Company a notice of exercise before the effective date of a Corporate Transaction, which exercise is contingent upon
the effectiveness of such Corporate Transaction;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->.</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><B>(iv)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT></B>arrange for the lapse, in whole or in part, of any reacquisition or repurchase rights held by the Company with respect to the
Stock Award;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><B>(v)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT></B>cancel or arrange for the cancellation of the Stock Award, to the extent not vested or not exercised prior to the effective
time of the Corporate Transaction, in exchange for such cash consideration (including no consideration) as the Board, in its sole discretion,
may consider appropriate; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><B>(vi)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT></B>make a payment, in such form as may be determined by the Board equal to the excess, if any, of (A) the value of the property
the Participant would have received upon the exercise of the Stock Award immediately prior to the effective time of the Corporate Transaction,
over (B) any exercise price payable by such holder in connection with such exercise. For clarity, this payment may be zero ($0) if the
value of the property is equal to or less than the exercise price. Payments under this provision may be delayed to the same extent that
payment of consideration to the holders of the Company&rsquo;s Common Stock in connection with the Corporate Transaction is delayed as
a result of escrows, earn outs, holdbacks or any other contingencies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">The Board need not
take the same action or actions with respect to all Stock Awards or portions thereof or with respect to all Participants. The Board may
take different actions with respect to the vested and unvested portions of a Stock Award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Change in Control</B>. A Stock Award may be subject to additional acceleration of vesting and exercisability upon or after a Change
in Control as may be provided in the Stock Award Agreement for such Stock Award or as may be provided in any other written agreement between
the Company or any Affiliate and the Participant, but in the absence of such provision, no such acceleration will occur.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 35.95pt">10.</TD><TD>Plan Term; Earlier Termination or Suspension of the Plan<FONT STYLE="font-weight: normal">.</FONT></TD></TR></TABLE>

<P STYLE="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Plan Term</B>. The Board may suspend or terminate the Plan at any time. Unless terminated sooner by the Board, the Plan will automatically
terminate on the day before the 10th anniversary of the earlier of (i) the date the Plan is adopted by the Board, or (ii) the date the
Plan is approved by the stockholders of the Company. No Stock Awards may be granted under the Plan while the Plan is suspended or after
it is terminated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>No Impairment of Rights</B>. Suspension or termination of the Plan will not impair rights and obligations under any Stock Award
granted while the Plan is in effect except with the written consent of the affected Participant or as otherwise permitted in the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 35.95pt">11.</TD><TD>Effective Date of Plan<FONT STYLE="font-weight: normal">.</FONT></TD></TR></TABLE>

<P STYLE="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: left; text-indent: 0in">This Plan will become
effective on the Effective Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: left; text-indent: 0in">&nbsp;</P>


<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->.</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: left; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 35.95pt">12.</TD><TD STYLE="text-align: justify">Choice of Law<FONT STYLE="font-weight: normal">.</FONT></TD></TR></TABLE>

<P STYLE="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in">The laws of the State
of Delaware will govern all questions concerning the construction, validity and interpretation of this Plan, without regard to that state&rsquo;s
conflict of laws rules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><B>13.</B></TD><TD STYLE="text-align: justify"><B>Definitions</B>. As used in the Plan or any Stock Award Agreement, the following definitions
will apply to the capitalized terms indicated below, unless otherwise defined in the applicable Stock Award Agreement:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT></B>&ldquo;<B><I>Affiliate</I></B>&rdquo; means, at the time of determination, any &ldquo;parent&rdquo; or &ldquo;majority-owned
subsidiary&rdquo; of the Company, as such terms are defined in Rule 405. The Board will have the authority to determine the time or times
at which &ldquo;parent&rdquo; or &ldquo;majority-owned subsidiary&rdquo; status is determined within the foregoing definition.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt"> <B>(b)</B> &ldquo;<B><I>Board</I></B>&rdquo; means the Board of Directors of the Company.</P>



<P STYLE="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT></B>&ldquo;<B><I>Capitalization Adjustment</I></B>&rdquo; means any change that is made in, or other events that occur with respect
to, the Common Stock subject to the Plan or subject to any Stock Award after the Effective Date without the receipt of consideration by
the Company through merger, consolidation, reorganization, recapitalization, reincorporation, stock dividend, dividend in property other
than cash, large nonrecurring cash dividend, stock split, reverse stock split, liquidating dividend, combination of shares, exchange of
shares, change in corporate structure, or any similar equity restructuring transaction, as that term is used in Statement of Financial
Accounting Standards Board Accounting Standards Codification Topic 718 (or any successor thereto). Notwithstanding the foregoing, the
conversion of any convertible securities of the Company will not be treated as a Capitalization Adjustment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT></B>&ldquo;<B><I>Cause</I></B>&rdquo; will have the meaning ascribed to such term in any written agreement between the Participant
and the Company defining such term and, in the absence of such agreement, such term means, with respect to a Participant, the occurrence
of any of the following events: (i) such Participant&rsquo;s commission of any felony or any crime involving fraud, dishonesty or moral
turpitude under the laws of the United States or any state thereof; (ii) such Participant&rsquo;s attempted commission of, or participation
in, a fraud or act of dishonesty against the Company, or any of its employees or directors; (iii) such Participant&rsquo;s intentional,
material violation of any contract or agreement between the Participant and the Company, the Company&rsquo;s employment policies, or of
any statutory or other duty owed to the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">(iv) such Participant&rsquo;s
unauthorized use or disclosure of the Company&rsquo;s confidential information or trade secrets; or (v) such Participant&rsquo;s gross
misconduct. The determination that a termination of the Participant&rsquo;s Continuous Service is either for Cause or without Cause will
be made by the Company, in its sole discretion. Any determination by the Company that the Continuous Service of a Participant was terminated
with or without Cause for the purposes of outstanding Stock Awards held by such Participant will have no effect upon any determination
of the rights or obligations of the Company or such Participant for any other purpose.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->.</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT></B>&ldquo;<B><I>Change in Control</I></B>&rdquo; means the occurrence, in a single transaction or in a series of related transactions,
of any one or more of the following events:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><B>(i)</B> any
Exchange Act Person becomes the Owner, directly or indirectly, of securities of the Company representing more than 50% of the
combined voting power of the Company&rsquo;s then outstanding securities other than by virtue of a merger, consolidation or similar
transaction. Notwithstanding the foregoing, a Change in Control will not be deemed to occur (A) on account of the acquisition of
securities of the Company directly from the Company, (B) on account of the acquisition of securities of the Company by an investor,
any affiliate thereof or any other Exchange Act Person that acquires the Company&rsquo;s securities in a transaction or series of
related transactions the primary purpose of which is to obtain financing for the Company through the issuance of equity securities
or (C) solely because the level of Ownership held by any Exchange Act Person (the &ldquo;<B><I>Subject Person</I></B>&rdquo;)
exceeds the designated percentage threshold of the outstanding voting securities as a result of a repurchase or other acquisition of
voting securities by the Company reducing the number of shares outstanding, provided that if a Change in Control would occur (but
for the operation of this sentence) as a result of the acquisition of voting securities by the Company, and after such share
acquisition, the Subject Person becomes the Owner of any additional voting securities that, assuming the repurchase or other
acquisition had not occurred, increases the percentage of the then outstanding voting securities Owned by the Subject Person over
the designated percentage threshold, then a Change in Control will be deemed to occur;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><B>(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT></B>there is consummated a merger, consolidation or similar transaction involving (directly or indirectly) the Company and, immediately
after the consummation of such merger, consolidation or similar transaction, the stockholders of the Company immediately prior thereto
do not Own, directly or indirectly, either (A) outstanding voting securities representing more than 50% of the combined outstanding voting
power of the surviving Entity in such merger, consolidation or similar transaction or (B) more than 50% of the combined outstanding voting
power of the parent of the surviving Entity in such merger, consolidation or similar transaction, in each case in substantially the same
proportions as their Ownership of the outstanding voting securities of the Company immediately prior to such transaction; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><B>(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT></B>there is consummated a sale, lease, exclusive license or other disposition of all or substantially all of the consolidated
assets of the Company and its Subsidiaries, other than a sale, lease, license or other disposition of all or substantially all of the
consolidated assets of the Company and its Subsidiaries to an Entity, more than 50% of the combined voting power of the voting securities
of which are Owned by stockholders of the Company in substantially the same proportions as their Ownership of the outstanding voting securities
of the Company immediately prior to such sale, lease, license or other disposition.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">Notwithstanding the
foregoing definition or any other provision of this Plan, (A) the term Change in Control will not include a sale of assets, merger or
other transaction effected exclusively for the purpose of changing the domicile of the Company, (B) the definition of Change in Control
(or any analogous term) in an individual written agreement between the Company or any Affiliate and the Participant will supersede the
foregoing definition with respect to Stock Awards subject to such agreement; <I>provided, however</I>, that if no definition of Change
in Control or any analogous term is set forth in such an individual written agreement, the definition set forth herein will apply, and
(C) if at any time the Company&rsquo;s Certificate of Incorporation provides definitions of various analogous transactions that would
be deemed a liquidation event for the Company, then such definition will apply as if it were the definition set forth herein except as
is otherwise expressly provided in an individual written agreement between the Company or any Affiliate and the Participant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"><B>(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT></B>&ldquo;<B><I>Code</I></B>&rdquo; means the Internal Revenue Code of 1986, as amended, including any applicable regulations
and guidance thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"><B>(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT></B>&ldquo;<B><I>Committee</I></B>&rdquo; means a committee of one or more Directors to whom authority has been delegated by the
Board in accordance with Section 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->.</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 40pt; margin-top: 0pt; margin-bottom: 0pt"> <B>(h)</B> &ldquo;<B><I>Common Stock</I></B>&rdquo; means the common stock of the Company.</P>



<P STYLE="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 40pt; margin-top: 0pt; margin-bottom: 0pt"> <B>(i)</B> &ldquo;<B><I>Company</I></B>&rdquo; means Klustr, Inc., a Delaware corporation.</P>



<P STYLE="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>(j)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT></B>&ldquo;<B><I>Consultant</I></B>&rdquo; means any person, including an advisor, who is (i) engaged by the Company or an Affiliate
to render consulting or advisory services (whether directly or indirectly, including without limitation through an engagement with a professional
employer organization, employer of record or similar arrangement, and is deemed pursuant to such arrangement to be a consultant or advisor
of the Company or an Affiliate under applicable laws) and is compensated for such services, or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">(ii) serving as a
member of the board of directors of an Affiliate and is compensated for such services. However, service solely as a Director, or payment
of a fee for such service, will not cause a Director to be considered a &ldquo;Consultant&rdquo; for purposes of the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>(k)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT></B>&ldquo;<B><I>Continuous Service</I></B>&rdquo; means that the Participant&rsquo;s service with the Company or an Affiliate,
whether as an Employee, Director or Consultant, is not interrupted or terminated. A change in the capacity in which the Participant renders
service to the Company or an Affiliate as an Employee, Director or Consultant or a change in the Entity for which the Participant renders
such service, provided that there is no interruption or termination of the Participant&rsquo;s service with the Company or an Affiliate,
will not terminate a Participant&rsquo;s Continuous Service; <I>provided, however</I>, that if the Entity for which a Participant is rendering
services ceases to qualify as an Affiliate, as determined by the Board in its sole discretion, such Participant&rsquo;s Continuous Service
will be considered to have terminated on the date such Entity ceases to qualify as an Affiliate. For example, a change in status from
an Employee of the Company to a Consultant of an Affiliate or to a Director will not constitute an interruption of Continuous Service.
To the extent permitted by law, the Board or the chief executive officer of the Company, in that party&rsquo;s sole discretion, may determine
whether Continuous Service will be considered interrupted in the case of (i) any leave of absence approved by the Board or chief executive
officer, including sick leave, military leave or any other personal leave, or (ii) transfers between the Company, an Affiliate, or their
successors. Notwithstanding the foregoing, a leave of absence will be treated as Continuous Service for purposes of vesting in a Stock
Award only to such extent as may be provided in the Company&rsquo;s leave of absence policy, in the written terms of any leave of absence
agreement or policy applicable to the Participant, or as otherwise required by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>(l)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT></B>&ldquo;<B><I>Corporate Transaction</I></B>&rdquo; means the consummation, in a single transaction or in a series of related
transactions, of any one or more of the following events:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><B>(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT></B>a sale or other disposition of all or substantially all, as determined by the Board in its sole discretion, of the consolidated
assets of the Company and its Subsidiaries;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 1in"><B>(ii)</B> a sale or other disposition of more
than 50% of the outstanding securities of the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><B>(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT></B>a merger, consolidation or similar transaction following which the Company is not the surviving corporation; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><B>(iv)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT></B>a merger, consolidation or similar transaction following which the Company is the surviving corporation but the shares of Common
Stock outstanding immediately preceding the merger, consolidation or similar transaction are converted or exchanged by virtue of the merger,
consolidation or similar transaction into other property, whether in the form of securities, cash or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence -->.</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt"> <B>(m)</B> &ldquo;<B><I>Director</I></B>&rdquo; means a member of the Board.</P>



<P STYLE="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>(n)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT></B>&ldquo;<B><I>Disability</I></B>&rdquo; means, with respect to a Participant, the inability of such Participant to engage in
any substantial gainful activity by reason of any medically determinable physical or mental impairment that can be expected to result
in death or that has lasted or can be expected to last for a continuous period of not less than twelve (12) months as provided in Sections
22(e)(3) and 409A(a)(2)(c)(i) of the Code, and will be determined by the Board on the basis of such medical evidence as the Board deems
warranted under the circumstances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>(o)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT></B>&ldquo;<B><I>Effective Date</I></B>&rdquo; means the effective date of this Plan, which is the earlier of (i) the date that
this Plan is first approved by the Company&rsquo;s stockholders, and (ii) the date this Plan is adopted by the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>(p)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT></B>&ldquo;<B><I>Employee</I></B>&rdquo; means any person employed by the Company or an Affiliate (whether directly or indirectly,
including without limitation through an engagement with a professional employer organization, employer of record or similar arrangement,
and is deemed pursuant to such arrangement to be an employee of the Company or an Affiliate under applicable laws). However, service solely
as a Director, or payment of a fee for such services, will not cause a Director to be considered an &ldquo;Employee&rdquo; for purposes
of the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt"> <B>(q)</B> &ldquo;<B><I>Entity</I></B>&rdquo; means a corporation, partnership, limited liability company or other entity.</P>



<P STYLE="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>(r)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT></B>&ldquo;<B><I>Exchange Act</I></B>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations
promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>(s)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT></B>&ldquo;<B><I>Exchange Act Person</I></B>&rdquo; means any natural person, Entity or &ldquo;group&rdquo; (within the meaning
of Section 13(d) or 14(d) of the Exchange Act), except that &ldquo;Exchange Act Person&rdquo; will not include (i) the Company or any
Subsidiary of the Company, (ii) any employee benefit plan of the Company or any Subsidiary of the Company or any trustee or other fiduciary
holding securities under an employee benefit plan of the Company or any Subsidiary of the Company, (iii) an underwriter temporarily holding
securities pursuant to a registered public offering of such securities, (iv) an Entity Owned, directly or indirectly, by the stockholders
of the Company in substantially the same proportions as their Ownership of stock of the Company; or (v) any natural person, Entity or
&ldquo;group&rdquo; (within the meaning of Section 13(d) or 14(d) of the Exchange Act) that, as of the Effective Date, is the Owner, directly
or indirectly, of securities of the Company representing more than 50% of the combined voting power of the Company&rsquo;s then outstanding
securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>(t)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT></B>&ldquo;<B><I>Fair Market Value</I></B>&rdquo; means, as of any date, the value of the Common Stock determined by the Board
in compliance with Section 409A of the Code or, in the case of an Incentive Stock Option, in compliance with Section 422 of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence -->.</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>(u)</B>
&ldquo;<B><I>Good Reason</I></B>&rdquo; will have the meaning ascribed to such term in any written agreement between the Participant
and the Company defining such term and, in the absence of a definition of such term in the applicable written agreement, such term
means, with respect to a Participant, a material and unreasonable diminution of such Participant&rsquo;s duties (as determined by
the Board in its sole discretion) without such Participant&rsquo;s consent; provided, however, that the following shall not
constitute Good Reason: (i) a change of title; (ii) a reduction in such Participant&rsquo;s duties by virtue of the Company
undergoing a Change in Control and/or being made part of a larger entity or group of entities; and/or (iii) cessation of such
Participant&rsquo;s service, if any, on the Board or a committee thereof. For such Participant to receive the benefits under the
applicable written agreement between such Participant and the Company as a result of a voluntary resignation for Good Reason, unless
otherwise provided in such agreement, all of the following requirements must be satisfied: (A) such Participant must provide notice
to the Company of such Participant&rsquo;s intent to assert Good Reason within thirty (30) days of the initial existence of the
condition set forth in the previous sentence; (B) the Company will have thirty (30) days (the &ldquo;<B><I>Company Cure
Period</I></B>&rdquo;) from the date of such notice to remedy the condition and, if it does so, such Participant may withdraw such
Participant&rsquo;s resignation or such Participant may resign with no benefits under the applicable written agreement; and (C) any
termination of such Participant&rsquo;s Continuous Service under this provision must occur within ten (10) days of the earlier of
expiration of the Company Cure Period or written notice from the Company that it will not undertake to cure the applicable
condition. Unless otherwise set forth in the applicable written agreement, should the Company remedy the condition as set forth
above and then such condition arises again, such Participant may assert Good Reason again subject to all of the conditions set forth
herein. Unless otherwise set forth in the applicable written agreement, the term &ldquo;Company&rdquo; for purposes of &ldquo;Good
Reason&rdquo; will be interpreted to include any Affiliate of the Company to which such Participant provides services, if
appropriate, as determined by the Board in its sole discretion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>(v)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT></B>&ldquo;<B><I>Incentive Stock Option</I></B>&rdquo; means an option granted pursuant to Section 5 of the Plan that is intended
to be, and that qualifies as, an &ldquo;incentive stock option&rdquo; within the meaning of Section 422 of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>(w)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT></B>&ldquo;<B><I>Nonstatutory Stock Option</I></B>&rdquo; means an option granted pursuant to Section 5 of the Plan that does not
qualify as an Incentive Stock Option.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt"> <B>(x)</B> &ldquo;<B><I>Officer</I></B>&rdquo; means any person designated by the Company as an officer.</P>



<P STYLE="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>(y)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT></B>&ldquo;<B><I>Option</I></B>&rdquo; means an Incentive Stock Option or a Nonstatutory Stock Option to purchase shares of Common
Stock granted pursuant to the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>(z)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT></B>&ldquo;<B><I>Option Agreement</I></B>&rdquo; means a written agreement between the Company and an Optionholder evidencing the
terms and conditions of an Option grant. Each Option Agreement will be subject to the terms and conditions of the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>(aa)</B> &ldquo;<B><I>Optionholder</I></B>&rdquo;
means a person to whom an Option is granted pursuant to the Plan or, if applicable, such other person who holds an outstanding Option.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>(bb)</B> &ldquo;<B><I>Other
Stock Award</I></B>&rdquo; means an award based in whole or in part by reference to the Common Stock which is granted pursuant to the
terms and conditions of Section 6(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>(cc)</B> &ldquo;<B><I>Other
Stock Award Agreement</I></B>&rdquo; means a written agreement between the Company and a holder of an Other Stock Award evidencing the
terms and conditions of an Other Stock Award grant. Each Other Stock Award Agreement will be subject to the terms and conditions of the
Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>(dd)</B> &ldquo;<B><I>Own</I></B>,&rdquo;
&ldquo;<B><I>Owned</I></B>,&rdquo; &ldquo;<B><I>Owner</I></B>,&rdquo; &ldquo;<B><I>Ownership</I></B>&rdquo; A person or Entity will be
deemed to &ldquo;Own,&rdquo; to have &ldquo;Owned,&rdquo; to be the &ldquo;Owner&rdquo; of, or to have acquired &ldquo;Ownership&rdquo;
of securities if such person or Entity, directly or indirectly, through any contract, arrangement, understanding, relationship or otherwise,
has or shares voting power, which includes the power to vote or to direct the voting, with respect to such securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>(ee)</B> &ldquo;<B><I>Participant</I></B>&rdquo;
means a person to whom a Stock Award is granted pursuant to the Plan or, if applicable, such other person who holds an outstanding Stock
Award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence -->.</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><B>(ff)</B> &ldquo;<B><I>Plan</I></B>&rdquo;
means this 2024 Equity Incentive Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>(gg)</B> &ldquo;<B><I>Restricted
Stock Award</I></B>&rdquo; means an award of shares of Common Stock which is granted pursuant to the terms and conditions of Section 6(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>(hh)</B> &ldquo;<B><I>Restricted
Stock Award Agreement</I></B>&rdquo; means a written agreement between the Company and a holder of a Restricted Stock Award evidencing
the terms and conditions of a Restricted Stock Award grant. Each Restricted Stock Award Agreement will be subject to the terms and conditions
of the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><B>(ii) </B>&ldquo;<B><I>Restricted
Stock Unit Award</I></B>&rdquo; means a right to receive shares of Common Stock which is granted pursuant to the terms and conditions
of Section 6(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>(jj)</B> &ldquo;<B><I>Restricted
Stock Unit Award Agreement</I></B>&rdquo; means a written agreement between the Company and a holder of a Restricted Stock Unit Award
evidencing the terms and conditions of a Restricted Stock Unit Award grant. Each Restricted Stock Unit Award Agreement will be subject
to the terms and conditions of the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><B>(kk)</B> &ldquo;<B><I>Rule
405</I></B>&rdquo; means Rule 405 promulgated under the Securities Act. <B>(ll)</B> &ldquo;<B><I>Rule 701</I></B>&rdquo; means Rule 701
promulgated under the Securities Act. <B>(mm)</B> &ldquo;<B><I>Securities Act</I></B>&rdquo; means the Securities Act of 1933, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>(nn)</B> &ldquo;<B><I>Stock
Appreciation Right</I></B>&rdquo; or &ldquo;<B><I>SAR</I></B>&rdquo; means a right to receive the appreciation on Common Stock that is
granted pursuant to the terms and conditions of Section 5.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>(oo)</B> &ldquo;<B><I>Stock
Appreciation Right Agreement</I></B>&rdquo; means a written agreement between the Company and a holder of a Stock Appreciation Right evidencing
the terms and conditions of a Stock Appreciation Right grant. Each Stock Appreciation Right Agreement will be subject to the terms and
conditions of the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>(pp)</B> &ldquo;<B><I>Stock
Award</I></B>&rdquo; means any right to receive Common Stock granted under the Plan, including an Incentive Stock Option, a Nonstatutory
Stock Option, a Restricted Stock Award, a Restricted Stock Unit Award, a Stock Appreciation Right or any Other Stock Award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>(qq)</B> &ldquo;<B><I>Stock
Award Agreement</I></B>&rdquo; means a written agreement between the Company and a Participant evidencing the terms and conditions of
a Stock Award grant. Each Stock Award Agreement will be subject to the terms and conditions of the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>(rr)</B> &ldquo;<B><I>Subsidiary</I></B>&rdquo;
means, with respect to the Company, (i) any corporation of which more than 50% of the outstanding capital stock having ordinary voting
power to elect a majority of the board of directors of such corporation (irrespective of whether, at the time, stock of any other class
or classes of such corporation will have or might have voting power by reason of the happening of any contingency) is at the time, directly
or indirectly, Owned by the Company, and (ii) any partnership, limited liability company or other entity in which the Company has a direct
or indirect interest (whether in the form of voting or participation in profits or capital contribution) of more than 50%.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>(ss)</B> &ldquo;<B><I>Ten
Percent Stockholder</I></B>&rdquo; means a person who Owns (or is deemed to Own pursuant to Section 424(d) of the Code) stock possessing
more than 10% of the total combined voting power of all classes of stock of the Company or any Affiliate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 22; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence -->.</P></DIV>
    <!-- Field: /Page -->



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.3
<SEQUENCE>4
<FILENAME>ea028760001ex31-3.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 31.3</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY
ACT OF 2002</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I, Jay Crystal, certify that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
have reviewed this Amendment No. 1 to the Annual Report on Form 10-K of Corvex, Inc.; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make
the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered
by this report.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Date: April 27, 2026</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Jay Crystal</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD STYLE="width: 35%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jay Crystal</FONT></TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal Executive Officer)</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.4
<SEQUENCE>5
<FILENAME>ea028760001ex31-4.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 31.4</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATION OF THE PRINCIPAL FINANCIAL OFFICER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY
ACT OF 2002</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I, J. Cogan, certify that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I have reviewed this Amendment No. 1 to the Annual Report on Form 10-K of Corvex, Inc.; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Date: April 27, 2026</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ J. Cogan</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD STYLE="width: 35%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">J. Cogan</FONT></TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal Financial Officer and <BR>
Principal Accounting Officer)</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>move-20251231.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by Broadridge Transform (tm) - http://www.broadridge.com -->
<!-- Created: Mon Apr 27 21:52:02 UTC 2026 -->
<xs:schema xmlns:move="http://www.movano.com/20251231" elementFormDefault="qualified" xmlns:srt-types="http://fasb.org/srt-types/2025" targetNamespace="http://www.movano.com/20251231" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-types="http://fasb.org/us-types/2025" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dtr="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="move-20251231_lab.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="move-20251231_pre.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef"/>
      <link:roleType roleURI="http://www.movano.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000 - Document - Document And Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-types/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://fasb.org/srt-types/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/sic/2025" schemaLocation="https://xbrl.sec.gov/sic/2025/sic-2025.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd/2025" schemaLocation="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd-sub/2025" schemaLocation="https://xbrl.sec.gov/ecd/2025/ecd-sub-2025.xsd"/>
<!-- [WMV7][IWwsyemK0B7MoOGojGoW59Fv1V8/9YoLq6zgPjfOajaAJ/DKdb/YTc8T9DbfNeNZGL+KXVd0PIGwQ3CNHnpAaQNiAnZC5BvXQ/dhEu8nXBFOBp7FlbkTxCo4Batwws9e2cgHtDTL4g/7Wd3quByp9y4aItbeKbQhM4Hr+XAUpQ2uYAoBf3eH4OLe6mrsdh6EGlD3hMfMwhZDnbphsgeO389GevyQWPWNyY1hCnxO+ME/020qWNpMlZw3camHdaE1W7dCa2Tl7/2Ck5fO+TygfX416FI+GcZjkXViNokBn74uTbhGwk46M5ObfuC7PJrNzpRiQalgzqiT4qEHymcrXjSwlis8EI+cMpzGElrKMrYNZEVqMNSXAfZWTKSW1M90] CSR-->
  <xs:element name="DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="move_DocumentAndEntityInformationAbstract"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>7
<FILENAME>move-20251231_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by Broadridge Transform (tm) - http://www.broadridge.com -->
<!-- Created: Mon Apr 27 21:52:02 UTC 2026 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Entity Ex Transition Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_IcfrAuditorAttestationFlag"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_IcfrAuditorAttestationFlag_lbl" xml:lang="en-US">ICFR Auditor Attestation Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_IcfrAuditorAttestationFlag" xlink:to="dei_IcfrAuditorAttestationFlag_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFinStmtErrorCorrectionFlag"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag_lbl" xml:lang="en-US">Document Financial Statement Error Correction [Flag]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFinStmtErrorCorrectionFlag" xlink:to="dei_DocumentFinStmtErrorCorrectionFlag_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentDescription" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl0" xml:lang="en-US">Entity Address, Postal Zip Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl0" xml:lang="en-US">Document Type</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl0" xml:lang="en-US">City Area Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl0" xml:lang="en-US">Entity Current Reporting Status</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl0" xml:lang="en-US">Entity Emerging Growth Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl0" xml:lang="en-US">Entity Tax Identification Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl0" xml:lang="en-US">Entity Small Business</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl0" xml:lang="en-US">Entity File Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl0" xml:lang="en-US">Entity Address, City or Town</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl0" xml:lang="en-US">Entity Well-known Seasoned Issuer</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl0" xml:lang="en-US">Amendment Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl0" xml:lang="en-US">Document Period End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl0" xml:lang="en-US">Entity Public Float</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl0" xml:lang="en-US">Entity Ex Transition Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl0" xml:lang="en-US">Entity Interactive Data Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl0" xml:lang="en-US">Title of 12(b) Security</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl0" xml:lang="en-US">Entity Voluntary Filers</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl0" xml:lang="en-US">Entity Central Index Key</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl0" xml:lang="en-US">Entity Filer Category</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl0" xml:lang="en-US">Document Transition Report</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag_lbl0" xml:lang="en-US">Document Financial Statement Error Correction [Flag]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFinStmtErrorCorrectionFlag" xlink:to="dei_DocumentFinStmtErrorCorrectionFlag_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl0" xml:lang="en-US">Document Annual Report</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl0" xml:lang="en-US">Security Exchange Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl0" xml:lang="en-US">Amendment Description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl0" xml:lang="en-US">Document Fiscal Period Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl0" xml:lang="en-US">Current Fiscal Year End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl0" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl0" xml:lang="en-US">Entity Address, State or Province</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl0" xml:lang="en-US">Trading Symbol</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl0" xml:lang="en-US">Entity Shell Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl0" xml:lang="en-US">Entity Common Stock, Shares Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl0" xml:lang="en-US">Entity Registrant Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl0" xml:lang="en-US">Entity Address, Address Line Two</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_IcfrAuditorAttestationFlag_lbl0" xml:lang="en-US">ICFR Auditor Attestation Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_IcfrAuditorAttestationFlag" xlink:to="dei_IcfrAuditorAttestationFlag_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl0" xml:lang="en-US">Entity Address, Address Line One</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl0" xml:lang="en-US">Local Phone Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl0" xml:lang="en-US">Entity Incorporation, State or Country Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl0" xml:lang="en-US">Document Fiscal Year Focus</label>
<!-- [WMV7][xZV4K6VtVLztRbt3zxFWH4AUEsDBtOL+fM9Apx527LEfOKu4AuLZu0BgAaUdsD01pwrTBiA82WBndC39MBHWzOX4BW5nb9HltmIxU5KaJZ7uPzQot38logcx88HS8QzTsLiJrbVMrTAUQO7yfBJJoOha8/4aFM73668HJwOfeRw7CWniyp4ksDbyyHxvKc0VgsZWGSXxu45fSNN92UGTRFqYOoQqDgqI9g+9gAwgD8jB/82fK1k7wFJpdob7CVotwtmWQjs56fU5hBFYCNvL8/I4XQyf3qAdDrVdqLVHL9Cyd/BxCgdTShX2ahcbQaJtjuoAoRQmZ5vNjhd1trgim/+GmuGECcmWNr+bh+RXVwTcD6Qwuoc4LrGpaj93mbkq] CSR-->
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl0"/>
  </labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>8
<FILENAME>move-20251231_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by Broadridge Transform (tm) - http://www.broadridge.com -->
<!-- Created: Mon Apr 27 21:52:02 UTC 2026 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="move-20251231.xsd#DocumentAndEntityInformation" roleURI="http://www.movano.com/role/DocumentAndEntityInformation"/>
  <presentationLink xlink:role="http://www.movano.com/role/DocumentAndEntityInformation" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="DocumentAndEntityInformationAbstract" xlink:href="move-20251231.xsd#move_DocumentAndEntityInformationAbstract"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentInformationTable"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentInformationLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentInformationTable" order="1.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationLineItems" order="1.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentAnnualReport" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CurrentFiscalYearEndDate" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalYearFocus" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentTransitionReport" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine2" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityWellKnownSeasonedIssuer" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityVoluntaryFilers" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCurrentReportingStatus" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityInteractiveDataCurrent" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFilerCategory" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntitySmallBusiness" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityExTransitionPeriod" order="28.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_IcfrAuditorAttestationFlag"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_IcfrAuditorAttestationFlag" order="29.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFinStmtErrorCorrectionFlag"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFinStmtErrorCorrectionFlag" order="30.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityShellCompany" order="31.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityPublicFloat" order="32.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCommonStockSharesOutstanding" order="33.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock" order="34.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentDescription" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentDescription" order="35.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" order="36.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus"/>
<!-- [WMV7][aCSlUr5ylhk46M6V0mY8E2S9PbKFWkEbgk9OAQu7L73tAESkg+bZjoBLf0xynhwvf9AiIGh8r2TmwrQa6GS0qWfKO57tLS23daLdeMnsweC0FyIhoRiMP0a2XaoRkeeZLXQiSV9scqK73MWEuxJjXxmjW2gXxs8HwOnjsOdQFxSiP6DjZtJAj67gByfrHunMdcyQbjthEgJjMZQJWXPPxJawbCBJBI8yFNqodgKoShx1k45AS+yt10WU+m1ONiuiRpBwl0Fa8+Y9XN0dd6Y9dtR3ZMKcfeuD/9sWJB9hWzilI8ZQvFxP2FiIDtRf5uavJKSnAI3w1vHwyfLvF2xScmSxqERmY6rcnepbZqb2A/moh4ybT9Y1owxxTojcl+yK] CSR-->
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalPeriodFocus" order="37.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document And Entity Information - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Apr. 20, 2026</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information Line Items</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001734750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K/A<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-40254<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CORVEX, INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">82-4233771<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">3401 North Fairfax Drive<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 3230<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Arlington<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">VA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">22226<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(866)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">438-4787<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.0001 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MOVE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFinStmtErrorCorrectionFlag', window );">Document Financial Statement Error Correction [Flag]</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,309,169<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,981,462<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference [Text Block]</a></td>
<td class="text">None<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentDescription', window );">Amendment Description</a></td>
<td class="text">This Amendment No. 1 on Form 10-K/A (this &#8220;Amendment
No. 1&#8221;) amends Corvex, Inc.&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 2025 (the &#8220;2025 Annual
Report&#8221;), originally filed with the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) on March 31, 2026. As used in
this Amendment No. 1, unless otherwise stated or the context otherwise requires, the terms &#8220;Corvex,&#8221; &#8220;we,&#8221; &#8220;us,&#8221;
&#8220;our&#8221; and the &#8220;Company&#8221; refer to Corvex, Inc. and its wholly-owned subsidiaries.We are filing this Amendment No. 1 pursuant to
General Instruction G(3) of Form 10-K, as we do not intend to file a definitive proxy statement for the 2026 annual meeting of stockholders
(the &#8220;Annual Meeting&#8221;) within 120 days of the end of our fiscal year ended December 31, 2025. Accordingly, this Amendment
is being filed solely to:

    &#160;
    &#9679;
    amend and restate Part III, Items 10 (Directors, Executive Officers and Corporate Governance), 11 (Executive Compensation), 12 (Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters), 13 (Certain Relationships and Related Transactions, and Director Independence) and 14 (Principal Accountant Fees and Services) of the 2025 Annual Report, in their entirety as set forth herein;


    &#160;
    &#9679;
    amend the reference on the cover page of our 2025 Annual Report to reflect that no documents will be incorporated by reference into our 2025 Annual Report; and


    &#160;
    &#9679;
    file new certifications of our principal executive officer and principal financial officer pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934, as amended, a copy of the Company&#8217;s 2024 Equity Incentive Plan, and a new description of our common stock as exhibits to this Amendment No. 1 under Item 15 of Part IV hereof.
  Because no financial statements have been included
in this Amendment No. 1, and because this Amendment No. 1 does not contain or amend any disclosure with respect to paragraphs 3, 4 and
5 of Items 307 and 308 of Regulation S-K, the corresponding certifications have been omitted. We are not including the certifications
under Section 906 of the Sarbanes-Oxley Act of 2002 as no financial statements are being filed with this Amendment No. 1.Except as set forth above, no other Items of our
2025 Annual Report have been amended or revised in this Amendment No. 1, and all such other Items shall be as set forth in such 2025 Annual
Report. Accordingly, this Amendment No. 1 should be read in conjunction with the 2025 Annual Report and our other filings with the SEC.
Certain capitalized terms used and not otherwise defined in this Amendment No. 1 have the meanings given to them in the 2025 Annual Report.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of changes contained within amended document.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFinStmtErrorCorrectionFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates whether any of the financial statement period in the filing include a restatement due to error correction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection w<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFinStmtErrorCorrectionFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Policies and Procedures<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTradingPoliciesProcLineItems', window );"><strong>Insider Trading Policies and Procedures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTrdPoliciesProcAdoptedFlag', window );">Insider Trading Policies and Procedures Adopted</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTradingPoliciesProcLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTradingPoliciesProcLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTrdPoliciesProcAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTrdPoliciesProcAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.26.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>39</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>2</UnitCount>
  <MyReports>
    <Report instance="ea0287600-10ka1_corvex.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.movano.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="ea0287600-10ka1_corvex.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995447 - Disclosure - Insider Trading Policies and Procedures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc</Role>
      <ShortName>Insider Trading Policies and Procedures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K/A" isDefinitelyFs="true" isUsgaap="true" original="ea0287600-10ka1_corvex.htm">ea0287600-10ka1_corvex.htm</File>
    <File>move-20251231.xsd</File>
    <File>move-20251231_lab.xml</File>
    <File>move-20251231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="38">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
    <BaseTaxonomy items="1">http://xbrl.sec.gov/ecd/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ea0287600-10ka1_corvex.htm": {
   "nsprefix": "move",
   "nsuri": "http://www.movano.com/20251231",
   "dts": {
    "inline": {
     "local": [
      "ea0287600-10ka1_corvex.htm"
     ]
    },
    "schema": {
     "local": [
      "move-20251231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd",
      "https://xbrl.sec.gov/ecd/2025/ecd-sub-2025.xsd",
      "https://xbrl.sec.gov/sic/2025/sic-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "move-20251231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "move-20251231_pre.xml"
     ]
    }
   },
   "keyStandard": 39,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2025": 3
   },
   "contextCount": 3,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 150,
   "unitCount": 2,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 38,
    "http://xbrl.sec.gov/ecd/2025": 1
   },
   "report": {
    "R1": {
     "role": "http://www.movano.com/role/DocumentAndEntityInformation",
     "longName": "000 - Document - Document And Entity Information",
     "shortName": "Document And Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "b",
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0287600-10ka1_corvex.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "b",
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0287600-10ka1_corvex.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc",
     "longName": "995447 - Disclosure - Insider Trading Policies and Procedures",
     "shortName": "Insider Trading Policies and Procedures",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0287600-10ka1_corvex.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0287600-10ka1_corvex.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional 402(v) Disclosure [Text Block]",
        "terseLabel": "Additional 402(v) Disclosure"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation Amount",
        "terseLabel": "Adjustment to Compensation, Amount"
       }
      }
     },
     "auth_ref": [
      "r52"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation [Axis]",
        "terseLabel": "Adjustment to Compensation:"
       }
      }
     },
     "auth_ref": [
      "r52"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]",
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote"
       }
      }
     },
     "auth_ref": [
      "r52"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]",
        "terseLabel": "Adjustment To PEO Compensation, Footnote"
       }
      }
     },
     "auth_ref": [
      "r52"
     ]
    },
    "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]",
        "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r86"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Amount",
        "terseLabel": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r10",
      "r21",
      "r31",
      "r64"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]",
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined"
       }
      }
     },
     "auth_ref": [
      "r13",
      "r24",
      "r34",
      "r67"
     ]
    },
    "ecd_AggtPnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtPnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Pension Adjustments Service Cost [Member]",
        "terseLabel": "Aggregate Pension Adjustments Service Cost"
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Adjustments to Compensation [Member]",
        "terseLabel": "All Adjustments to Compensation"
       }
      }
     },
     "auth_ref": [
      "r52"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Executive Categories [Member]",
        "terseLabel": "All Executive Categories"
       }
      }
     },
     "auth_ref": [
      "r59"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Individuals [Member]",
        "terseLabel": "All Individuals"
       }
      }
     },
     "auth_ref": [
      "r14",
      "r25",
      "r35",
      "r59",
      "r68",
      "r72",
      "r80"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Trading Arrangements [Member]",
        "terseLabel": "All Trading Arrangements"
       }
      }
     },
     "auth_ref": [
      "r78"
     ]
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://www.movano.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Description",
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.movano.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Exercise Price",
        "terseLabel": "Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Grant Date Fair Value",
        "terseLabel": "Fair Value as of Grant Date"
       }
      }
     },
     "auth_ref": [
      "r76"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]",
        "terseLabel": "Award Timing Disclosures"
       }
      }
     },
     "auth_ref": [
      "r71"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing, How MNPI Considered [Text Block]",
        "terseLabel": "Award Timing, How MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r71"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Method [Text Block]",
        "terseLabel": "Award Timing Method"
       }
      }
     },
     "auth_ref": [
      "r71"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Considered [Flag]",
        "terseLabel": "Award Timing MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r71"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Disclosure [Text Block]",
        "terseLabel": "Award Timing MNPI Disclosure"
       }
      }
     },
     "auth_ref": [
      "r71"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Predetermined [Flag]",
        "terseLabel": "Award Timing Predetermined"
       }
      }
     },
     "auth_ref": [
      "r71"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Underlying Securities Amount",
        "terseLabel": "Underlying Securities"
       }
      }
     },
     "auth_ref": [
      "r74"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r73"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures"
       }
      }
     },
     "auth_ref": [
      "r72"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table"
       }
      }
     },
     "auth_ref": [
      "r72"
     ]
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changed Peer Group, Footnote [Text Block]",
        "terseLabel": "Changed Peer Group, Footnote"
       }
      }
     },
     "auth_ref": [
      "r50"
     ]
    },
    "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]",
        "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year"
       }
      }
     },
     "auth_ref": [
      "r47"
     ]
    },
    "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]",
        "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested"
       }
      }
     },
     "auth_ref": [
      "r45"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.movano.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Amount",
        "terseLabel": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r51"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Name",
        "terseLabel": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r51"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure"
       }
      }
     },
     "auth_ref": [
      "r56"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Net Income [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Net Income"
       }
      }
     },
     "auth_ref": [
      "r55"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Other Measure"
       }
      }
     },
     "auth_ref": [
      "r57"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return"
       }
      }
     },
     "auth_ref": [
      "r54"
     ]
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://www.movano.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current Fiscal Year End Date",
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "move_DocumentAndEntityInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.movano.com/20251231",
     "localname": "DocumentAndEntityInformationAbstract",
     "auth_ref": []
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://www.movano.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Annual Report",
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r5",
      "r17"
     ]
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://www.movano.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Financial Statement Error Correction [Flag]",
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r5",
      "r17",
      "r60"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://www.movano.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Period Focus",
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://www.movano.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Year Focus",
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://www.movano.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentInformationTable",
     "presentation": [
      "http://www.movano.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.movano.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://www.movano.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Transition Report",
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r38"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://www.movano.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://www.movano.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Documents Incorporated by Reference [Text Block]",
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]",
        "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year"
       }
      }
     },
     "auth_ref": [
      "r49"
     ]
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee Stock Option [Member]",
        "terseLabel": "Employee Stock Option"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.movano.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://www.movano.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line Two",
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.movano.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.movano.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.movano.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.movano.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://www.movano.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Common Stock, Shares Outstanding",
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://www.movano.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Current Reporting Status",
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.movano.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://www.movano.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Ex Transition Period",
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r91"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.movano.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://www.movano.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Filer Category",
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.movano.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://www.movano.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Interactive Data Current",
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://www.movano.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Public Float",
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.movano.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://www.movano.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Shell Company",
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://www.movano.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Small Business",
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.movano.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://www.movano.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Voluntary Filers",
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://www.movano.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Well-known Seasoned Issuer",
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r90"
     ]
    },
    "ecd_EqtyAwrdsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Footnote [Text Block]",
        "terseLabel": "Equity Awards Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r43"
     ]
    },
    "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]",
        "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r85"
     ]
    },
    "ecd_EqtyAwrdsAdjsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsAdjsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments [Member]",
        "terseLabel": "Equity Awards Adjustments"
       }
      }
     },
     "auth_ref": [
      "r85"
     ]
    },
    "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]",
        "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r85"
     ]
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]",
        "terseLabel": "Equity Valuation Assumption Difference, Footnote"
       }
      }
     },
     "auth_ref": [
      "r53"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneous Compensation Analysis [Text Block]",
        "terseLabel": "Erroneous Compensation Analysis"
       }
      }
     },
     "auth_ref": [
      "r10",
      "r21",
      "r31",
      "r64"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneously Awarded Compensation Recovery [Table]",
        "terseLabel": "Erroneously Awarded Compensation Recovery"
       }
      }
     },
     "auth_ref": [
      "r7",
      "r18",
      "r28",
      "r61"
     ]
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Executive Category [Axis]",
        "terseLabel": "Executive Category:"
       }
      }
     },
     "auth_ref": [
      "r59"
     ]
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r14",
      "r25",
      "r35",
      "r68"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Expense of Enforcement, Amount",
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r14",
      "r25",
      "r35",
      "r68"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r14",
      "r25",
      "r35",
      "r68"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]",
        "terseLabel": "Forgone Recovery, Explanation of Impracticability"
       }
      }
     },
     "auth_ref": [
      "r14",
      "r25",
      "r35",
      "r68"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r14",
      "r25",
      "r35",
      "r68"
     ]
    },
    "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]",
        "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year"
       }
      }
     },
     "auth_ref": [
      "r48"
     ]
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://www.movano.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ICFR Auditor Attestation Flag",
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r4",
      "r5",
      "r17"
     ]
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Individual [Axis]",
        "terseLabel": "Individual:"
       }
      }
     },
     "auth_ref": [
      "r14",
      "r25",
      "r35",
      "r59",
      "r68",
      "r72",
      "r80"
     ]
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]",
        "terseLabel": "Insider Trading Arrangements:"
       }
      }
     },
     "auth_ref": [
      "r78"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]",
        "terseLabel": "Insider Trading Policies and Procedures:"
       }
      }
     },
     "auth_ref": [
      "r6",
      "r84"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Adopted [Flag]",
        "terseLabel": "Insider Trading Policies and Procedures Adopted"
       }
      }
     },
     "auth_ref": [
      "r6",
      "r84"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]",
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted"
       }
      }
     },
     "auth_ref": [
      "r6",
      "r84"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.movano.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure [Axis]",
        "terseLabel": "Measure:"
       }
      }
     },
     "auth_ref": [
      "r51"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r51"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]",
        "terseLabel": "MNPI Disclosure Timed for Compensation Value"
       }
      }
     },
     "auth_ref": [
      "r71"
     ]
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Terms of Trading Arrangement [Text Block]",
        "terseLabel": "Material Terms of Trading Arrangement"
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Named Executive Officers, Footnote [Text Block]",
        "terseLabel": "Named Executive Officers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r52"
     ]
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss)",
        "terseLabel": "Net Income (Loss)"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-GAAP Measure Description [Text Block]",
        "terseLabel": "Non-GAAP Measure Description"
       }
      }
     },
     "auth_ref": [
      "r51"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-NEOs [Member]",
        "terseLabel": "Non-NEOs"
       }
      }
     },
     "auth_ref": [
      "r14",
      "r25",
      "r35",
      "r59",
      "r68"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r42"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Total Compensation Amount",
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r41"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO [Member]",
        "terseLabel": "Non-PEO NEO"
       }
      }
     },
     "auth_ref": [
      "r59"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Performance Measure, Amount",
        "terseLabel": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r51"
     ]
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Aggregate Erroneous Compensation Amount",
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r12",
      "r23",
      "r33",
      "r66"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery Compensation Amount",
        "terseLabel": "Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r15",
      "r26",
      "r36",
      "r69"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r15",
      "r26",
      "r36",
      "r69"
     ]
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Issuers, Footnote [Text Block]",
        "terseLabel": "Peer Group Issuers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r50"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Total Shareholder Return Amount",
        "terseLabel": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r50"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Actually Paid Compensation Amount",
        "terseLabel": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r42"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO [Member]",
        "terseLabel": "PEO"
       }
      }
     },
     "auth_ref": [
      "r59"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Name",
        "terseLabel": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r52"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Total Compensation Amount",
        "terseLabel": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r41"
     ]
    },
    "ecd_PnsnAdjsPrrSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PnsnAdjsPrrSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Adjustments Prior Service Cost [Member]",
        "terseLabel": "Pension Adjustments Prior Service Cost"
       }
      }
     },
     "auth_ref": [
      "r43"
     ]
    },
    "ecd_PnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Adjustments Service Cost [Member]",
        "terseLabel": "Pension Adjustments Service Cost"
       }
      }
     },
     "auth_ref": [
      "r88"
     ]
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Benefits Adjustments, Footnote [Text Block]",
        "terseLabel": "Pension Benefits Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r42"
     ]
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Table]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance [Table Text Block]",
        "terseLabel": "Pay vs Performance Disclosure, Table"
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]",
        "terseLabel": "Recovery of Erroneously Awarded Compensation Disclosure"
       }
      }
     },
     "auth_ref": [
      "r7",
      "r18",
      "r28",
      "r61"
     ]
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date [Axis]",
        "terseLabel": "Restatement Determination Date:"
       }
      }
     },
     "auth_ref": [
      "r8",
      "r19",
      "r29",
      "r62"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date",
        "terseLabel": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r9",
      "r20",
      "r30",
      "r63"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Does Not Require Recovery [Text Block]",
        "terseLabel": "Restatement does not require Recovery"
       }
      }
     },
     "auth_ref": [
      "r16",
      "r27",
      "r37",
      "r70"
     ]
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.movano.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.movano.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Award Types",
        "terseLabel": "All Award Types"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Price or TSR Estimation Method [Text Block]",
        "terseLabel": "Stock Price or TSR Estimation Method"
       }
      }
     },
     "auth_ref": [
      "r11",
      "r22",
      "r32",
      "r65"
     ]
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "terseLabel": "Stock Appreciation Rights (SARs)"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tabular List [Table Text Block]",
        "terseLabel": "Tabular List, Table"
       }
      }
     },
     "auth_ref": [
      "r58"
     ]
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Amount",
        "terseLabel": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r50"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Vs Peer Group [Text Block]",
        "terseLabel": "Total Shareholder Return Vs Peer Group"
       }
      }
     },
     "auth_ref": [
      "r57"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement [Axis]",
        "terseLabel": "Trading Arrangement:"
       }
      }
     },
     "auth_ref": [
      "r78"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangements, by Individual [Table]",
        "terseLabel": "Trading Arrangements, by Individual"
       }
      }
     },
     "auth_ref": [
      "r80"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.movano.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Adoption Date",
        "terseLabel": "Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r81"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Duration",
        "terseLabel": "Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r82"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Expiration Date",
        "terseLabel": "Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r82"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r80"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Title",
        "terseLabel": "Title"
       }
      }
     },
     "auth_ref": [
      "r80"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Securities Aggregate Available Amount",
        "terseLabel": "Aggregate Available"
       }
      }
     },
     "auth_ref": [
      "r83"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Termination Date",
        "terseLabel": "Termination Date"
       }
      }
     },
     "auth_ref": [
      "r81"
     ]
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Security Market Price Change, Percent",
        "terseLabel": "Underlying Security Market Price Change"
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]",
        "terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year"
       }
      }
     },
     "auth_ref": [
      "r46"
     ]
    },
    "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]",
        "terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r20": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r21": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r22": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r23": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r24": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r25": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r26": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r27": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r28": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r29": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r30": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r31": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r32": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r33": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r34": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r35": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r36": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r37": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r38": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r39": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r40": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r41": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r42": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r43": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r44": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "i"
  },
  "r45": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r46": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iii"
  },
  "r47": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iv"
  },
  "r48": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "v"
  },
  "r49": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "vi"
  },
  "r50": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r51": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r52": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r53": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r54": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r55": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r56": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r57": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r58": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r59": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r60": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r61": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r62": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r63": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r64": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r65": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r66": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r67": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r68": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r69": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r70": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r71": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r72": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r73": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r74": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r75": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r76": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r77": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r78": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r79": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r80": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r81": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r82": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r83": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r84": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r85": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Number": "229",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1"
  },
  "r86": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "A",
   "Number": "229"
  },
  "r87": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Number": "229"
  },
  "r88": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "i",
   "Number": "229"
  },
  "r89": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r90": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r91": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0001213900-26-048135-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001213900-26-048135-xbrl.zip
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M*QYYHQUZ"P%X@_^^GZH!)FYTXP5O61V>>#,M/(4LYI/'?6 PEZG/]R]<X%/
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M@Q8/W;]*A@8B*(8N7YZPSY^/OP-M]X\T!C7_7G[H!:CVPX.UMA?L')T&0S0
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MSH>I.',' R!HD1*#6XS"75#Y*<@ P7[%%_$$S@'05:38%<.4%C>XMY'5PV#
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ME[81]!R7;T_-CR9A3-P&<.;?DR_#Y[@6N,C" &]%*EWP5TJ9D37V@R3E3^2
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M# *K AC".XJ-$"N4S66H!Z&'V^]J7FS%XFH1W9G<*=;D\H#)41VKNQ!K6KM
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M1&;VJ&E%AY.DE*H+":PN5@=/>\ M\ PA<058:Q]@MV!"K/:>("SM>EW9;FK
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M<@]4YT4NVF9WA?A>+Q"=.PM(S&$M-GK!6'?C$ ;!M-&T_X?L]9O?S D&76/
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M%AR-FW1PO_?T*<#8MOX:S\3,Y (LA)"Y+YEL-2A*">5;[#U= ,D<\#?*1>;
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M+\RB/,Q.$QA-'U(K$O_>DCNP$&XSRV2&,VG65K*#9$S8Q"=F(C-*-TQA6N1
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MG/K^/\61435_YJ3(M"KZ^WU/1-I:$9%JC@2_>9-^&L5952?5&W+,71^P+--
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M8^/' ]JN7GI/[/.E2E3#;1.QP%_(UA2/O>G<^[A"TYZ+X_)0F]%NN]T?YZ-
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M8%123\YT$Z3GG!6 !J(N$@4#@KC"36.:'$BUFY)=@53K&IM@F:9]H!$S.TO
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MAPI.E"UQJ,:*B/Z_'6AJ9Z! SB"S*L8"R(P-EN!1 X8L/-Y8FQ@]2S:L-(,
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M,4M%":88R5,1MD23Z3@D]F <DK5H'%*Y(N<2<4B5T+_&(;W&(<V.0Q)4+8!
MTI;1-KG4YM>(F^<6<7/067/$3761^6T.O<&*STZIC]^S"%IQJCW*WWW("I8S
M[FY#\N*LH*+M"A%9W>DOE\P7)[^QT3ZAATW';M=+6>=/D*!H'VYZ_Q<^EFL-
MLFQN=+_;[:;=/#Q\^OUNV]VNL_WY[!L-"7LIS'A= 2J9IO346MCW$1^E>PFA
MGW/_^.1<-A&I#(M"^P!\F%?_\?E<44I1^-?*FSI,*\?B$4\O:(,6[!Q9VB"S
M6<S#,6RF<>D[0NZ"'0HW$AUH/10=R+8U.G"M]GGE9F5D'I96O%[)BG<NRT"^
M+*-]J29#ARB@75EOU9+F_")JKM(^5G>F4 [#75JN! !HK7XV;^9_J%BK556L
ME>H4%RJP4KGE4L^DTMZ*<JK%6@Q920/^%S8W@J7_0#'JPG0>6/.J./S05%),
MC9&D:8!!F;TSZ8S,SEF!TOX]R\GM-JU2L0MJM#.35\RZ+1\91#R?*5AYIL!.
MW#FKM*7[0S@B[K%X:I3*,OQI0&9^H'IOR(,A!@^-75&16_:L$N$'^<@!X>H(
MB:X4**J#52*Z'"A_0[9)[5K;J'[Z @)K^D?8(&42>".XI?)'+,XU4M%QG\4Z
M^?"9]=ES^T!?R3T[#>(T<M?=:^5):PK\SD4\7,YEZ16P:/@KLU+-"]:N)1=E
M;/H\;>P<A]<HM3+ OEK8M!)#A6$HZ@F107 OYM(G.3>')>=0@N\H]7V,-H9U
M(DN<8JQ*(J/6/G(?N]UQ!O^8QZ^X5.R6_15['0!BB5-A8"'(2%' [S75C#AB
M^8]T>",69,$+KH_..!M=C++V@&BF)XKRRE9Y,&\:R;!FA#CC4%$9=<AQ!'=0
MU?REEQ7@+G,0<?+-9W 2*BR?A8BFB/S($U),FBA)1O0+T6Y4N'9N 0#9(GPN
MC,\M!*=_=!'ZWL"36W2!R!JFD6C=,J_#SKHR,C9\W,]S_5_<(=P8>.^PNPA/
M2C"O@\P4$7=/5(WD(WRV1#TF1J=YC(K.BMAEQN@Q@UV&(_( F\>NT)S'[%.!
M_G@O5A!0:D!<" 3,@FGS'F7LNR5PW*I3T>]+?I.*SDHR"FW_GZ)?IHQ/T[7T
M>X.DU%+#MBB+_^;_MW?ES6DCV_[_? H]SYNJY,88;6S)Q*]L;"=.O(VQDYFY
M=>N6@,9H+"2BQ8;Y].^<;DD($!B$! W6U%0*L[1Z^9W]]#F1"PZC+DW[02N(
M^4TWD +#,9S)09Q1PXI(3P[:=M0:=>6@M< Q-?&9]@1QPVZ<DYTYG%'?#9;Q
M,+'+25M28)V4L!'3F[%&3&P+)GH(P:I16!P!QW)I<!;A1O:%)C(A[%'L=BV'
M4&[,^INY$<&"ZAKN0!L9%YL MCL)&I6XFO-(=:(WM'$ U7G@$U@I><*LB Y,
M@8&SI=LMK^>X*-*=" ME\\"V*@8<&%.P4$LDOH0::WE$;YF8 FMK1(O>A_V,
MZ"+>T,LNK)]1,]+-B')S6$<OY+,&,1_<L6T*:XUY9G!0HY9'PS [Q!=P/O<>
M/])@]#?!5H7)'9&.3CM[EV2I%,M:GF(YG6)9SE,LUU-1;.%NE.54NU'.OMTT
M$I62>H I(R9*&0,$80M%"RW-29B8?]/P5<1=:D(9&I"!!+JEUPZI673C-4'W
M"+8"I=R9;O?H?JS%-@P\JFOFIW%ID+0/UTC[&[F!T"IZ Y:SP=J!H1G5\IT5
M( ?]#\ FN3UN7 H7%S>L'"C5"%"PH>N&_17:'Z$,M(0P>95= O'O8X$E8@RC
MMI#O;P/;IF!U"GVK]4@"[]J;T*X+K3 TC?"L;3_\X9#PV2RSUM1H9FYPE2&8
M%]5T@GL:U$ %-98\6/80E8-1L[?QV K=/@ZZ%FYQCF-,'MS+,A>(5*C[YS,9
MCH@9,#8M;N%<OH7JA2TR:P2\G\SX]G^GPBBKYC!RO6Z5K3NU96>3N) T-67O
MD%E!5';,2SA,LO61; 91E>)&6FU@:EW(L2-ED0\T2@=-G GD;W<A\.V,MGU&
MMM>&\SPKU?U2B9/B9$GF/X&0M29[)LDRNM,&OAJ7:7[1C&W94,&I1+/)@+YG
M\//I>1P9AM_Z.'I6<X>9"_OE"G_.V]WE1IJ__PMOQQ(7$U[+-F3+-R:GI.+&
MLNL6+TQ>37($\".A;8'-258\@5D#!<F&Y?)^J28ML(;D*.1Z Q9$X (;D&T%
MO#1-O#7:<2Q!+%[ED"LPP Q'3VI)WTRW#M6[>2(T@Z<S11_](L%]5_9'A\5I
M.\3!C R\L#KR>* [PO<L4/<*'<*/M6NFZ='KK7X%+'CT3T^S76Q:Z8=CX"V,
M@H09#YJ#K90QX!'$%MI!0 ZS6ZR6Q\)06,JK/<IJ:9S6#X0QQ3@6WSG<)N F
M;QQN8X;.-.S:'L;18 K4JS^*](]@T2/$I1?B(MZWN ;,\479:/RRHSMP*L*0
M:"RM< DH[4@<BM;:P6[B1T'$>U;>P=I+\6RT#A Z52>"P!.9"'Z0G];V\W."
M'%8_$(.Z(6"94SETQ/KY-),8C<:3^\R%KXU<^!W=[HTETHQ[GVDZ0Y!#]&;:
M/;T?3H(46/1[-)&)-3)O<MS"V\2@WO-V9!BLR,5*!+$:2;2R45?3;0Q)FV],
M @]WL(0/$C-2I][#Z0?1;\TOZG/$4A$"E_7X)&F G@W:@\/!==@$BPF-"![3
MJ:;F#.> TS'A<-\XK2Z &.6&SS/BESGVZ+%#C!X?C0H 203>\B@/P1,<E:T0
M%(EEZ6ZH?=9&8C$SYK!4P%L6\X#W=,"[D@>\-])"ZR4RFHB"5S*,@@?U$S ]
M\.CV3CC_OE:AN. .5->?!P":V^F@JS=U-#7\PDV T$:H[='4KX8O!]:;#9#(
M]EU\"F-FRYRH:.IVBMH?+.*Q9]]+T731-FFZ7( I$6>0^J4B601>=WP=Y0.O
MYL268T^M;@9[TL$&H1?'UH2W#@DO;\5^@?(]K]]G"?ZHC)]HKN:GFJ"6/.*B
M5?IE,#,L&\!+=7W_,E>35A^&UZ!PO#M8&ZAS_*:,7YDS_(XDLO!V]-(WZV+A
M3'._FU@RT KNS)"6YCDLMUPW.ZB:4D^/;Y,':5VC9/O@AB)P:<RD!HL/S&V*
M)TPE=P2G:SV;03(R6N'45&>I=#$S@A_!,-3VAW%=ZUU.'MM*'LHFR</77P5,
M[!P(;^]H^CQ3:2>Q'*H<VKC2<4N5#GH%P<"$T+!>XMC8:V3@6Z>5O%Q%8 8@
M0LLL-3P$FS0-R+4\9$VHW_0JPVRRRJPJA\U%>JVFN24TN7ND@]&IHM\Q4,"8
M\<H1+#+9@L9I'>2M08J3RXTD4+P4HH\YNEFY%C[/*"7/WXM?AL]YZ419[]U9
MQ_=2-LB,Q+1U,I[TMCD^O2ZSG3\A83&+?/L1Y6O@84B\C'E] ;Z% ?M\Z]>U
M]6 $Y9N]ILWV^4R^W_ @94V,!>]R4[X."M)+&Q])+^=[,\&\B-@NZ]C)VTAF
MS!P-A6E<+YKSJR>Z9V!?R ?2+['*\H+YZJ,I:4+7)IU/>UW7[3L?BL7GY^<#
MA[0.'JRGXI'=ZNI/Q"F2]H-F%]N:JQ6EBJ)62F)1%$5)EI2:*,HE2:Q42Y4B
MT42YK*K5LBB1@5R0_MNSGC33.NBZO;W#46$NFH!C:+3H!"O7%/3%TVC1AAD5
MP9KL_CVK74-;UOG''.E%=T$>M-8PK"F^+X#%<<!Z-=UU+3LHS=CPFO03%LZ;
MM7T+7MR98SE4"]\2G4[P>SCEE7X_T<)+9%NYTI!PZ@45!E$7S?J>04$+%" .
M,2H?R+^DB/)D("^+2KDLUBC(*U5%%AG(91_=/98C@TB[)30;KRTL#OGQ^H<O
M8#T.R?M"I(%,#!5D#O44O+Z2B.323\;04IP'P&WE:; #]1.ERIM>481H^U/>
MAFT3?0HR18[<1!DL,0VA+(E2I5*1@%])2E6I K-2)B3R'5:VH2N+Y5YUQ ,M
M$$4OX(]\=Y&F22.VQ/C+AHYE=QZR'C\DU4MV>H6\,8GT5\@D#"K&(&%V?;$1
M 1;K,<]0^4P3DS)7Q\2IX%+$DJC6JBBXJF)9*DT+KHADHNL#840E&%6U_2P+
M*MQRP<;-0W+!E@NVQ9[_U3.)(#/+2=GQM:8LUSBPS?@ZL:Q%7#()IXIEL22+
MU)4DUB1%$F.LLUS(;=]#<B&7"[E%A9PQ%'R'O+KC:]T1XXVO8^)5LM7$DJI2
MR295I5(NV7;D(;EDRR7;8L^_;KD6;6=6RH7;5EIP):Y.C$\Y5Q)K%5666<:+
M6*ZJ&Y=S![F@VR*N 8*N>+3C:WP]HJX:Y%7M]&IWQ(PK<W5,?(JWLJA(5;5,
MQ5M5%A69B3=U2JZE+=-8 MM^)#ESEV7-#C$'EKO'XQ+#[+G)7C.9\)3)M,%7
ML/S)5$<.=B)6!&UH>Z;%YBZD8%:X(G8^I6CLM8@%C,03VAE;8\TTL68LSI$X
M;$NF>EGG8G*+Q&3NX-S^%0:7:H31?9J=7N^.V'U5KHZ)3XDUP^Z3DHFJXUQ4
M;3'9YZ)J^U<X?JUPQQ>[>Y&X&E<GME4B2TXFLNJYR-IB#O :1!9?5XARD<63
MR-J4:26)7)W35@DJ)9F@.LD%U1;3_6L05'Q=!,H%%4^"B@/;2N++]M\JF55B
M,JM!6I8Y(]'C>&AHSTZ>CK_55,]O4L?N,H*L!-54?L9N+G8G+"J5,\<TIX5"
M)%%2RPHM%**4Y6J)#-2)Y(I&G[1@'JP(:#3WT"9]FV"39FQ_XG0U['$*LJIE
M]7JTF2X85+GLVFI&T"A(.Y]ASQN?R,S($E]%D2M%40IR22Y7I!VQLE3.O-5;
M),?D,3F&A>\#M^ ]&%OVLPUZB2W\T.Q<,&T9E;\.P<07X>>"B2O!M"FKBB^7
M-+?22"S+$I-&JB154!HI,Z51K///%TMX'^S&@Z=J#A'JS+2BL2I!=QR/=?U#
M"ZMO:"V_3/H#_NLW]QL97MC55:I\=(#6I*K0M_4GM.'"G_ESZ<"FF ^Y+-PB
MQ@*R<,=7R!O327^%9Z1I>]A_6<YEX78::7R5:-DBL:CR(Q9KN5C<'1[S&L0B
M7TPG%XO9BL6Q)MQ37;C#N]>S6VC'?7?Z6_]3* AG.C':'X0;8)H?8;H_/>PM
M_$&0I8_"=\WP<,9"H>#_D.X1^RW\,_Z, DAL^++<=X-^.F'7NS*^-]$)[WBR
M$UZRSCW3QQ0^G<Y'C)D.$W*1Q0?+_BC<#?NPXB-;:^JMC\*5UB-L:ZXLW 2I
M&OU5,?@9W1]Z33W8F5D[U;2)]EAHDHYEP\!]NN?1V99C9HL[.KTW)DA/S5AZ
MBWQM8:SCT=Z\R4?7BQLQPD(26/+0V7U]:N=8.VGUH!3+9R)]*9?KTA;MHIR=
MSE:.U]E\O6U1%0UT,6#JXE13M>4V(;*;+W]KB0T-^$9D?*I29#6X>E#.9G!)
M^35.DF;R*/'7<2FV-@_GY.XE;VY(T_0J99&V)@2H,XQ'FH2S$DL1.$_E./@O
M">:5 P4XGD\-#=*B TAR\!MXQ[-U5P>^=CH 2C&!EQZU7/Q8JBGJ_'Z#"^@F
M@U5^75SH$3R-N?0/U^YR4+'H2RHX7:DYD%A62YB1*E5D55&C.3^ZV4K&U5?&
M:LS7EQUBLE5L>AAC:2+9#/U5,REK5L)V+2MLP29:RZI8%X)'4,N3H/9!'.+Z
MB#J%PA:S03_9R1,)>\DVB?M,R*0/B76F!76RH[=\F7 '[SL=8B.)@"4WW'GJ
MD%\5=23F_K44"25I=P&Y5JVRZPBB(HDUIN=(<U7Z&YL4SCSJC0WDP$B)/^K;
MNN&7*=]QE&<F ]@>*D&U=PX@OIP P-NK? )[1A+8A%;S*M&<&<_F#\V)&;8D
M<0#L6E6M^/U@0+61?(X]GV7'(-M[@%EQ VU)+/R>(:?.C%4'I>O8SR1UG[W@
M!NK+,&Y)/$@3WZGE[@(VQM%]25^'^,;2UO'Q81K&O>Z9>M-S\&MX/>6)"#>&
M9@H8ZY75CPN!/PV$^UFJ*]%(PO,)!IA,L5QAJ-3\>@EY,>R%S -6)]WA@-7Y
M.@:S"*^9\_#H6<.Z[H'%*:!2;<]#+5OD!J"[*G"3'58PP%R']<:@NR1O36:L
MIHI70%994N1B1Q(?<1\I7I5)O\B5919.>WW#&A(20O=$MTG+M9@/@YB.1@%\
M8QEZ:QCPTK>DTT&O-H 5-(R.[L >"D.BV;2HZSM.](S,=.BI,TYQ;/_*,6/=
MJQ'3AK5HV*5DJE'VG'M&]IG/N<^!.0-3IO==*?,.V?;+_D"BP>G!&+KK"&V?
MDASVR8"T/$HR5@>&)O"V3TW!MFP/DU]-Y=T))E_B%-JE,6A?8PYCB.T+XL*>
M!>[NL!BW3 OQ8#F>E_%]J;>Z&C%@**W9VXQRO2IXDYW<+/ *?* W.8].*X*>
M-I KV0+YZP$H. _;B>!DP>2=8K\<Q--C42O-3Y+"S"? JTM&T?10NU@G E?C
M6NB?2,8V^,9@<B;*020\'H[C7-3WG86('/.A@4AO@^X+3T+K;RHZ'OB1*_3$
MP#Z9IR5H,(AM"=_A]YX-8-=LUP2-=U^XN*AO$Z>5<E:;:O Z55?QXAI"> ZL
MW:BTD()@=4T ,N+8M5P-T+R=CN35$+Q;GN14X]6I8KDZKC;HMA-)5XIV"67^
M.OH7P_@TIP[1'AS;EAAV*8 ]F1SF&>S+QO5X#>S)XJ81'EA\&PNMK(YO.1G_
MXAG?*S!S#N*"LJBHBB(CU,M2M5*.B6&'V [1?F4="!(BG86WYX2U.8EH3Z8C
MK3V>_=4SB2#+',5$EF7+:<8$D^83E<62++)$N9K$\HD61*N<HW4IM!JA9.(C
M.6@%)IMF""]I+V 9=H !MURKEN4E@*ODP%UB@!/2\MNS5H+VK!R =UE6FU9D
M;NQ*(.+-K]U?M^PG,MAG>$(2%TY_>KH[G(#/9F_QI8%'[H;8" /D(#Y6$A70
M,TN4 \H5J:0$B*Q.>L#TUBB1!RQYAP06$U/]68 LQEPZ)K:I&6 ?V7W+QE(X
M-YK]*)R?%TZIRY9^%TVJ9>XU;4$6SX2_(/5<^-H6LU$.(FPS<5];U)? 2&*<
M%/RK'KXUL9.DL-A]:SSEVNH,?;O(8 5)P$&0;Q9%3'C76'NAQ4DBN&W)#DK=
M29I8W=VV373!0=4H.:\:-5TUJI97C<JK1BTI=S9_>WRFV!GWP=QU=7L9J8->
M72F7.>,R)^/+YCSI8C-,DK \5BSGF2>9EZL=)LUZ0"I.2TFL5BK,:2DIU5JL
MT_+"TLP1O837#&AA$=OJZ8YC@5:&^8(365AE=HJ+A#U/GW0B?+$,9)9.;/Y5
MLMW[-4YTIE"-[87Q9]X?#D=/.J_93YQ1 &+E)TK*C)^&&<V2&D.NB?93$F<\
M:_.&5<)0]#K(55[4T8"4/)VG$)ZCDB:];L )F^6M_:E+HRF./9^0.)-[,^DC
MS42'=.E#6=CM\ *!I"K0=H] ,KMNRB>!K"!+.+A\'=OZ&XDE8B7-)8Z0@J*Q
M&]]0*B]-(HLGW6=,(QE6-<K^1G:P_5S0Q[("A(<DCG@!HDX*$"R,.YRVB;*T
M?W9/7*BYN%B0,M*\QITN98Q?Y#Z''3,,TG(]S0BIX\:V^K!#PZ"@]#"GEV3T
M$F]?[RR]+"L^TDR!24HD8J5:\HE$5:OE6'?:5 DFK]^W;'?)*[9;K05E7O\N
M2&SE \DK</XT\UO2!?7\NF(75NNQ<-]_3:!>@WN()U ORY[3S$M)%\DSFM\&
M[)G8V +C"/AT<]1GXQ7A>@U>'9YPO0*SYB $/@/BXP9LO7MZ-E+/ITI\+*)_
MU[N:W=9,H:[U=5<ST/OS2%QN-/%L*6(-ABM/%+%L8<G-EUN?10:EV600X)MR
M]UO]H0M@SBF"(],T#8I@7]^\I% XN/\^R_^OCMT?"NF#WB.:5W75OX<F1*JN
M3I1<+=.2JZL5=>*>$C*3#=OOX%<XN H_"_7^K;E158?9SGW-6236Y2?\T?<;
MQ.T*)Z3GD.$RMS6WF@XRDP@ITD%XQDDRLB.9Q9@*'*&I_N'F! O'@>5REB3V
M51L*=7OH@.;U:D@LOB<K7R2V*5'#04WO67106;*>]ZO!<^45X3DIBZ^EVA,G
M,;#+9;%&@5VI JXIL&L%*0@".SKV#;FS-8S.^N;!JO!-W$@WVZL0D^>1.FK]
MUI*KH98S_6899BY+O")>E@+$8V1 ;^L:#13XW;-3ZJW*)^RG#H5/V&^86<L*
MM]!5 NC6+=/!]$Y [>UQXU*XN+C9IZI('RL03;:+;P(G%XY:+=@<%UG[F6[W
M\*>1VD6; WP*3([13#_^XE$*V$YAB@Q4_124OXPG.DG'L5/>M""+/'Y-XDQ)
MM5%<NCQ!GN()Q]HC:G*Z80R%^\8^8P\=L%S@W>WD$IF*Q<G#S<5B' FH!PD[
M.RQFGNN#_VM;K4^)B:$@B8__;='P!]+#+]I_P7[?.[RQG@'T .,CU[5LDPR%
MM[K9,CRLTP?FN@,SU&@; 2QWL')SN9T6@W*&S<HYI)-EY(/"K;FCA.;.K6<0
M05+>:N\*D@K_%J72V[;_6JCCGH1.+""7&QO(1.]KAG :]I9C=1;LW90"*1"@
M(C,EC^,I3JMW7-!:0ID$9,>I6@9D)Z]&=F>ZJ<%+>(6!DHA>MG$J_,WI:V84
MB86.UM.-X8?Y6 S(%W^='8DDG1NCW4SGEGL&?9I-*]HY5D07*$[A3-"E<4R#
ME7GTCGU]A2$V(9_2BFA.8EWE6[JD7V!ZF[^^$<PNQ91E;NT7.?1YCZ'YQK,=
M3V,5#J2J<'_0.*@?X%U5^JFDE,1]S$<Y:EM]E[JW1E\/OE03RT'8IZ'93<TD
M3N%Z8) AT(/+&FJ*\K]R/>L5ZUD;MF]J%5[)LE89Y0W@9L$XA6/- 4H;RS&^
M)2T+MF@XGFR<DU2J<V,HR79NW'D>^+:  "_2P?E5X^4EPN_QY#[M21+2DJ&;
M1/CC^/9".#<=5\/RO2=6RZ.U?#+C072VC?J7%69[IPTLT^H-P8AR@?J1]ANM
M+NEIX?0/,MCA^M%%NG.N:T;+,QCONM#-QR:P-#H0_I?62EXXB)/3LW07=4(Z
MNJEGNZ:XT[DX.DYW(1=:$YN(^FM8UWG<W)ZFNXP;FV"@-F.439_( J;HV#+J
M*+II?7$!*\38&KL>= )Z MB/8'>^Q9"RYK+4[W !T=6C<=D"_JS!.VU!-V$7
MNGI3=X%=2^\B*_QMO*3\5/'NA#Q^1G7QZ<UZ9IL5;,E:"H//FL2+ISVSJ#&6
M'-+-Q)K$1X%^U]'_(6P]N"&^PK:8=C%2.U.;P:5F @"I_$,@(0@%RX;7OI:)
M-8S[V% -WM1L6S,?_/O]HQDO1D,14DEO]O_:X,Z=>;:I.UV@NRZQR;/N=CG9
ME%\VN"EW8.P[H)BT/0-^A^R),([DH&< 70&7Q'Z(M@46NAHPO2;>7K%Z.F5V
M_8@SX=PE/<8VRJ+TMOGNK?R._8FI>>3!5R;86XW"MP/VZ@@ W!^BCP%OP@3C
M!A/#>14!S_[4@&\8!LQ Z(0GZL_5+\VE^TLY';2Z2 !H@V%];Y0O7A_^L;$5
MA!-/%&.<ES.^N^YY+->#1,E[D$SU()'%O ?)[!XD.T5.H27>/&R<?[XZNKN_
M/06#MQE#19ELP)K9QMYAU(>,W!>YJFY3(>&PDD.!\QF4D3<T$!/ZET>,.F32
MOI-9JBGJOC]>6)FBJSE"&SO]MC0/G6IN5W?@<UIP#IX.L@ 3UU@*&\JN)NEJ
M1@=O6^) @ ABLR_LOW%1^GLF_(H.J'ENU[)!(K8/-GY.F^^W\W$I=7N^R22G
MJ:=$^\"NHK9-6 AE>:%^#LIBWRK]FB!4E8E*>8+WCS\$W1<K@8]Q6LU,\9G'
MPP_S%-D)8=Z,$>:I3:7H%(6OH/4]8&?@%73\!4.7*<X\F'73+AZ^J7=UTHF$
MIH-8-/WP[>+!ZW>;5737+IB64UO5C\(UK8;G?! N-,?-=== =Y62Z*X;4O]F
M@RQR=&W=Z1O:$'5A$\T;??"A2S0X)R  ?*VWV\1DK^$;5UX/GMZB?A9XX"V&
M#5L@D$W8)QB+Z!].@<S<89V@'\; BR2#;V2X)^CM3WOZX*F@JM4JAE5$/XKX
M6W%LX"4>%#8P.#.TA[$'U/8.7=LCR8<._*MGM,K1#7S;:I_!>T[T,35Q[_#L
MS^F'%"=VS28=T*X ),[A;X9N/GYP:- #'BL,Z-\L^-JSGD@!RV!)LB(=#)SV
MGO^Q"X#\M.?HO;Y!]HJ'=/S(F/XS',NSX4]AT#-,9RR4.VC:QH%E/Q1E452*
MNA\R@I/&#_0/_BX$/V0KA.V@_)!]A= C]1'-WM+Q;I#>T8E-/1*X<3'1X_KY
MM_&SGOPQ8[J33_&?T:?[/O98F+OMHB _Q)TJB!+\'_Q^]%GT%X"1T?<EN:!(
MH^>U@V\';P5/#/[V]V;^5DE\;A4[:-??J')!&8WI?[+JPN7-+9QRU'__N/Q>
M^<^_[\^??GYVY0?W[H=]=^J5O"<XUM^]SNUCY\GYN_KU\]V7XQ\_'._ONG?M
MGM_]]?WZSON]>*Q6]:.Z=?;/X/W/XDWQ_O<OY][=\^5I\?+;\,?EX]^/GSOG
MQ<;S4+IWWBO>]U[C^HQ8^K>!_?[];562+XXK/^J#RO?Z8^/[7[>>>7O[_B]=
M*;M77V][?Y1^]W33>+3?5\26_<\/\[Y(VN\'-WKCZIX8_W1;;>OS'^7FC7MR
M*O:M9^OYZO)/Y_SL^?>;+^7SLV^7C9N3/QX'/R[/!HWJEWKO_.FR0JQF_UOK
MJT/T)ZVHM/ZZ^O.'^W!W?B&=&)UOY6^GUS=MYUE]JBGESP]/+E&_*F>BX6E6
MA?QS]MD@]:^W3F/XW;W[8LC%\NW)#\^QCXZ/?QBWO7OI6['TV5.^7']Y7_G[
MM-EZ?WU^1WIZ17]_8W:].UOZ>=8ZUBME4OO2;3_7KHP[^>ZZ>'57<YROL+CS
MR_NC3Y_^(]0;MR#4%D5DN2"J!7D%1'JF/@%'#SAFY/D]HCF>30YUQU)EJ?+A
MOG$2#!5\%(Z-@\T>V.EJP%[CQO;Y#OW\A<&+42;-_@RE+!/)_K]-JXWX+G;=
MGG'X_U!+ P04    " #GDYM<693X3$5?   )6@( %@   &5A,#(X-S8P,# Q
M97@Q,"TQ-2YH=&WM?6MSVTBRY7=&\#]@._;>("-@M^5'O]S7$6I;?<=Q/6VO
MK9X;\Q$D00EMD.  H&3-K]]\5556H4!2MFG)%C=V=]HB'H6JK*Q\G#SYZ]].
M__[JV7#PZ]].CE_ _R;X?WX]?7GZZN39K]_S_\*OW\O/O_[V^L4_DW>G_WQU
M\E_?S:ME^TMR]&#5)J?%(F^2/_++Y&VUR)8I_R%-WN5U,?\.;H1;WYC[VOQ#
M>R\KB[/E+TE=G)VW3Y-%5I\5\,\'WSW[];=G)Q_.BTG1PJ/O'SWY]?O?8"1O
M-CQCFB_;O#8/N==6*WB0_>>D:MMJ08_^S^6D63WM/FS7#PE>L6J[+\&_=<=&
M7_4_K_Y\=_HV35[^\?Q^_*.^P#AN=@H>/GCX.#GY?W^^//TG3L/)'Z<O_W&2
MO'EU_,<=G9#C%Z_?G)Z\2'[[9W+ZMY/DM]?';U\DKW]/7KQ\>_+\]/7;=[\,
M!W]4%_EBDM?)DS3!"?SUM[>X48_?O'G[^A_NWG>GKY__S]]>OWIQ G<E/3>=
MGKS]^\L_CD]?OOXC>7%\>J(N?(P7/GI\6Q;B]/BW5R?)\Y-7K]X<OWCQ\H__
M_J_O'GQ'_W[WYOBY^??_OGQQ^K?_^N[HP8/_^&XO8X55.GUKGGR1UVTQS4HS
M=+@1==NOIR_,%9?%K#UG-?;]Z8MGW5\>/;G_\Q-Z[&_/CD0-^!?JN2GS.5_Z
MW_DRK[,2K[_/-WQ_^A;_/YRE8*UV6H'==??GVB#T8O?_?"'X:]VTQ?Q*_E@L
M9SD^_,'])\62OG^4C7_]_?4?I_KE]^;9HBBO?MGV>KJV*?Z=\VB_>Y;@@89/
M>W8";R\F99Z\:ZOI^^3X,JMGR=M\6JP*&$!#TYV<+%9E=97C$U\4=3YMJ[I)
MLN4L>5XMFW799G!EDM5YDINGM54"U^7%A??@YOY-3N+M6,;)7I;Q^"(KRBQ8
M1UF]T_,\>5-FRV155Q?%#-XPK^JDA;^>U;!R236G?\RKLJPNB^59TEZMX"+X
MLW[6+\FH&"<OEZBLW+*^7K4%R$ Z'(P*^/D/^.\V:]<@(%?!%7 [7B&/7*U
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M$*\0@1\?;2P0@0L>PP/#TA#X\Y,Q0P@DJS'Z82P6(^+:R%XDQ- L%[R2=:Y
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ML#3SG!#1DXRC=?#&.G>%+"Y(0]@M V,T04X8*#+#89G5(L\Q_H1T +!0R.C
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MBSEQ.G)Q>,Z^$H<AD8G?C$)?0]/BW6/GA\.7Q*,5CYJ[2"7\2<?'J=&!Z93
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M)PM_1B524IB&_W>!:D 74N=D(E*75ZO[G*74-2]'_-[AP$!%PD'0IQ^_Y4C
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MN@8G,S/"VHZ0#*X4"SX+"ITLD'\3Z>,L?:!*+=D(\*RXJ(@4J38%)AP%0I0
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M=CQR%Y#<67^%%J-P9UB237F=(MM3O=']ODH!84;CQ/[.%L'M/90!Y_'K"8S
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MQ!7,DJI;42X,[.A&,1);- Q["BB8::=29V2..JS'A'5=HUN=&4C<S/B*G7;
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M0.&B<'92*LKL,HDQ4:&EA\9GA=8*N7-A(#VX$99IFBW1:X[<JW.%@;6RHB"
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M5:LV#UO^J8(Y>PNW':=[T/NZ<#=M2*51DR_/+! E:D@' JY)9@?1 Y2YED:
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MYK)]Q,&65;.N\^#D4'MM.<=SNT5IT*2 >(8AD3>>/G"2-;8_5*^(G=55 ^.
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M1?66D'VD>2,QC.1J8[* $,PPHOL"V7U,8$'7.3@&9G\HODKA@W,C2AU8GB/
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M+5L[YBMUM@=YQ&PC(X3&'O@;56K?ADT^PWX-&98W;-B=E^0.%VQ'_%2RF3M
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MIOI[L,(F.5E52+V-,0U>?^HW8H(6: &2V4ADBO@G!%"9^]DF1R1KIE=I.-@
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MRJF&:4F&3 8PU6/3_;")9,ERTY?H%XB5(/_+^6(Y\E&N4,SM%K8GIK+U]0,
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MYP[PY! K3[1[D@F_?O@_4$L#!!0    ( .>3FUSUY>C@3P<  )9%   5
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M^AM02P$"% ,4    " #GDYM<M$1_N6&(  "<B00 &@              @ $
M    96$P,C@W-C P+3$P:V$Q7V-O<G9E>"YH=&U02P$"% ,4    " #GDYM<
M693X3$5?   )6@( %@              @ &9B   96$P,C@W-C P,#%E>#$P
M+3$U+FAT;5!+ 0(4 Q0    ( .>3FURK;ETJ<@,  #,0   5
M  "  1+H  !E83 R.#<V,# P,65X,S$M,RYH=&U02P$"% ,4    " #GDYM<
MB)*UDUH#   %$   %0              @ &WZP  96$P,C@W-C P,#%E>#,Q
M+30N:'1M4$L! A0#%     @ YY.;7"TPSW=&$@  CF   !0
M ( !1.\  &5A,#(X-S8P,# Q97@T+38N:'1M4$L! A0#%     @ YY.;7"@
MV4>1!   $ T  !$              ( !O $! &UO=F4M,C R-3$R,S$N>'-D
M4$L! A0#%     @ YY.;7';A&J(1"P  *H<  !4              ( !? 8!
M &UO=F4M,C R-3$R,S%?;&%B+GAM;%!+ 0(4 Q0    ( .>3FUSUY>C@3P<
M )9%   5              "  < 1 0!M;W9E+3(P,C4Q,C,Q7W!R92YX;6Q0
52P4&      @ "  9 @  0AD!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>ea0287600-10ka1_corvex_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="move-20251231.xsd" xlink:type="simple"/>
    <context id="c0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001734750</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001734750</identifier>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001734750</identifier>
        </entity>
        <period>
            <instant>2026-04-20</instant>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <dei:DocumentType contextRef="c0" id="ixv-4459">10-K/A</dei:DocumentType>
    <dei:DocumentAnnualReport contextRef="c0" id="ixv-4460">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="c0" id="ixv-4461">2025-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate contextRef="c0" id="ixv-4462">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus contextRef="c0" id="ixv-4463">2025</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport contextRef="c0" id="ixv-4464">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="c0" id="ixv-53">001-40254</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="c0" id="ixv-59">CORVEX, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c0" id="ixv-70">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="c0" id="ixv-4465">82-4233771</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c0" id="ixv-4466">3401 North Fairfax Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="c0" id="ixv-4467">Suite 3230</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="c0" id="ixv-4468">Arlington</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c0" id="ixv-4469">VA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c0" id="ixv-4470">22226</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c0" id="ixv-4471">(866)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c0" id="ixv-4472">438-4787</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="c0" id="ixv-120">Common Stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c0" id="ixv-124">MOVE</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c0" id="ixv-4473">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer contextRef="c0" id="ixv-4474">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="c0" id="ixv-4475">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="c0" id="ixv-4476">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="c0" id="ixv-4477">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="c0" id="ixv-166">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="c0" id="ixv-173">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="c0" id="ixv-180">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="c0" id="ixv-4478">false</dei:EntityExTransitionPeriod>
    <dei:IcfrAuditorAttestationFlag contextRef="c0" id="ixv-4479">false</dei:IcfrAuditorAttestationFlag>
    <dei:DocumentFinStmtErrorCorrectionFlag contextRef="c0" id="ixv-4480">false</dei:DocumentFinStmtErrorCorrectionFlag>
    <dei:EntityShellCompany contextRef="c0" id="ixv-4481">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat contextRef="c1" decimals="0" id="ixv-4482" unitRef="usd">5309169</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="c2"
      decimals="INF"
      id="ixv-4483"
      unitRef="shares">1981462</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock contextRef="c0" id="ixv-4484">None</dei:DocumentsIncorporatedByReferenceTextBlock>
    <dei:AmendmentDescription contextRef="c0" id="ixv-248">This Amendment No. 1 on Form 10-K/A (this &#x201c;Amendment
No. 1&#x201d;) amends Corvex, Inc.&#x2019;s Annual Report on Form 10-K for the fiscal year ended December 31, 2025 (the &#x201c;2025 Annual
Report&#x201d;), originally filed with the U.S. Securities and Exchange Commission (the &#x201c;SEC&#x201d;) on March 31, 2026. As used in
this Amendment No. 1, unless otherwise stated or the context otherwise requires, the terms &#x201c;Corvex,&#x201d; &#x201c;we,&#x201d; &#x201c;us,&#x201d;
&#x201c;our&#x201d; and the &#x201c;Company&#x201d; refer to Corvex, Inc. and its wholly-owned subsidiaries.We are filing this Amendment No. 1 pursuant to
General Instruction G(3) of Form 10-K, as we do not intend to file a definitive proxy statement for the 2026 annual meeting of stockholders
(the &#x201c;Annual Meeting&#x201d;) within 120 days of the end of our fiscal year ended December 31, 2025. Accordingly, this Amendment
is being filed solely to:

    &#160;
    &#x25cf;
    amend and restate Part III, Items 10 (Directors, Executive Officers and Corporate Governance), 11 (Executive Compensation), 12 (Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters), 13 (Certain Relationships and Related Transactions, and Director Independence) and 14 (Principal Accountant Fees and Services) of the 2025 Annual Report, in their entirety as set forth herein;


    &#160;
    &#x25cf;
    amend the reference on the cover page of our 2025 Annual Report to reflect that no documents will be incorporated by reference into our 2025 Annual Report; and


    &#160;
    &#x25cf;
    file new certifications of our principal executive officer and principal financial officer pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934, as amended, a copy of the Company&#x2019;s 2024 Equity Incentive Plan, and a new description of our common stock as exhibits to this Amendment No. 1 under Item 15 of Part IV hereof.
  Because no financial statements have been included
in this Amendment No. 1, and because this Amendment No. 1 does not contain or amend any disclosure with respect to paragraphs 3, 4 and
5 of Items 307 and 308 of Regulation S-K, the corresponding certifications have been omitted. We are not including the certifications
under Section 906 of the Sarbanes-Oxley Act of 2002 as no financial statements are being filed with this Amendment No. 1.Except as set forth above, no other Items of our
2025 Annual Report have been amended or revised in this Amendment No. 1, and all such other Items shall be as set forth in such 2025 Annual
Report. Accordingly, this Amendment No. 1 should be read in conjunction with the 2025 Annual Report and our other filings with the SEC.
Certain capitalized terms used and not otherwise defined in this Amendment No. 1 have the meanings given to them in the 2025 Annual Report.</dei:AmendmentDescription>
    <ecd:InsiderTrdPoliciesProcAdoptedFlag contextRef="c0" id="ixv-4485">true</ecd:InsiderTrdPoliciesProcAdoptedFlag>
    <dei:EntityCentralIndexKey contextRef="c0" id="ixv-4488">0001734750</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c0" id="ixv-4489">true</dei:AmendmentFlag>
    <dei:DocumentFiscalPeriodFocus contextRef="c0" id="ixv-4490">FY</dei:DocumentFiscalPeriodFocus>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
